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Despite the major welfare and economic burdens of bovine respiratory disease 
worldwide, Pasteurellaceae carriage in cattle has been relatively unexplored. To address 
this, molecular techniques and epidemiological studies were employed to investigate 
upper respiratory tract carriage of three important respiratory pathobionts, 
Histophilus somni, Mannheimia haemolytica and Pasteurella multocida, in cattle in an 
experimental beef production setting. 
Real-time PCR assays were optimised and validated to detect and quantify these three 
bacterial species. These assays were deployed to investigate pathobiont carriage in a 
longitudinal study of weaned cattle (n=90) during 2015-2016 winter housing. A separate 
cohort (n=30) was followed from birth in spring 2016 to just after weaning in November 
2016. Carriage was shown to be highly dynamic; different organisms predominated as 
calves aged, and during housing, carriage patterns were distinct among pathobiont 
species. Interval-censored exponential survival models estimated the median duration of 
H. somni and P. multocida carriage at 14.8 (CI95%: 10.6–20.9) and 55.5 (CI95%: 43.3–
71.3) days respectively; higher density P. multocida carriage was associated with slower 
clearance (p = 0.036). 
A double-blind cluster randomised controlled trial was conducted in housed cattle (n=87) 
over winter 2016-2017 to investigate the effect of bovine respiratory syncytial virus and 
parainfluenza-3 virus on respiratory bacterial carriage. Viral infection used a bivalent 
intranasal live-attenuated vaccine following a stepped wedge design. Mixed effect 
models showed that the M. haemolytica carriage rate declined significantly following 
respiratory viral infection (odds ratio: 0.48; CI95%: 0.27–0.85). Carriage of H. somni and 
P. multocida, declined similarly although these trends were not statistically significant. 
There were no consistent effects of viral infection on pathobiont carriage density. 
This research showed that improved molecular techniques can provide valuable novel 
insights into the carriage and biology of Pasteurellaceae and lays the foundation for 
further detailed investigations and modelling studies into the epidemiology of bovine 
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Chapter 1 Introduction  
 
1.1 Cattle production and its importance 
Livestock are a key component of global agriculture, providing meat, milk, draught 
power, manure and acting as an important source of income, investment and insurance 
for rural and poor families [1]. In 2013, the worldwide cattle population was estimated 
at 1.5 billion animals. The Americas, closely followed by Asia and Africa have the largest 
populations, with Europe contributing 10.6% of the total [2]. Amongst these continents 
distinct and dynamic farming systems exist, such as, smallholder, pastoralist, extensive 
commercial and intensive commercial. As our global population continues to increase, 
farming dynamics become increasingly unstable. Intensive systems in northern, 
temperate climates often depend on permanent housing, high-stocking densities and 
mainly cereal-based diets; conditions exacerbating disease transmission, with associated 
costs to animal and public health, and environmental preservation [3]. 
 
1.2 Beef production and bovine respiratory disease 
Bovine respiratory disease (BRD) is a global problem causing severe economic losses to 
the cattle farming industry and is a major welfare concern. It is the single most important 
disease syndrome affecting the beef industry; with high mortality and morbidity rates, 
particularly within ‘feedlot’ systems. Beef feedlots refer to the finishing (fattening) of 
vast numbers of cattle on grains and concentrates; commonly, feedlots are located in the 
grain producing regions of the United States and Canada [4]. In the 1970s feedlots had a 
one-time capacity of 1000 head or more, operations have since become more specialised 
and numbers have increased (>32,000 head capacity in 2002) [5]. Typically, beef feedlots 
are stocked with mainly steer calves purchased from either ‘cow-calf’ or dairy operations 
[4] [6]. Cow-calf operations rely on beef cows to raise calves at pasture until weaning, 
when they are sold [4]. Calves from multiple sources are transported to ‘order-buyer’ 
barns where they are auctioned and then transported to feedlots [7]. The travel to feedlots 
is often long, with reports of up to 3,500 km in Canada [6]. Travel is commonly by truck 
[6] [8] or even train [9]. On arrival to the feedlot animals from these multiple sources 
have comingled [10], and having had opportunities to exchange pathogens disease is 
commonly seen within days of arrival [11]. 
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In the UK, beef production occurs on a smaller scale with the average herd size in 2015 
at 88 [12]. Typically, beef production is seasonal and the majority of calvings occur 
between March to May [13]. Calves suckle with their dams during spring and summer, 
then at the start of winter are weaned and housed, the following spring they are turned 
out for grazing: farms commonly operate as closed herds. Dairy bull calves may also be 
raised for beef and in these circumstances mixing of bull calves from multiple farms can 
occur [14]. During winter housing either conserved forage, concentrates, or a 
combination of feeds are fed, but there is growing interest in raising animals from 
pasture-based diets as a step towards sustainable agriculture [15].   
 
BRD is estimated to cost the UK cattle industry £80 million per annum [16]. However, 
this cost was estimated approximately 20 years ago and is barely reflective of costs 
incurred today, yet despite the impact of the disease a more recent analysis has not been 
carried out. Total costs can be assessed in terms of: prevention and treatment with 
vaccines and medicines; veterinary professional fees and medical costs; increased 
husbandry; mortality (replacement costs); decreased production efficiency and reduced 
live-weight gain [17]. 
 
The clinical syndromes defining BRD complex include beef cattle pneumonia and 
enzootic (calf) pneumonia. Pneumonic pasteurellosis and shipping fever (or 
undifferentiated shipping fever) are also terms used, and relate to the diseases’ 
multifactorial aetiology, namely bacteria and viruses in combination with predisposing 
stress factors and management [18] [19]. Shipment or transport of cattle in North 
American feedlot operations often results in occurrence of respiratory disease shortly 
after transport. This has been termed shipping fever and can involve large numbers of 
animals, with disease usually occurring 7 to 10 days after transport [20]. The major cause 
of death is pneumonic pasteurellosis, an acute fibrinous pneumonia. In young calves 
suffering with BRD, commonly <6 months of age, suppurative bronchopneumonia is the 
most common pneumonia seen, largely associated with the bacterium 
Pasteurella multocida [18]. 
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1.3 Aetiological agents and predisposition to disease occurrence  
A number of viruses are associated with respiratory disease in calves and are ubiquitous 
in the cattle population: bovine respiratory syncytial virus (BRSV); bovine parainfluenza 
virus-3 (BPIV-3); bovine herpesvirus-1 (BHV-1); bovine viral diarrhoea virus (BVDV); 
bovine corona virus (BCV) and bovine adenovirus (BAV) [21]. Infection with viruses is 
usually transient and less frequent compared with carriage of the main commensal 
bacteria. Infection with respiratory viruses alone are generally not fatal, except some 
instances of BRSV. Rather, viral infection alters the respiratory environment to allow for 
colonisation and proliferation of opportunistic bacterial pathogens frequently implicated 
in BRD [19].  
 
Several consequences of viral infection could affect bacterial carriage either through 
evasion of adaptive and modification of innate immune responses, or physiological 
disruption to respiratory mucosa. For example, BPIV-3 can inhibit the bactericidal 
function of alveolar macrophages and enhance secondary bacterial infections through 
impaired phagocytosis and antigen presentation [22]. Disruption to epithelium through 
viral infection can also compromise mucociliary responses, in turn favouring bacterial 
colonisation and migration to the lower respiratory tract [17] [19]. Under healthy 
respiratory conditions these bacterial organisms reside as common commensals of the 
nasopharynx [19] [20] but at what density they colonise has been rarely explored, 
therefore they could exist at lower densities in the healthy nasopharynx but higher in 
animals suffering respiratory virus infection. Members of the Pasteurellaceae most 
frequently implicated in BRD include: Pasteurella multocida, Mannheimia haemolytica, 
Histophilus somni, and Bibersteinia trehalosi [19] [23] [24]. Mycoplasma bovis, 
Mycoplasma dispar, Arcanobacterium pyogenes, Ureaplasma spp., Fusobacterium spp., 
and Chlamydia spp. have also been associated with BRD [19] [21].  
 
1.4 Epidemiology of bovine respiratory disease 
1.4.1 Risk factors 
Reducing the risk of BRD may be achieved through good management practices that 
decrease stress. Various predisposing risk factors have been identified for BRD, 
including: transport, housing (ventilation, dust particles and humidity), diet change, 
increased stocking densities, surgical procedures, sex, breed and genetics [23]. 
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Transportation is considered as one of the most important risk factors, where longer 
transport distances have been found to be associated with increased morbidity incidence 
[25], and it is likely stress may increase as transport time increases. Transportation has 
been shown to activate the hypothalamic-pituitary-adrenal axis, resulting in increased 
plasma glucocorticoid and altered immune function [26]. Taylor et al. confirmed the role 
of M. haemolytica in BRD associated with transportation by isolating increased densities 
of M. haemolytica in calves after shipment; in addition the nasopharyngeal presence of 
M. haemolytica was more common in calves suffering with BRD, implying that this 
bacterium has a role within the disease complex [27].  
 
Mixing of cattle from multiple sources increases stress due to establishing social 
hierarchy and can provide exposure of naïve to infected individuals, subsequently 
initiating a disease outbreak. Youngstock may be more predisposed to stress from 
transport and weaning, and have less immunity to common pathogens compared to older 
cattle, hence their association with increased morbidity at feedlot entry [28]. As a result 
of the syndesmochorial character of the ruminant placenta prepartum transfer of 
immunoglobulins from cow to calf in utero is prevented [29]. Colostrum which is rich in 
IgG, particularly IgG1, is essential during the first 24 hours of life in order to acquire 
passive immunity [29]. Therefore, failure of passive transfer in bovine neonates can 
compromise a calves ability to mount adaptive immune responses, where inadequate 
levels of maternal IgG and other immunoglobulins can increase risk of respiratory 
infection [30]. Interestingly, a greater incidence of BRD has been reported in male calves 
than in female calves during both pre-weaning and feedlot periods [28]. Figure 1.1 




Figure 1.1: Schematic illustrating important stressors of feedlot cattle. Figure unedited from Aich et al. 
[31] 
 
1.4.2 Seasonality of respiratory disease  
BRD is usually seasonal with the highest deaths occurring in autumn and winter, 
particularly within feedlot systems [32]. Cyclical variation of M. haemolytica has also 
been observed in sheep; with the first peak occurring in late autumn, and the second in 
late spring to early summer, with this high carrier rate coinciding with enzootic 
pneumonia. Furthermore, disease attributable B. trehalosi in sheep generally occurs from 
August to November [33]. Submissions for necropsy examinations from 297 bovine 
carcasses with naturally occurring disease caused by H. somni between 1970–1990 in 
Saskatchewan, Canada demonstrated a strong seasonality: disease occurred frequently 
between late October to January [34]. However, this study, conducted some time ago 
only reflects a small number of the cattle population in Canada and gave no details on 
the farms where cattle came from. 
 
1.5 Clinical signs  
Clinical signs include increased respiratory rate and body temperature, the presence and 
character of nasal discharge (varies from serous to mucopurulent), coughing and/or 
increased respiratory sounds [21]. Lethargy, depression, ear/head tilt and reduced food 
intake may also be present [35]. Observations for signs of respiratory disease may be 
quantified to give a clinical score, for example using the Wisconsin scoring system for 
calf respiratory health (Figure 1.2) or the DART score (Depression, Appetite, Respiration 




Figure 1.2: Scoring system for calf respiratory health designed by researchers at the University of 
Wisconsin at Madison. Figure unedited [36]. 
 
Often, there will be no clinical signs i.e. subclinical. In these instances, decreased average 
daily gain (poor growth) can be observed and may act as a clue to subclinical infection. 
One study reported South African feedlot calves treated for BRD had increased growth 
compared to those with subclinical BRD [38], suggesting that treatment was effective 
and that animals suffering with BRD may have decreased growth rates. This observation 
is strengthened by that of Griffin et al. who also reported the average daily gain of feedlot 
cattle which received treatment for BRD to be increased compared to those that did not 
receive treatment [39]. These observations are further supported by reports of decreased 
average daily gain associated with lung lesions at slaughter in cattle [40] [41]. 
 
 
1.6 Diagnosis  
Clinical diagnosis can be made without any attempt to identify the aetiological agents 




Calf Health Scoring Criteria 
0 1 2 3 
Rectal temperature 
100-100.9 101-101.9 102-102.9 ≥103 
Cough 
None Induce single cough Induced repeated 







Small amount of 
unilateral cloudy 
discharge 






          
Eye scores 
Normal Small amount of 
ocular discharge 




             
Ear scores 
Normal Ear flick or head 
shake 
Slight unilateral droop Head tilt or bilateral 
droop 
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introduced above) are used. However, often a combination of clinical signs and 
diagnostic laboratory testing is used. If animals have not received anthelminthic 
treatment, then lungworm may be involved, providing treatment is effective/no 
resistance. A faecal sample can be collected to confirm lungworm infection through 
detecting larvae using the Baermann technique [42], or exposure can be confirmed using 
serology, which is useful for herd diagnosis [43].   
 
Bacterial and/or viral agents can be detected from samples collected from live animals: 
nasal or nasopharyngeal swabs, transtracheal wash or bronchoalveolar lavage (BAL). 
Bacterial culture or virus isolation from collected specimens can be used to detect viable 
bacteria and viruses respectively. Ideally, cultured bacterial species should be tested for 
susceptibility to antimicrobials to inform treatment practices [44]. If respiratory bacteria 
known to be involved in BRD are cultured it does not immediately imply they are of 
disease significance given carriage in healthy animals [45]. However, both of these 
culture-based techniques require skilled personnel, can take several days to weeks, and 
for virus isolation, may require specific cell lines not readily available [46]. Alternatively, 
bacterial or viral nucleic acid can be detected rapidly using PCR, often with increased 
specificity to culture. Multiplex PCR formats exist which allow simultaneous detection 
of multiple viruses and/or bacteria in the same assay, increasing throughput even further 
than conventional PCR [47] [48]. However, PCR does not give evidence for an active 
infection by detecting the presence of viable organisms, rather a recent footprint of 
colonisation/infection.  
 
Serology can be performed on paired blood samples to detect evidence of rising titres to 
viruses, or less commonly, bacteria using either virus neutralisation tests or enzyme-
linked immunosorbent assay (ELISA) [46]. The disadvantage to this approach is that two 
samples are collected, usually 2–3 weeks apart, increasing the time to result. In addition, 
an increase in antibody titre (seroconversion) does not necessarily indicate clinical 
disease when viral infections are suspected to be common [45], nor does seroconversion 
discriminate between vaccinal or natural exposure [46]. Furthermore, maternal antibody 
may be involved in animals under 6 months [49]. Serological results can be relevant to 




Diagnosis can also be made at post-mortem following gross and histopathologic 
examination. In addition, samples can be collected from affected tissues for laboratory 
diagnosis [45]. In conclusion, a combination of clinical, pathologic and microbiologic 
approaches can be used to diagnose cases of BRD. 
 
1.7 Control of bovine respiratory disease 
Control of BRD is through improving environmental and management conditions, and 
prevention of viral and secondary bacterial infections through vaccination and/or 
treatment with antimicrobial therapy [50] [51]. Metaphylactic administration of 
antimicrobials is often advocated for calves which may not have had time to mount an 
effective immune response to respiratory virus vaccination, or otherwise deemed to be at 
‘high risk’. However, this kind of mass medication of animals before development of 
signs of disease may promote selective antimicrobial resistance, and if live bacterial 
vaccines are being used, can compromise their efficacy [51] through inhibiting bacterial 
replication of vaccine organisms [52]. Resistance to antimicrobial drugs once used 
effectively in BRD treatment such as ampicillin, amoxicillin and oxytetracycline is now 
common. Newer compounds are available, such as long-acting macrolides (e.g. 
tulathromycin) and fluoroquinolones (e.g. danofloxacin), but a decline in BRD isolates 
susceptible even to these newer antimicrobials has been reported: antimicrobial 
stewardship is essential to preserve drug effectiveness for the future [53]. 
 
1.8 Vaccination of cattle in the UK 
In the UK, more than 40 vaccines are authorised for use in cattle [54]. Legally, farmers 
are required to record vaccine administration in a Medicines Book, available for 
inspection upon request [55]. Currently, there is no national recording system for data on 
vaccination use in animals. Therefore, sales data represent the best available 
approximation for vaccine coverage of cattle in the UK [56].  
 
The National Office of Animal Health (NOAH) and Executive Animal Health Study 
Centre (CEESA) conduct an independent sales survey to assess UK sales of authorised 
veterinary medicines. Many UK NOAH member companies participate, and a smaller 
number of companies independently provide sales data; together, data are estimated to 
represent around 95% of the total UK animal medicine market [57]. In 2017, 
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NOAH/CEESA sales survey data estimated 39% of medicine sales were for food 
producing animals, 58% for companion animals, and 3% for others and multi-species. 
Vaccines and antimicrobials accounted for 24.6% and 10.6% of the overall UK animal 
medicine market respectively [57]. Compared to the 2015/2016 annual review, vaccine 
use is increasing (2015/2016: 22%) and antimicrobial use decreasing (2015/2016: 16%). 
In addition, the relative proportion of sales to food producing animals is decreasing 
(2015/2016: 42%), while sales to companion animals are increasing (2015/2016: 55%) 
[56].  
 
1.9 Vaccines for respiratory disease in cattle  
Between 2011 and 2017, twelve vaccines for the control of respiratory disease in cattle 
were marketed in the UK (Table 1.1) [54]. In 2011, a questionnaire aimed to estimate 
usage and uptake of cattle vaccines by UK farmers [58]. From 266 respondents, 
motivations to vaccinate were grouped following responses to open questions. These 
motivations were due to losses (49%), on the basis of veterinary advice (26%), disease 
control (15%) and testing/monitoring (12%). Unfortunately, no further specific details to 
motivations were given. Sixty-five percent of farmers did not vaccinate because they did 
not perceive there to be a problem. To assess the uptake of vaccines used by respondents 
they were broadly categorised by disease. For respiratory disease, vaccine use was 
greater in beef (~35%) than in dairy (~18%) cattle. Rispoval 4 (BPIV-3, BRSV, BVDV, 
BHV-1) was the most widely used respiratory vaccine in both sectors. Rispoval 3, 
Rispoval RS, Bovipast RSP and Imuresp RP were only used in beef cattle. Interestingly, 
for 6 of the 8 disease categories surveyed, the beef sector used a greater number of 
different vaccines compared to dairy. It is not clear whether increased variety of vaccines 
represents increased diversity of respiratory agents in beef systems, differences in advice 
given to sectors, or farm experiences. A limitation to this survey is that it captures only 
a small proportion of farmers and relies on recall of information, moreover the 
categorisation of data resulted in loss of study detail, but it did capture motivation for 
vaccination, and attempted to compare coverage between beef and dairy.  
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Table 1.1: Vaccines licensed for use in cattle in the UK for respiratory disease. 
Target Pathogen(s) Company Product Name Formulation  Dosage and administration  
Mannheimia haemolytica 
type A1  
Boehringer Ingelheim 
Animal Health UK Ltd 
Bovalto Pastobov Inactivated, aluminium adjuvant  
Two injections, 3–4 weeks apart, calves over 12 weeks of 
age. Re-vaccination recommended before each risk period, 
no later than 1 year after previous vaccination. 
Mannheimia haemolytica 
type A1, BRSV, BPIV-3 
Boehringer Ingelheim 
Animal Health UK Ltd 
Bovalto Respi 3 
Inactivated: Aluminium 
hydroxide and Quillaja saponin 
adjuvants  
Two injections, 3 weeks apart. Re-vaccination 
recommended 6 months post primary vaccination.  
Mannheimia haemolytica 
type A1, BRSV, BPIV-3, 
BVDV 
Boehringer Ingelheim 
Animal Health UK Ltd 
Bovalto Respi 4 
Inactivated: Aluminium 
hydroxide and Quillaja saponin 
adjuvants 
Two injections, 3 weeks apart. Re-vaccination 
recommended 6 months post primary vaccination.  
BRSV, BPIV-3 
Boehringer Ingelheim 
Animal Health UK Ltd 
Bovalto Respi 
Intranasal  
Live - attenuated 
One dose, intranasally, calves from 10 days of age. Re-
vaccination recommended 10 days before each risk period. 
Duration of immunity 12 weeks.  
Mannheimia haemolytica 
type A1, BRSV, BPIV-3 
MSD Animal Health  Bovilis Bovipast RSP 
Inactivated: Aluminium 
hydroxide and Quillaja saponin 
adjuvants 
Two injections, ~4 weeks apart, calves from 2 weeks of 
age. Re-vaccination recommended 2 weeks before each 
risk period with a single dose. 
Mannheimia haemolytica 
type A1, Histophilus somni  
Hipra UK & Ireland Ltd 
Hiprabovis 
SOMNI/Lkt 
Inactivated: Liquid paraffin 
adjuvant 
Two injections, 3 weeks apart, calves from 2 months of 
age. Vaccination recommended 3 weeks prior to risk 
period.  
BPIV-3, IBR Zoetis UK Ltd Imuresp RP  Live - attenuated 
Single dose, intranasally, calves from 10 weeks of age. Re-
vaccination recommended every 6 months.  
BRSV, BPIV-3 Zoetis UK Ltd Rispoval® 3  
Live - attenuated, alhydrogel 
adjuvant 
Two injections, 3–4 weeks apart, calves over 12 weeks of 
age. Re-vaccination recommended every 6 months.  
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Table 1.1 continued     
Target Pathogen(s) Company Product Name Preparation  Course 
BRSV, BPIV-3 Zoetis UK Ltd Rispoval® 4 Attenuated 
Two injections, 3–4 weeks apart, calves over 12 weeks of 
age. Re-vaccination recommended 2 weeks before each risk 
period. Calves can be vaccinated from 3 weeks of age but 
re-vaccination at 12 weeks is recommended.  
BHV-1, BVDV (cytopathic 
and non-cytopathic type 1) 
  
Inactivated: Aluminium 
hydroxide adjuvant  
 




hydroxide and liquid paraffin 
adjuvants  
Single injection, calves over 12 weeks of age. Re-
vaccination necessary 7 days prior to next risk period, if risk 
is 17 weeks after previous dose.  
BRSV Zoetis UK Ltd Rispoval® RS Live - attenuated 
Two injections, 3–4 weeks apart, calves over 16 weeks of 
age. For calves from 7 days to 15 weeks: 2 doses, 3–4 weeks 
apart, a third dose at 16 weeks.  
BRSV, BPIV-3 Zoetis UK Ltd 
Rispoval® RS + PI3 
Intranasal  
Live - attenuated 
One dose, intranasally, calves from 9 days of age. Duration 
of immunity 12 weeks.  
Data compiled from the AHDB report ‘Use of vaccines and vaccination in dairy and beef cattle production 2011–2017’  
This list is non-exhaustive, and there are further vaccines for BVD and BHV-1 (both inactivated and live-attenuated) given in the report online [54]. 
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1.10 Surveillance of bovine respiratory disease in UK cattle 
The cattle dashboard is an online tool maintained by the Animal & Plant Health Agency 
(APHA) for sharing surveillance data collected from submissions to the GB veterinary 
diagnostic network: Veterinary Investigation Centres (England & Wales), SRUC 
(Scotland’s Rural College, Scotland), APHA’s network of universities and other partners 
providing post mortem services [59]. Similarly, the Veterinary Investigation Diagnosis 
Analysis database (VIDA) shares surveillance data recorded from diagnostic 
submissions from livestock and wildlife to the Great Britain veterinary diagnostic 
network and has been operating since 1975 [60]. There are limitations to these data, 
mainly concerning selection bias: higher counts could be due to increased submissions, 
maybe as a consequence of increased vigilance of farmers and vets; some diseases may 
not require laboratory testing, or veterinary practices may have private facilities; or 
submissions to aid in the epidemiology of certain diseases may be encouraged e.g. 
Schmallenberg. Further recognised bias includes submissions recorded that represent 
only the clinical material submitted to centres with no denominator data available. 
Clinical samples are of different types (blood, faeces, tissue) and carcasses (post-mortem 
examination). Samples submitted do not capture all cases of disease and factors affecting 
submission may vary over time due to the ad hoc submission of material for 
investigation. Nevertheless, the cattle dashboard and VIDA provides an approximate 
overview of diseases affecting livestock or wildlife in the UK. 
 
The number of cases of pneumonia in cattle and agents relating to the BRD complex 
were extracted from the cattle dashboard. The count of diagnoses made for each sector 
category (beef, dairy, calf rearing, other/unknown) for all ages between 2012–2017 were 
considered. The number of diagnoses for pneumonia by sector showed beef, in general, 
to contribute a greater number of diagnoses for each condition (9/14) compared to dairy, 
calf rearing and other/unknown sectors (Figure 1.3). BVD (bovine viral diarrhoea), 
persistent infection with BVD, infectious bovine rhinotracheitis (IBR), parasitic 
pneumonia and T. pyogenes diagnoses were more prevalent in dairy cattle. Of the various 
bacterial agents identified, M. haemolytica was the one most frequently detected in beef, 
dairy, and calf rearing sectors (Figure 1.3). For respiratory viruses, BHV-1 (IBR) was 
most frequently detected, followed by BRSV and BPIV-3. Interstitial pneumonia, BVD 




Figure 1.3: Number of diagnoses for pneumonia and agent’s related to the bovine respiratory disease 
complex by cattle production system between 2012–2017. Cattle dashboard data.  
 
Trends in the UK beef sector as reported in the cattle dashboard between 2012–2017 
show that diagnoses due to pneumonia have been slowly decreasing or remaining 
constant. M. haemoytica, BHV-1 and P. multocida were the most commonly detected 
organisms during this period (Figure 1.4). Interestingly, persistently infected BVD cases 
have sharply declined across this period (80% decrease). This decline could be due to 
uptake of vaccination and/or BVD eradication programs which aim to identify and 
remove all BVD persistently infected cattle in England, North Ireland, Scotland and 
Wales [61]. For example, in May 2017, 7 years since the introduction of the scheme into 
Scotland, herds testing ‘not negative’ (i.e. where an animal has tested positive for BVD 
virus) decreased from 40% to 10% [62]. In addition to the general decline in pneumonia 
diagnoses, the number of submissions from the beef and dairy sectors between 2012–
2016 has been decreasing and this could be reflected in the apparent decrease in 
pneumonia diagnoses. Declines in submissions could occur due to economic pressures 
on farmers, veterinarians utilising alternatives to veterinary investigation centres, or 
changes to the surveillance structure [63]. Therefore, the apparent downward trend in 
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Consequently, efficiently evaluating the true impact of respiratory disease on the UK 
cattle sectors using the VIDA and cattle dashboard is troublesome. 
 
 
Figure 1.4: Diagnosis of pneumonia and agents relating to pneumonia of beef cattle between 2012 to 2017. 
Cattle dashboard data. *Isolation of Bibersteinia trehalosi in association with respiratory disease. 
 
1.11  Pasteurellaceae  
Bacterial pneumonia in cattle is commonly attributed to members of the Pasteurellaceae 
family. The genus Pasteurella was named after Louis Pasteur, who was one of the early 
investigators involved in identifying the bacterium as the causative agent of fowl cholera 
[64]. It was Toussaint in 1879 that first isolated P. multocida [65] but Pasteur attenuated 
the bacterium (at first by accident) and thereby claimed the first production of an 
attenuated vaccine [66] (Jenner’s having been obtained from a milk maid’s hand). 
 
Pasteurellaceae have been classified and described based on common phenotypic criteria 
and biochemical features, supported by genetic studies such as extended 
deoxyribonucleic acid (DNA) DNA-DNA, or DNA – ribosomal ribonucleic acid (rRNA) 
hybridisation studies [65]. With respect to phenotype, members of the family may be 
defined as small facultatively anaerobic or microaerophilic, Gram-negative rods or 
coccobacilli, usually 0.2–0.4 x 0.4–2.0 μm in size [67]. Pasteurellaceae grow between 
30°C and 40°C [65], optimally at 37°C [68] and are opportunistic pathogens of 
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vertebrates, primarily birds and mammals, but also reptiles. They normally inhabit the 
mucous membranes of the alimentary, genital and respiratory tracts [67].  
 
Since the first isolation of P. multocida the family has undergone extensive 
reorganisation and classification. More recently, novel molecular techniques have been 
used to revise the taxonomy of these closely related organisms and to resolve 
misidentification based on phenotypic characterisation [68] [69]. Using 16S rRNA gene 
sequence comparisons, Pasteurellaceae is the only family of the order Pasteurellales, 
included within the class Gammaproteobacteria of the phylum Proteobacteria [67]. 
Examples of changes to nomenclature include renaming Haemophilus somnus and the 
ovine isolates Histophilus ovis and Histophilus agnis to Histophilus somni (H. somni is 
the only species of the genus Histophilus) [70]. There is a long history of reorganisation 
and naming within the Mannheimia genus, where M. haemolytica was first named 
Bacterium bipolare multocidum (1885) and later renamed Pasteurella haemolytica (for 
its weak haemolytic activity on sheep blood agar, 1932) and classified into 16 serotypes  
[51]. The species was then divided into biotypes based on the ability to ferment arabinose 
(biotype A) or trehalose (biotype T) [71]. However, following DNA-DNA hybridization 
studies and 16S rRNA sequencing T biotypes were renamed Pasteurella trehalosi, and 
then Bibersteinia trehalosi. A new genus, Mannheimia was proposed for the trehalose 
negative (biotype A) P. haemolytica complex, this involved renaming two species and 
describing three new species, resulting in at least five species that we know today: 
P. haemolytica was reclassified as M. haemolytica; P. granulomatis, Bisgaard taxon 20 
and P. haemolytica biovar 3J were combined and reclassified to M. granulomatis; 
P. haemolytica biogroups 3A-3H and the beta-glucosidase and meso-inositol-positive 
strains of P. haemolytica biogroup 9 were  combined and reclassified as M. glucocida; 
Bisgaard taxon 18 and P. haemolytica biogroup 8D strains were combined and 
reclassified as M. ruminalis and finally, P. haemolytica biogroup 6, Bisgaard taxon 15 
and Bisgaard taxon 36 were combined and reclassified as M. varigena [72].  
 
P. multocida has undergone similarly lengthy changes: first, organisms with similar 
phenotypic characteristics to that of the agent causing fowl cholera were grouped and 
originally named as P. septica, prior to naming as P. multocida. The Pasteurella genus 
was then reclassified into 11 species, with four subspecies of P. multocida: multocida, 
septica, gallicida (based on sugar fermentation) [73] and more recently tigris (based on 
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16S rRNA sequencing) following isolation from a wound infection from a tiger bite  [74]. 
P. multocida strains are classified into 5 serotypes (A, B, D, E and F) based on capsule 
antigens and further classified into 16 Heddleston serovars based on lipopolysaccharide 
antigens [75] [76]. Of note, P. multocida serotypes were previously referred to as 
serogroups, similarly serovars were referred to as serotypes. The serotypes B:2 and E:2 
are most commonly responsible for epidemics of haemorrhagic septicaemia in cattle and 
buffalo in Asia (B:2) and Africa (E:2) [64] [77]. Elucidation of the Pasteurellaceae 
family continues and genome sequencing can now assist in phylogenetic rearrangement 
[78].  
 
1.12 Bacterial colonisation and carriage 
Bacterial colonisation refers to ‘establishment and proliferation’ of bacteria at specific 
sites in the host [9] and differs to ‘infection’ by not causing disease [79]. The Oxford 
dictionary defines carriage as ‘the harbouring of a potentially disease-causing organism 
by a person or animal that does not contract the disease’ [80]. Thus, carriage describes 
the occurrence of a given organism. Carriage is frequently reported as a rate to describe 
the proportion of individuals within a population, at a given point, who are harbouring 
the organism of interest (point-prevalence carriage rate) [81] [82] [83]. However, 
‘carrier’ and ‘colonised’ are often used interchangeably to denote that an organism has 
been detected from an asymptomatic individual. Carriage can imply a temporal 
association with carrier status through categorisation into ‘carrier types’ such as, 
‘persistent’ or ‘intermittent’, which imply either uninterrupted/continuous or 
interrupted/non-continuous carriage respectively [84].  
 
1.13 Factors that influence Pasteurellaceae colonisation 
Bacteria may reside within the mucus layer but are subjected to mucociliary clearance 
and removal through local innate and adaptive immune responses [85]. Adhesive 
interactions between respiratory bacteria and epithelial cell surfaces can help prevent 
clearance and enable colonisation via specific or non-specific adhesins, but adhesion can 
also initiate invasion [86]. Using PCR, several genes encoding for adhesins have been 
identified for P. multocida isolated from the lungs of pneumonic cattle, these include 
type IV fimbriae (ptfA), fimbriae (fimA), haemagglutinin (pfhA), autotransporter proteins 
(hsf-1, hsf-2) and a putative non-specific tight adherence protein (tadD) [87]. In vitro, 
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adherence of M. haemolytica to bovine bronchial epithelial cells  has been demonstrated 
to occur through outer membrane protein A (OmpA) and lipoprotein 1 (Lpp1) [88]. In 
competition assays, binding of H. somni to bovine pulmonary artery [89] and brain [90] 
endothelial cells has been demonstrated to occur through heparin binding proteins. 
Bacterial flora may also protect the host from colonisation, either through competition 
for receptor binding sites or nutrients, therefore from an ecological perspective the hosts’ 
niche could be unfavourable for colonisation [91]. 
 
1.14 Pasteurellaceae virulence factors  
Pulmonary damage caused by bacteria results from invasion and production of virulence 
factors, facilitating colonisation of the lower respiratory tract [92]. A signature of acute 
pulmonary infection in cattle is fibrinosuppurative and necrotizing inflammatory 
responses [51]. Various virulence factors have been shown to enhance the ability of 
M. haemolytica, P. multocida and H. somni to colonise tissues and cause disease. For 
example: capsule, adhesin, fimbriae, ruminant-specific leukotoxin (Lkt) of 
M. haemolytica, lipopolysaccharide (LPS), outer membrane proteins and colonisation 
factors [51] [93] [18].  
 
1.15 Bovine respiratory disease associated with H. somni 
Respiratory disease due to H. somni is seen in young calves but commonly feedlot cattle 
[93] [94]. This bacterium causes histophilosis which manifests as several clinical 
syndromes: bronchopneumonia, thrombotic meningoencephalitis, pleuritis, 
polysynovitis, septicaemia, myocarditis, infertility, abortion and mastitis [94] [95]. 
However, in the 1950s the pathogenic potential of H. somni was not first recognised for 
involvement with respiratory disease, but for causing thrombotic meningoencephalitis in 
US feedlot cattle [96] originally described as a haemophilus-like organism [97]. This 
disease was initially called sleeper syndrome [98] due to the appearance of affected 
cattle: partially closed eyes and severe depression, resulting from H. somni binding to 
endothelial cells, invading to cause septicaemia, followed by vasculitis and thrombosis 
in the brain [34] [99].  
 
H. somni commonly exists as a commensal at reproductive and respiratory mucosa [93]. 
However, this bacterium has several potential virulence factors: immunoglobulin-
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binding proteins on the cell surface; the ability to survive phagocytosis by bovine alveolar 
macrophages; lipopolysaccharide with endotoxic activity; and the ability to undergo 
phase and antigenic variation [100]. This ability to undergo phase and antigenic variation 
suggests that there are immunological pressures resulting from the host’s attempts to 
control colonisation. H. somni can incorporate phosphorylcholine (ChoP) into the 
lipooligosachharide (LOS) molecule, however ChoP was not found to augment 
adherence of H. somni to bovine nasal turbinate cells but may play a role in pathogenesis 
through binding to the platelet activating factor receptor on epithelial cells [101] [102]. 
Naturally occurring respiratory disease due to H. somni is characterised by consolidation 
of the cranioventral lung. Histologically, there is bronchopneumonia with fibrinocellular 
thrombosis of septal lymphatics, neutrophilic, necrotising bronchiolitis and multifocal 
haemorrhage [103]. In calves suffering chronic respiratory disease after deliberate 
infection with H. somni coughing was rarely observed and severe clinical signs were only 
observed for a few days when calves experienced chronic infection [104], leading Corbeil 
et al. to suggest that chronic H. somni infection can be subclinical for weeks [93]. As 
with human respiratory disease, nasal colonisation is recognised as an important first step 
for invasion [86] [105]. Given the mobility of this pathobiont to cause a spectrum of 
diseases understanding asymptomatic carriage in the nasal passages of cattle is of 
interest. 
 
1.16 Bovine respiratory disease associated with M. haemolytica  
M. haemolytica is frequently associated with shipping fever, i.e. following transport 
(shipping) of calves, namely from several sources to feedlot operations and has 
commonly been isolated from severe fibrinous pneumonia cases [106] [51]. Several 
virulence factors have been described, these include: adhesin protein, fimbriae, outer 
membrane proteins and lipopolysaccharide [51]. A major virulence factor of 
M. haemolytica is the ruminant-specific Lkt. Lkt is an exotoxin and member of the 
repeats in toxin (RTX) family. Lkt shares homology with exotoxins produced by other 
Gram-negative bacteria, for example Escherichia coli and Actinobacillus 
pleuropneumoniae: however, there are differences among the family with respect to the 
toxin’s target cell type [107]. All serotypes of M. haemolytica secrete Lkt during 
logarithmic growth in vitro, with different serotypes shown to produce different Lkt types 
[108]. Lkt can passively adsorb onto the surface of bovine leukocytes or bind through 
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surface receptors, namely b2-integrins (amino acids 5–17 of CD18) [109]. Lkt acts on 
bovine leukocytes in a dose dependent manner: at low concentrations it activates 
neutrophils and macrophages, stimulating respiratory burst and degranulation [110]; at 
higher concentrations target cells are triggered to undergo apoptosis [111] [112] and 
necrosis occurs as a result of pore-like structures forming in the plasma membrane of 
target cells [113]. In the lower respiratory tract, Lkt is responsible for major lung injury 
and as b2-integrins are present on leukocytes, damage to these cells from Lkt could allow 
the bacterium to evade phagocytosis [85]. In one study, six 10-month-old beef calves 
were infected with BHV-1 by intranasal inoculation. Blood and BAL was collected from 
both infected and control (n = 4) calves. Expression of the b2-integrin CD11a/CD18 was 
comparable between groups on BAL but slightly increased on mononuclear cells in 
BHV-1 infected calves 3, 5, and 7 days post infection, and significantly increased on 
granulocytes 5 and 7-days post infection. In addition, increased binding of Lkt to BAL 
cells of BHV-1 infected calves was observed, as well as increased cytotoxicity [114]. 
Therefore, respiratory viral infection may increase susceptibility of cattle to 
pasteurellosis. 
 
1.17 Bovine respiratory disease associated with P. multocida 
Pulmonary lesions attributable to infection with P. multocida have been characterised as 
bronchopneumonia. Typically, bronchi and bronchioles are filled with neutrophils, 
macrophages and necrotic epithelium [18] [115]. P. multocida is organised into 5 
capsular serotypes: A, B, D, E and F. Serotype A is mainly associated with respiratory 
disease in cattle [116], mostly A:3 and A:1 [18] [76] [117]. Serotypes B and E cause 
haemorrhagic septicaemia in cattle [64] [77]. Serotype D causes atrophic rhinitis in pigs 
but has been isolated from pneumonic sheep and cattle lungs [18]. Serotype F strains are 
predominately associated with diseased poultry [118] but have been isolated from fatal 
cases of fibrinous peritonitis in calves [18]. The polysaccharide capsule is an important 
virulence factor, for example through antiphagocytic activity [119] and molecular 
mimicry - some strains express hyaluronic acid which is often found naturally in the host 
and therefore prevents strong antibody responses [76]. Loss of virulence has been 
reported for an acapsular mutant strain in mice and chickens  [120]. Interestingly, 
vaccination against fowl cholera with acapsular P. multocida serotype A:1 was found to 
stimulate immunity against wild-type challenge [121]. LPS is also a major virulence 
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factor of P. multocida - it is highly antigenic but poorly immunogenic unless complexed 
with proteins [18]. The lipid A component of LPS is responsible for inducing endotoxic 
shock [122], and it has also been demonstrated in vitro to have a role in neutrophil 
adhesion and migration through bovine aortic endothelial cell monolayers [123]. Despite 
its similarity to LPS of other Gram-negative bacteria (Haemophilus influenzae, 
Campylobacter jejuni and Neisseria spp.) there is no evidence to suggest that LPS genes 
found in the P. multocida genome are capable of phase-variation [124]. 
 
1.18 Immune responses against bovine respiratory bacteria  
Microorganisms produce conserved molecular patterns: pathogen associated molecular 
patterns (PAMPs), for example LPS from Gram-negative Pasteurellaceae. These 
PAMPs are recognised by epithelia, alveolar macrophages and pulmonary intravascular 
macrophages, and in acute inflammation neutrophils recognise PAMPs. Recognition of 
PAMPs occurs via Pattern Recognition Receptors (PRR), of which Toll-like receptors 
(TLR) are transmembrane PRR on respiratory epithelia. LPS from H. somni, 
M. haemolytica and P. multocida binds to TLR4 which can signal through MyD88 or 
TRIF/TRAF leading to inflammatory reactions [30].  
Neutrophil influx to the lung is common in calves suffering with pasteurellosis [125] 
[85]. M. haemolytica has been reported to upregulate production of the chemokine IL-8 
by alveolar macrophages, in turn increasing the migration of neutrophils to sites of 
infection [125] [126]. In cattle, γδ T-cells represent between 15–20% of the circulating 
lymphocytes, a comparatively higher number than in mice and humans [127]. The pro-
inflammatory cytokine IL-17 is primarily produced by activated γδ T-cells and CD4+  
T-cells. Expression of IL-17 stimulates stromal and epithelial cells to produce 
chemokines, one of which is IL-8, resulting in neutrophil recruitment. In an in vitro co-
infection model, expression of IL-17 was induced by BRSV and significantly increased 
with co-infection of M. haemolytica; production of IL-17 was primarily mediated by γδ 
T-cells [128].  
 
Colostrum from dairy cows previously exposed to M. haemolytica and P. multocida 
contains antibodies to both bacterial species, these bacteria-specific antibodies are then 
transferred to the calf during suckling [129]. In neonatal beef calves, passively acquired 
anti-P. multocida and anti-M. haemolytica antibodies have been detected by ELISA: by 
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60–90 days of age passively acquired IgG1 antibodies have waned, with autogenous 
production of anti-bacterial IgG1 and IgG2 starting between 90-120 days of age [106]. 
Specific antibodies may facilitate phagocytosis of bacteria through the process of 
opsonisation, whereby phagocyte cell receptors bind to the antibodies’ Fc-region. 
Antibodies (IgG and IgM) can trigger the complement system and opsonise bacteria, 
leading to enhanced phagocytic action of macrophages and neutrophils [130]. In the 
bovine respiratory tract IgG1 and to a lesser extent IgG2 are major secretory 
immunoglobins [131]. Bovine alveolar macrophages have a greater affinity for IgG1 
compared to IgG2, with IgA potentially having a secondary role in opsonisation [132]. 
IgG2 has been shown to be protective against H. somni [93]. Exposure to live 
M. haemolytica through deliberate infection results in production of antibodies to 
antigens on the surface of the bacterium and leukotoxin-specific neutralizing antibodies 
[133]; anti-leukotoxin antibodies can prevent impairment of phagocyte function [130]. 
Interestingly, in vitro M. haemolytica has demonstrated the ability to secrete proteases 
which have activity against IgG1 but the presence of IgG2 specific proteases could not 
be confirmed [131]. This observation has not been confirmed in vivo but genome 
sequence analysis of M. haemolytica A1 has identified two autotransporters (MHA_0563 
and MHA_2800) which are orthologs to H. influenzae and N. meningitidis IgA, an IgA 
peptidase/adhesin. These autotransporters may cleave secreted IgG in the bovine 
respiratory tract and play a role in adhesion to host receptors on epithelial cells [134].  
 
1.19 Colonisation locations 
Despite several authors attempting to characterise and compare colonisation between the 
upper and lower respiratory tract, exact colonisation locations of pathogens involved in 
BRD have not been described in detail.  These efforts have been directed at ascertaining 
whether sampling the URT through nasopharyngeal swabs is indicative of the organisms 
eliciting disease in the lung and hence of diagnostic value, rather than increasing 
understanding of the biology of carriage. In one study, DeRosa et al. investigated the 
distribution of P. multocida, M. haemolytica and H. somni in the respiratory tracts of 
calves showing clinical signs of respiratory disease after shipment. Bacterial pathogens 
recovered from both nasal and transtracheal swabs were the same 68.4% of the time, with 
nasal swab culture giving ribotype profiles genetically identical to the organisms causing 
disease in the lung for 70% of the calves [135]. Other studies showed lower levels of 
 22 
concordance, demonstrating greater differences both between the bacterial species 
isolated and their density between the different respiratory tract locations [136] [137]. In 
one study, intrabronchial inoculation of cattle with H. somni resulted in an increased 
isolation from bronchoalveolar lavage fluid compared to nasal swabs collected from 
calves with chronic disease [104]. This observation led authors to suggest that H. somni 
preferentially colonises the lower respiratory tract. However, this is unsurprising given 
the route of inoculation. Pass et al. investigated the location and extent of colonisation 
by M. haemolytica in the nasal cavity of fifteen beef calves. They considered right and 
left nasal cavities separately, finding little or no difference between them. Results did not 
consistently define areas of high and low density colonisation [9].  
 
The bovine palatine tonsil is believed to be a colonisation site for Pasteurellaceae. Frank 
et al. also showed the tonsil to be a site for M. haemolytica [138] [139], contrasting with 
the previously held view that it is a commensal of bovine nares [20]. In addition, 
B. trehalosi has been shown to colonise ovine tonsils [33]. Frank showed M. haemolytica 
serotype A1 to colonise the tonsils of healthy calves for at least three weeks, suggesting 
that carriage could be prolonged in the tonsils [138]. Nasal secretions however, had low 
numbers of M. haemolytica with an A1 isolate, implying the tonsil may not continually 
shed bacteria, or they could be rapidly cleared [138]. Bovine respiratory bacteria and 
viruses are transmitted in nasal secretions to susceptible individuals in the herd [140] 
[35] [113]. Discrepancies regarding bacterial colonisation of the bovine tonsil or nasal 
passage could impact on understanding bacterial transmission, and sampling methods 
used to ascertain presence and density of colonisation accurately. 
 
Swabs collected from the sinuses of healthy slaughtered cattle and those submitted for 
post mortem examination were cultured: bacteria were undetected from 94 of the 99 
healthy animals (94.9%) and 17 of the 30 diseased animals (56.7%). Of the diseased 
animals, only nine were diagnosed with BRD, but H. somni (n = 5), 
M. haemolytica (n = 1), E. coli (n = 2) and Clostridium spp. (n = 1) were isolated from 8 
of these 9 animals. This study provides weak evidence that the sinuses may act as 
reservoirs for bacteria commonly associated with BRD [141]. 
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1.20 Colonisation dynamics 
Rapid proliferation of bacterial pathogens in the nasopharynx can cause carrier cattle to 
become a source of infection for healthy non-infected cattle [65]. Transmission dynamics 
of opportunistic Pasteurellaceae are still not clear and it is debatable whether associated 
BRD episodes are due to predisposing factors allowing resident commensal flora to 
overcome the hosts immune system and cause disease or, whether a contagious virulent 
clone is spread between penmates [142]. Restriction endonuclease analysis, ribotyping, 
plasmid content analysis and antimicrobial resistance profiles have been used to 
distinguish different isolates of M. haemolytica and gain insight into its epidemiology 
[143]. Pulsed-field gel electrophoresis has also been applied to monitor transmission 
dynamics within BRD cases; significant within-pen diversity of M. haemolytica has led 
to the conclusion that disease did not occur as a result of spread of a single virulent clone 
[142]. Likewise in commercial feedlots, PCR-fingerprinting revealed significant 
diversity between P. multocida isolates from fatal BRD calf cases [144], indicating that 
complex bacterial communities exist within an individual’s nasopharynx, although it is 
unclear to what extent predisposing factors have a role in enabling resident flora to cause 
disease.  
 
1.21 Carriage rates  
Culture of nasal swabs, bronchoalveolar lavage and tracheal aspirate samples has 
frequently revealed M. haemolytica and P. multocida to have involvement in BRD; with 
M. haemolytica being the predominant pathogenic agent detected [24] [136]. High 
isolation rates seen in nasal and bronchoalveolar lavage samples from clinically healthy 
cattle suggest that P. multocida is a commensal organism [145] [146] [147], but also 
exists as an opportunistic pathogen, evident from Angen et al. reporting detection from 
82% and 74% of diseased animals sampled by trans-tracheal aspiration, processed by 
culture and PCR respectively [148]. 
 
Several authors have attempted to understand the relationship between nasopharyngeal 
commensals and disease in the bovine URT through assessing microbial flora, largely 
through nasopharyngeal swab sampling and culture-based methods. Table 1.2 
summarises the key findings from a selection of studies chosen based on their interest in 
understanding carriage rates for bacterial species reported to be associated with BRD. It 
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can be seen that P. multocida has been reported with the highest prevalence, followed by 
M. haemolytica and H. somni. Difficulties exist when comparing studies due to 
inconsistencies in sampling and processing methods, advances in these methodologies 
over time, as well as differences between cohorts of animals sampled, for example age, 
breed, health status and farming system. H. somni has been reported at the lowest 
prevalence, which may not be a true reflection of carriage density; colonies are very slow 
growing and small, therefore overgrowth is easy [149] [67]. Recent advances have led to 
the development of several PCR assays which can reliably detect and in some cases 
quantify bacterial pathogens, overcoming issues posed by traditional culture [150] [151] 
[152]. A limitation of PCR is the possibility of detecting bacterial DNA in the absence 
of viable bacterial cells. However, when supplementing PCR with culture this issue can 
be addressed. 
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Table 1.2: Reported carriage rates in cattle for Mannheimia haemolytica (Mh), 
Pasteurella multocida (Pm), Histophilus somni (Hs) and other bacterial species.  
  Bacterial carriage rates (%)     
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1.22  Predominant serotypes  
A focus of previous work has been to determine the main serotypes of bacterial pathogens 
involved with BRD and their colonisation patterns. Frank et al. demonstrated  
M. haemolytica serotype A1 to be the most common isolate from nasal swab samples of 
stressed feeder calves [20], a finding concordant with work by DeRosa et al. [135].  
M. haemolytica A1 and A2 are both able to colonise the upper respiratory tract of cattle 
and sheep. Capsular serotypes A1 and A6 are commonly associated with BRD [154] and 
more recently serotype A6 has shown to be increasingly prevalent in the UK and USA 
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[155]. These findings are supported by Katsuda et al. where investigation over a 20 year 
period showed serotypes A1, A2 and A6 to be most prevalent in calves affected with 
pneumonic pasteurellosis, with a similar recent increase in A6 [156]. In a further study, 
92% of isolates from cattle with BRD were either A1 or A6 while recovery of A2 was 
substantially more prevalent from healthy cattle compared to those with disease [154], 
suggesting A2 to have a commensal role, opposed to the opportunistic nature of A1 and 
A6. Similarly, different serotypes of P. multocida are involved with pasteurellosis in 
different animal host species [157]. BRD is predominantly associated with serotype A 
isolates [65]. Serotyping however, is no longer considered to be sufficiently reliable for 
identifying P. multocida or M. haemolytica and laborious methodology based on culture 
and antigenic methods for detection and identification is being overtaken and replaced 
by PCR [66]. 
 
1.23 Respiratory microbiome  
Using culture, Frank noted that the normal bacterial respiratory flora appeared to remain 
stable throughout exposure to M. haemolytica and respiratory viruses (BHV-1 or  
BPIV-3) but no attempts were made to provide further information on characterising 
bacterial nasal flora [158]. In addition, use of culture-based methods has resulted in 
research to date reporting association of culturable bacterial species with BRD, rather 
than those that are deemed unculturable but may have a role in modulating colonisation 
patterns with organisms associated with BRD. The potential value of attempting to 
characterise the URT microbiota further was demonstrated by Corbeil et al. who showed 
in most cases aerobic bacterial isolates from healthy bovine nasal flora to enhance the 
growth of M. haemolytica, P. multocida, and H. somni in vitro, and to a lesser extent 
inhibit them [159]. Their work provides evidence for the capacity of bacterial 
communities to regulate microbial populations, adding to understanding of how 
microbial communities in the bovine URT exist. Nevertheless, given the in vitro nature 
of the study, results may not accurately reflect dynamics in the host.  
 
In children, it has been shown that stability of the respiratory microbiome changes with 
age and can be influenced by the presence or absence of certain bacterial species. 
Furthermore, patterns of change have been associated with parent-reported respiratory 
infection [160]. Therefore, enhancement of proliferation of certain species due to 
 27 
respiratory virus infection could disrupt microbiome ecology and thus lead to changes in 
colonisation by occasionally pathogenic nasopharyngeal bacterial residents. The 
application of transcriptomic approaches may offer insight into conditions that promote 
up-regulation of opportunistic pathogens to elicit disease.  
 
1.24 Viral-bacterial synergy 
Viral-bacterial synergy refers to the phenomenon of increased risk of bacterial respiratory 
infection following a primary viral infection. It was first identified following human 
influenza epidemics when several secondary bacterial respiratory infections were 
associated with increased mortality, and has been observed for a variety of bacterial 
species [31]. Enhanced understanding of viral-bacterial synergism could aid future 
prevention, control and treatment strategies. Interactions between influenza and 
pneumococcal infections have been extensively researched [161]. In an early study, 
secondary bacterial pneumonia was experimentally induced in mice through intranasal 
co-infection with influenza virus A and either Haemophilus influenzae, 
Streptococcus pneumoniae or Staphylococcus aureus [162]. Given the multifactorial 
aetiology of BRD there is scope for greater understanding of viral-bacterial synergy 
elicited in the bovine URT as well as factors influencing transmission of potentially 
pathogenic bacteria. 
 
1.25 Bacterial adherence following respiratory viral infection 
It is thought that after infection with respiratory viruses in cattle, nasal mucosal 
commensals may proliferate, often replicating in tonsillar crypts and nasal mucin [30]. 
Disease can subsequently result from inhalation deeper into the respiratory tract [19] but 
it is uncertain as to whether high density bacterial colonisation is sufficient to cause 
pneumonia.  
 
Respiratory viruses of cattle are transmitted in nasal secretions either by direct contact 
(nose-to-nose), indirectly through people and fomites or are aerosolised over short 
distances [163]. Viral infection in the upper respiratory tract can damage host epithelium 
rendering cells more susceptible to colonisation with bacteria. Loss of cells or damage 
can impair normal non-specific defense mechanisms e.g. reduced mucociliary function, 
or altered mucous composition and viscosity. Furthermore, bacterial elimination may be 
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reduced if virally infected cells do not express antimicrobial peptides sufficiently. 
Moreover, bacterial colonisation may be upregulated indirectly; viral infection 
upregulates various receptors (adhesion proteins) on a range of host cells (e.g. epithelial 
cells) to allow immune cells to bind to virally infected cells. Subsequently, bacterial 
adherence is promoted as bacteria can bind to the same adhesion proteins as immune 
cells [91].  
 
1.26 Investigating viral-bacterial interactions in cattle  
The distribution of these opportunist pathogens (H. somni, M. haemolytica and 
P. multocida), their density and co-occurrence with other bacterial and viral agents is 
variable within the bovine respiratory tract, thus influencing their pathogenicity and 
efficiency of transmission [24]. One hypothesis is that vaccination, particularly with live 
virus may enhance bacterial proliferation in the bovine URT through mimicking a natural 
viral infection [137]. Therefore, the use of live vaccines offers a practical and ethical 
model of viral infection, where this model can be applied to explore the effects of 
respiratory viral infection on the URT microbiome. Interestingly, calves suffering with 
BHV-1 induced respiratory disease are susceptible to active colonisation of the 
nasopharynx by M. haemolytica as a result of tonsillar colonisation [138]. This 
phenomenon has been shown by others, and subsequently bacterial shedding in nasal 
mucus for seven days or more has been demonstrated [158] [139]. Thus, findings are 
consistent with the argument that respiratory virus infection does indeed promote 
bacterial proliferation and hence shedding in nasal secretions. 
 
1.27 Concluding remarks 
Despite availability of antimicrobial drugs and vaccines, pneumonia still remains a major 
cause of morbidity, mortality and economic loss to beef and dairy industries. 
Understanding the disease syndrome can enhance treatment and prevention plans but this 
is complicated by the disease’s multifactorial nature. At present, much of the research 
concerning bacterial species and their involvement with BRD has been conducted using 
culture. Molecular based methods such as PCR and sequencing can be employed to detect 
and quantify bacterial species rapidly, often with enhanced sensitivity and specificity. 
This review has provided strong evidence that Pasteurellaceae are common residents of 
the bovine nasal passages, but on occasion they are pathogens. However, the commensal 
 29 
role members of Pasteurellaceae have within the bovine respiratory niche is not well 
defined and neither are the factors that drive the switch from commensal to pathogen 
status. Understanding the biology of carriage with respiratory bacteria in healthy animals 
is essential to inform future strategies to control disease. Furthermore, knowledge and 
understanding of BRD in suckler beef herds is limited; previous research has focused 
mainly on feedlot cattle and dairy calves, where substantial economic loss and welfare 
burden occurs. However, pneumonia is a disease that threatens all cattle, particularly 
calves. Moreover, health status and production efficiencies in all systems need to be 
carefully considered within a one-health framework to ensure both health and food 
security.  
 
1.28 Hypothesis and aims 
Histophilus somni, Mannheimia haemolytica and Pasteurella multocida are frequently 
implicated alongside respiratory viruses in cases of bovine respiratory disease 
worldwide. Given the recent evidence in humans and mice that following attenuated 
influenza infection nasal bacterial carriage rates, carriage duration, and density of 
carriage with important pathobionts increases, it was hypothesised that following 
respiratory viral infection, using a live-attenuated respiratory viral vaccine in cattle, rates 
and density of carriage with common bovine pathobionts may increase.  
 
The aims of the work presented in this thesis were:-  
i) To characterise the carriage rate and density of Histophilus somni, 
Mannheimia haemolytica and Pasteurella multocida in the nasal passages of 
healthy beef calves 
ii) To investigate the effect of respiratory viral infection on nasal bacterial 
carriage rates and densities 
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Chapter 2 General Materials and Methods 
2.1 The North Wyke Farm Platform 
All cattle studies were performed at the North Wyke Farm Platform (NWFP), Devon, UK 
(Rothamsted Research). The research facility is a ‘national capability’ funded by the 
Biotechnology and Biological Sciences Research Council (BBSRC) and aims to improve 
sustainability of grazing livestock production through multi-disciplinary research, focusing on, 
but not exclusively: animal health, welfare and productivity, soil health, water quality and 
climate-related metrics. 
 
The NWFP comprises three hydrologically-isolated farming systems called ‘farmlets’. Each 
farmlet consists of five component fields of just over 20 ha in total per farmlet (Figure 2.1). 
Each farmlet is managed differently and the impact of these different management regimens 
(coded Green, Blue and Red) on beef and sheep production, water, air and soil are continually 
evaluated. Water leaving individual fields is restricted in vertical movement by a natural 
impervious layer of stagnogley and is channelled laterally through a network of French drains 
and perforated plastic pipes to individual, fully-instrumented flumes (n = 15), enabling 
measurement of flow rate and automated water collection for subsequent analysis for nutrient 
loss and water quality parameters. In addition, each farmlet field is equipped with a 




Figure 2.1: North Wyke Farm Platform field plan highlighting isolated Blue, Green and Red farmlets with 
respective component fields. 
 
2.2 Management of farmlets 
Prior to implementation of farmlet treatments baseline data collection was conducted over a 
two-year period between April 2011 and March 2013. Following baseline collection, each of 
the three farmlets progressively moved onto different pasture management systems, with 
swards of: 1) permanent pasture (Green Farmlet); 2) white clover/high sugar perennial ryegrass 
mix (Blue Farmlet); and 3) high sugar perennial ryegrass monoculture (Red Farmlet) [164]. 
Further details on sward management specifics are given in Appendix A. 
 
2.3 Forage sampling of farmlets  
For each barn/farmlet, pasture and silage samples were collected for forage quality analysis as 
part of the standard management practices on the NWFP. Pasture samples were collected for 
both 2015 and 2016 grazing years. Pasture samples were collected between April and October 
2015 and between May and October 2016 from fields in which cattle grazed. For silage, 
samples were collected between October 2015 and March 2016 and between September 2016 
and April 2017 from silage fed to animals during the respective housing period. Samples were 
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processed following standard protocols given below for estimation of metabolisable energy 
(ME), indicating digestibility, and crude protein (CP).  
 
2.4 Forage processing protocol 
For both pasture and silage samples the modified acid detergent fibre (MADF) composition 
was quantified using a FOSS Fibertec 8000 Auto Fiber Analysis System following the method 
of Clancy and Wilson (1966) [165]. The derived MADF fractions were converted to 
corresponding ME values using equations independently calibrated for UK pastures and silages 
[166]. These values were further converted to digestible organic matter content (DOMD; 
reported as digestible energy) using a separate equation [166] [167]. 
 
2.5 Forage quality statistical analysis 
To investigate differences in ME and CP in each farmlet on the NWFP a linear mixed effect 
model was fitted with a fixed effect of farmlet and random effect of time to account for 
variation introduced by repeated measures. Where technical replicates were present (ME only) 
an additional random effect of replicate was included nested within time. The impact of the 
fixed effect (farmlet) versus the null model (no fixed effect) was assessed by comparing the 
change in residual deviance from a nested, simpler model with the upper-tailed critical value 
(p < 0.05) of the appropriate chi-squared distribution (as identified by the change in the residual 
degrees of freedom between the models). For significant effects, a Tukey test was used to 
determine which farmlets were different. Mixed effect models were conducted using the R 
package lme4 (version 1.1.17) and Tukey post-hoc tests conducted using the R package 
lsmeans (version 2.30.0). For silage fed to the 2016 born cohort there was considerable 
variation between silage samples collected from bales or the silage clamp. As animals were fed 
silage from both locations samples were stratified on location for statistical analysis. For CP 
of silage, one-way analysis of variance (ANOVA) was performed, including a fixed effect of 
farmlet (because the mixed model failed to converge). For significant effects, a Tukey test was 
used to determine which farmlets were different. 
 
2.6 Livestock operations 
A herd of 100 Suffolk ewes and 90 Hereford-Friesian x Charolais calves are bred each year. 
Livestock are born in the early Spring (March onwards) and stay with their respective ewe/dam 
housed until Summer turnout, usually around May to June. When calves and lambs are at 
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pasture with their mothers they are off the NWFP and graze a permanent pasture. During the 
winter housing period animals are fed a diet of conserved forage produced from the farmlet 
they are allocated to. The following Spring calves and lambs are turned out once more, but this 
time to graze their allocated farmlet pasture. One of the key metrics for production of both 
sheep and beef enterprises is growth rate. Animals with increased growth rates take less time 
to finish compared to less efficient animals, therefore all livestock are weighed on and off the 
grazing to determine live-weight gain. During winter, livestock are weighed approximately 
every two weeks.  
 
Heifers are serviced by bulls naturally on the FP (further details are given in Appendix A). The 
calving period takes between March to May each Spring. In-calf heifers are housed on deep-
litter straw bedding in a barn located on a site separate to the cattle winter housing facilities 
located at Rowden. Calves are ear tagged shortly after birth and ear notch tested for BVDV. 
From the maternity unit they are moved to a separate barn close by (~250 m). Here, calves are 
penned in groups of five per pen with their respective dams. At an age of approximately two 
months, and when the weather permits, they are turned out to pasture separate to the NWFP. 
 
2.7 Cattle facilities  
The cattle facility, newly built in winter 2013/2014 comprises of three identical purpose-built 
barns, silage clamps, farmyard manure middens and ancillary buildings, as seen in Figure 2.2. 
A distance of approximately 6 meters separates the three barns. Silage is stored in clamps or in 
bales, maintaining segregation respective to farmlet. Resulting farmyard manure collected 





Figure 2.2: Aerial view of cattle housing and handling facilities at Rowden site, North Wyke Farm Platform 
(Rothamsted Research, Devon). Image source: Google maps. 
 
Each barn has solid concrete sidewalls to animal height (~1.5 m) and is ventilated naturally 
above animal height with space boarding, there is a midden at the rear and feeding area in front 
of the scrape (Figure 2.3, panel a and b). Barns are orientated to face south west onto handling 
facilities (Figure 2.3, panel c) such that the prevailing winds [168] [169] assist with their 
ventilation through end apertures (solid gates approximately 2 m high with openings above and 
a space-boarded gable end). During harsh weather windbreaks are used to provide protection. 
The handling facilities are within a yard which includes several holding pens and a race leading 














Figure 2.3: Exterior and interior barn environment: a) Floor plan of purpose-built cattle housing, b) calves feeding 
inside one of the three barns, and c) exterior of the three identical purpose-built cattle housing facilities, located 
at Rowden, 2.5 km from the main farm buildings where breeding heifers are housed. 
 
2.8 Allocation of animals to farmlets 
At the end of the summer grazing season on fields separate from the NWFP, 90 calves are 
weaned and housed in one of the three farmlet barns at approximately 7 months of age (n = 30 
per barn). Calves are housed over the winter, together with approximately 15–20 finishing 
cattle from the previous year.  
 
Two calf cohorts born in Spring 2015 and 2016 were studied. Allocation of calves to farmlet 
was conducted immediately prior to winter housing for both cohorts. In 2015, calves were 
allocated based on body weight. In 2016, allocation was performed following a modified 
method of covariate-constrained randomisation, the following covariates were considered: age, 
breed, body weight, growth rate, sex and sire [170]. Further details on the methods for each 

























2.9 Sample Collection 
2.9.1 Ethical Approval 
All animal studies were approved by the Rothamsted Research Ethical Review Board and 
animal care and use protocol protocols adhered to the Animals (Scientific Procedures) Act 
1986 as revised 1 January 2013 to comply with European Directive 2010/63/EU, permit 
number (3003338). 
 
2.9.2 Animal handling 
On the day of sampling, animals were herded from their barn to a handling area consisting of 
consecutive pens leading to a race and cattle crush. All procedures were performed on animals 
restrained within the crush. Animals were restrained using a halter for collection of nasal 
swabs, jugular blood samples and administration of intra-nasal vaccine/diluent. In some 
instances, smaller individuals were physically restrained by placing an arm over the animals’ 
head and holding it close to the handlers’ body. When collecting jugular blood, a tail bar was 
employed to prevent backwards movement of the animal in the crush. 
 
2.9.3 Sample collection workflow 
Procedures were performed in the following order: i) nasal swab, ii) rectal temperature, iii) 
intra-nasal vaccination/saline, and iv) jugular blood collection. The same individual (Amy 
Thomas; AT) collected nasal swabs, administered vaccine and performed clinical observations. 
 
2.9.4 Sample labelling 
Swabs and blood samples were marked with pre-printed labels, each consisting of a unique 
laboratory reference number, visit and study number, shortened management tag identification 
number and details of sample type. Laboratory reference numbers ranged between 1 to 90 for 
animals born in 2015, and between 91 to 179 for animals born in 2016. Each reference number 
was randomly affiliated to an animal’s management tag number, this was performed by 
generating random values using the RAND() function in Microsoft Excel® (version 16.16.1 
[180814]) for each animals management tag, then sorting the random number list in ascending 
order; the smallest random value corresponded to the start of the laboratory reference number 
list (ordered smallest to largest). Only laboratory reference numbers were used in the laboratory 
to identify samples during processing.  
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2.9.5 Nasal swabs: collection, processing and storage 
2.9.5.1 Short nasal swabs 
Nasal swabs with breakable cotton tips (Medical Wire & Equipment, Corsham, UK) were 
collected from each calf as follows: any excessive debris on nares was cleaned with a 
disposable tissue/paper towel. The 15 cm long swab was inserted to approximately 10cm depth 
and rotated 360° against the mucous membranes, then withdrawn carefully, avoiding contact 
with other areas of the nasal cavity. The cotton tip was aseptically broken off into 1.5 ml skim 
milk, tryptone, glucose, glycerol (STGG) broth (Media services, School of Cellular and 
Molecular Medicine, University of Bristol, UK) for culture and qPCR.  
Dual-tipped cotton swabs (Dual HydraFlock, Standard Tip, Flexible Shaft, 30 mm Moulded 
Breakpoint, Medical Wire & Equipment, Corsham, UK) were collected according to single 
tipped swabs, however one tip was transferred to STGG and the other to RNAlater stabilisation 
solution (ThermoFisher Scientific, UK). Swab samples were marked with a random number 
using pre-printed labels, maintained at 4°C for no more than 3 hours and then vortexed to 
release bacteria into the STGG and frozen at -70°C until further analysis [171] [172]. Gloves 
were changed between handling each animal. 
 
2.9.5.2 Deep guarded nasal swabs  
Deep guarded nasopharyngeal swabs with cotton tips (Duggan Veterinary Supplies Ltd., 
Ireland) were collected from a subset of calves following collection of short nasal swabs, 
providing a set of paired samples. The same nostril was sampled using both short and deep 
nasal swabs. Deep nasal swabs (Figure 2.4) were collected as follows: the distance from the 
nostril to the medial canthus of the eye was measured and the guarded swab inserted into the 
ventral meatus of the nose, then advanced as far as the pre-measured distance (from nostril to 
eye). The outer sheath was retracted 1–2 inches and the swab pushed through the protective 
capped-end and rotated against the pharyngeal mucosa. Finally, the swab was retracted back 
into the protective outer sheath (minimum retraction of 3 cm) and carefully withdrawn. Using 
a sterile pair of scissors (Rocket Suture Scissors 11cm, Rocket Medical) the swabs’ shaft was 
cut approximately 1–2 cm below the cotton tip, and aseptically transferred into STGG medium 
for bacteriology and qPCR. Gloves were changed between animals. One pair of scissors was 




Figure 2.4: Photograph of the tip of a deep guarded nasopharyngeal swab, pictured with i) the cap in place and ii) 
with the cap removed and inner swab extended. 
 
2.9.5.3 Transport and storage of nasal swabs 
Nasal swabs stored in STGG transport medium and RNAlater stabilisation solution 
(ThermoFisher Scientific, UK) were maintained at 4°C during sample collection and transport 
to the laboratory for further processing and storage. Swabs stored in STGG were maintained 
for no more than 3 hours, then kept on ice, vortexed for 30 s and transferred to -70°C until 
analysis [171] [172]. Swabs stored in RNAlater were processed identically following overnight 
storage at 4°C.  
 
2.9.6 Jugular blood samples: collection, processing and storage 
Paired jugular blood samples were collected to detect evidence of natural viral infection on the 
NWFP by common bovine viruses and Mycoplasma bovis.  
A jugular venous blood sample was collected into a plain Vacutainer (Becton Dickinson, 
Plymouth UK). Blood samples were allowed to clot at room temperature for a minimum of  
30–60 minutes and were either processed immediately or stored overnight at 4°C. Samples 
were centrifuged at room temperature for 15 minutes, 1000-1200 g and serum aspirated into 
cryovials (approximately 1.5ml aliquots). Sera were stored at -70°C until processed. 
Sera were analysed for the presence of antibodies against BHV-1, BVDV, BRSV, BPIV-3 and 
Mycoplasma bovis using a semi-quantitative indirect ELISA (Bio K 284, Multiscreen Ab 
ELISA Bovine Respiratory, BioX Belgium). Following the manufacturer’s protocol, test 
samples were tested in duplicate.  
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2.10 Calf health observations and rectal temperatures 
Animals were observed daily by animal technicians for signs of abnormal behaviour or reduced 
feed intake. Any cattle showing abnormal behaviour that might have indicated poor health were 
observed in more detail by AT for signs of respiratory disease and observations were recorded 
using a standardised scoring system that included cough, nasal and ocular discharge, abnormal 
ear/head tilt and rectal temperature (as shown previously in Chapter 1, Figure 1.2) [36] [37]. 




Calves were vaccinated with modified live BRSV and BPIV-3 (Rispoval RS+PI3 IntraNasal, 
Zoetis Animal Health). The vaccine contained BPIV-3 thermosensitive strain RLB103, 
between 105.0 and 108.6 cell culture 50% infective doses (CCID50) and BRSV, strain 375, 
between 105.0 and 107.2 CCID50, supplied with sterile diluent (water for injection and sodium 
chloride, 18 mg per 2 ml) for reconstitution. Vaccine was administered bilaterally as a single 
2 ml dose with an intranasal applicator supplied by the vaccine manufacturer. Gloves and 
applicators were changed between animals. Control calves in the stepped-wedge trial received 
2 ml of saline (0.9% w/v sodium chloride, Zoetis Animal Health) by an identical route.  
 
2.12 Preparation and completion of ELISAs 
2.12.1 BioX ELISA principle 
The commercial BioX indirect ELISA employs a 96 well microtitration plate sensitized by 
monoclonal antibodies to BHV-1, BVDV, BRSV and BPIV-3. Recombinant protein from 
Mycoplasma bovis expressed in E. coli is also used (Figure 2.5). If specific immunoglobulins 
are present in the test sera the conjugate remains bound to the corresponding microwell and the 
enzyme catalyses the colour change to blue, the intensity of the blue colour is proportionate to 
the titre of specific antibody in the sample. 
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Figure 2.5: Principle of BioX multiplex ELISA detecting and semi-quantifying antibodies to: bovine herpes virus 
1 (BHV-1), bovine viral diarrhoeal virus (BVDV), bovine respiratory syncytial virus (BRSV), bovine 
parainfluenza virus (BPIV-3) and Mycoplasma bovis. 
 
2.12.2 BioX ELISA conduct 
Each 96 well plate was loaded with 12 samples in total, tested in duplicate, an example of the 
plate layout is given Figure 2.6. 
 
Diluted test sera (1:100) and positive and negative controls were incubated on a 96 well plate 
for one hour 21°C +/- 3°C. After washing, a peroxidase-labelled anti-bovine IgG1 monoclonal 
antibody (conjugate) was added to the wells and incubated to detect bound antibody. The plate 
was washed for a second time and a positive result was visualised following addition of 
chromogen (tetramethylbenzidine) - positivity was signified by the colourless chromagen 
transforming into a pigmented compound. Signals from negative control wells were subtracted 
from the corresponding positive microwells. Reactivity of test serum was quantified into six 




1 2 3 4 5 6 7 8 9 10 11 12 
A SAMPLE 1  SAMPLE 1  SAMPLE 1 SAMPLE 1 SAMPLE 1 SAMPLE 1 SAMPLE 7 SAMPLE 7 SAMPLE 7 SAMPLE 7 SAMPLE 7 SAMPLE 7 
B SAMPLE 2 SAMPLE 2 SAMPLE 2 SAMPLE 2 SAMPLE 2 SAMPLE 2 SAMPLE 8 SAMPLE 8 SAMPLE 8 SAMPLE 8 SAMPLE 8 SAMPLE 8 
C SAMPLE 3 SAMPLE 3 SAMPLE 3 SAMPLE 3 SAMPLE 3 SAMPLE 3 SAMPLE 9 SAMPLE 9 SAMPLE 9 SAMPLE 9 SAMPLE 9 SAMPLE 9 
D SAMPLE 4  SAMPLE 4  SAMPLE 4 SAMPLE 4 SAMPLE 4 SAMPLE 4 SAMPLE 10 SAMPLE 10 SAMPLE 10 SAMPLE 10 SAMPLE 10 SAMPLE 10 
E SAMPLE 5  SAMPLE 5  SAMPLE 5 SAMPLE 5 SAMPLE 5 SAMPLE 5 SAMPLE 11 SAMPLE 11 SAMPLE 11 SAMPLE 11 SAMPLE 11 SAMPLE 11 
F SAMPLE 6  SAMPLE 6  SAMPLE 6 SAMPLE 6 SAMPLE 6 SAMPLE 6 SAMPLE 12 SAMPLE 12 SAMPLE 12 SAMPLE 12 SAMPLE 12 SAMPLE 12 
G                         
H                         
             
Col: 6 & 12 One monoclonal antibody 
         
  Positive serum H1 - H12 
         
  Negative serum G1 - G12 
         
 
Figure 2.6: BioX ELISA sample plate layout template. 
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The optical density (OD) of the blank wells (e.g. column 6) was subtracted from the OD of 
corresponding wells containing sample (e.g. columns 1 to 5). This was repeated for positive 
and negative control wells (e.g. G1 to G6; H1 to H6). The test was validated only if the positive 
serum yielded a difference in optical density at 10 minutes greater for each valence than: 
BHV-1 > 1.000; BVDV > 1.100; BRSV > 1.100; BPIV-3 > 1.000; M. bovis > 1.100, 
and the negative serum yielded a difference in optical density that was lower than 0.300. 
The signal read for each sample was divided by the corresponding positive control serum signal 
and multiplied by 100 to express it as a percentage.  
Value  =  (Delta OD Sample * 100) / (Delta OD positive) 
The guide table provided in the kit instructions was used to determine the sample serum’s 
degree of positivity (Table 2.1). A frank seroconversion was considered to have occurred if the 
signal increased by two orders of magnitude/two categories of seropositivity (for example, 2 
to 4 or 1 to 3). A sample was considered positive if its category was determined at 1 or more 
(denoted by + in Table 2.1).  
 
Table 2.1: Values to determine serum degree of positivity 
 
 
2.13 Preparation and completion of bacterial nucleic acid extraction 
2.13.1 Preparation of bacterial stocks  
For bacterial stocks of reference strains stored in glycerol broth, a 50 µl aliquot of sample was 
diluted 1:10 with 450 µl of L6 lysis buffer (Public Health England, Bristol, UK). Dilutions 
were prepared in 2 ml screw cap extraction tube and extracted no later than 2 h post preparation.  
 
2.13.2 Preparation of nasal swabs 
Frozen nasal swab samples were thawed on ice and then vortexed for 30 s. Sample (300 µl) 




2.13.3 Extraction of nucleic acid  
Extractions of nucleic acid from bacterial stocks and nasal swabs were carried out using a 
proprietary kit (QIAsymphony DSP virus/pathogen Mini Kit, Qiagen, CA, USA) in an 
automated instrument (QIAsymphony SP, Qiagen, CA, USA). An elution volume of 140 µl 
was produced from 200 µl of the 300 µl sample aliquot. To determine successful DNA 
extraction and absence of PCR inhibition the enterobacteriophage T4 was used as an internal 
amplification control [171]. Prior to nucleic acid extraction, bacterial stocks either inactivated 
with heat or L6 buffer were plated onto solid agar and incubated overnight, no growth was 
observed for either methods confirming successful inactivation.  
 
2.14 Conduct of real-time PCR assays for detection of Pasteurellaceae 
PCR runs were carried out using MicroAmp optical 384-well reaction plates (Life 
Technologies, USA), performed on a ViiA7 real-time PCR instrument (ThermoFisher 
Scientific) or a QS7 real-time PCR instrument (ThermoFisher Scientific) where specified. The 
PCR was performed in a 20 µl reaction mix containing 10 µl TaqMan® (Applied Biosystems), 
5 µl Primer/Probe Mix (Sigma Life Science) and 5 µl nucleic acid template. Working 
concentrations of primers and probes were 300 nM and 100 nM respectively.  
 
Primer and probe details used to detect and quantify H. somni, M. haemolytica and P. multocida 
are given in Table 2.2 and those to detect T4 are given in Table 2.3. Cycling conditions for 
H. somni, P. multocida and T4 assays were performed using standard TaqMan cycling 
conditions: 95°C for 20 s hold stage, followed by 50 cycles of 95°C for 3 s and 60°C for 60 s. 
The T4 PCR assay detected presence of the enterobacteriophage T4 in all samples extracted by 
automated methods described in 2.13.3. Presence of T4 indicated successful DNA extraction 
and no evidence of PCR inhibition. Cross-reactivity was observed for M. haemolytica using 
standard TaqMan conditions (further details are given in Chapter 3). Optimised conditions 
were employed: 95°C for 20 s hold stage, followed by 50 cycles of 95°C for 3 s and 60°C for 
60 s.
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Table 2.2: Primer and probe sequences used to detect and quantify Histophilus somni, Mannheimia haemolytica and Pasteurella multocida from bovine nasal swabs using 
qPCR 





H. somni  16S rRNA Hsomni-TMF  AGGAAGGCGATTAGTTTAAGAGATTAATT  29 58.8 
Mahony and 
Horwood 2007 
H. somni  16S rRNA Hsomni-TMR TCACACCTCACTTAAGTCACCACCT  25 60.0 
Mahony and 
Horwood 2007 
H. somni  16S rRNA Hsomni-TMP ATTGACGATAATCACAGAAGAAGCACCGGC  30 69.7 
Mahony and 
Horwood 2007 
M. haemolytica sodA Mhae-SGF AGCAGCGACTACTCGTGTTGGTTCAG 26 65.6 Guenther et al. 2008  
M. haemolytica sodA Mhae-SGR AAGACTAAAATCGGATAGCCTGAAACGCC 29 68.7 Guenther et al. 2008  
M. haemolytica sodA Mhae-TCR TTGTAAACTGGGACGAAGCC 20 56.7 This study  
M. haemolytica sodA Mhae-BV1P FAM TTCAACCGCTAACCAGGACAACCCAC 26 59.7 This study 
P. multocida 16S rRNA Pmulti-TMF CGCAGGCAATGAATTCTCTTC 21 56.2 
Mahony and 
Horwood 2007 
P. multocida 16S rRNA Pmulti-TMR GGCGCTCTTCAGCTGTTTTT 20 57.1 
Mahony and 
Horwood 2007  
P. multocida 16S rRNA Pmulti-TMP ACTGCACCAACAAATGCTTGCTGAGTTAGC  30 58.4 
Mahony and 
Horwood 2007  
* PP: Primer and probe 
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Table 2.3: Primer and probe sequences used to detect enterobacteriophage T4 for assurance of successful DNA extraction and amplification  




Enterobacterio phage T4 gp18 tail sheath gene T4-BV1F GTTGAAAACGAATATCGGACGTAGT 25 58.6 
Unpublished 
B. Vipond 
Enterobacterio phage T4 gp18 tail sheath gene T4-BV1FR CCTTGTAAGTACTGGGCAGTTTCTG 25 59.3 
Unpublished 
B. Vipond 
Enterobacterio phage T4 gp18 tail sheath gene T4-BV1P CAACGCGTTTACTCGTTCATCATTCC 27 68.5 
Unpublished 
B. Vipond 
* PP: Primer and probe 
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2.15 Analysis of PCR assays: thresholds and baseline settings 
Table 2.4 illustrates threshold values set for H. somni, M. haemolytica, P. multocida and 
T4 PCR assays during method development and analysis of nasal swabs. Thresholds were 
manually set above any background amplification visualised on amplification plots, and 
in the exponential phase of amplification. Baseline settings were not changed from the 
software auto-baseline function. Cycle quantification (Cq) values were obtained when 
amplification curves intersected the defined threshold. 
 
Table 2.4: Analysis settings used to define qPCR thresholds  
Species/Target 
Assay development threshold 
(fluorescence units) 
Nasal swab threshold 
(fluorescence units) 
 Viia* QS7* Viia* QS7* 
H. somni 0.005 0.005 0.005 0.005 
M. haemolytica 0.005 0.015 NA 0.015 
P. multocida  0.005 0.005 0.005 0.005 
T4  NA NA 0.01 0.01 
* PCR instrument 
 
2.16 Sequencing  
2.16.1 DNA preparation for sequencing 
Bacterial isolates were sequenced following amplification of variable regions of the 
16S rRNA genome. DNA was extracted from bacterial isolates as previously described 
(see 2.13.3). PCR runs were carried out using 96 well FrameStar® Break-A-way plates 
and sealed with FrameStrips™ (Brooks Life Sciences, 4titude, UK) performed on a 
Mx3005P qPCR instrument (Agilent Technologies, Santa Clara, USA). The PCR was 
performed in a 25 µl reaction mix containing: 9 µl Nuclease-Free Water (Promega, UK), 
12.5 µl Go Taq Hot Start (Promega, Madison, USA), 0.5 µl SYBR™ Green I Nucleic 
Acid Gel Stain (1:1000 dilution in Nuclease-free water; Life Technologies, Carlsbad, 
USA), 1 µl forward primer, 1 µl reverse primer and 1 µl nucleic acid template. Working 
concentrations of primers were 100 nM (diluted in AE buffer; Qiagen, Hilden, Germany) 
and purchased from Eurofins Genomics (Ebersberg, Germany).  
DNA extracts were amplified using two sets of primers (PP1: 337F & 518R; PP2: 928F 
& 1100R) described in ( 
Table 2.5) under the following cycling conditions: 95°C for 10 minutes (1 cycle, hot start 
stage), followed by 40 cycles of 95°C for 30 s and 60°C for 60 s, finally a dissociation 
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curve was run for 1 cycle of 95°C for 60 s, 55°C for 30 s and 95°C for 30 s. PCR products 
were visualised on a 1% agarose gel; 10 µl product with 2 µl orange loading dye (Sigma 
Aldrich). Gels were prepared according to the recipe given in Appendix A. Gels were 
run at 100 V for ~70 min and included 3 µl of a 50 bp and 100 bp ladder (Bioline, UK). 
Gels were visualised using a UV transilluminator instrument (Ultra-Violet Products Ltd, 
Cambridge, UK). PCR product sizes for PP1 and PP2 were expected at 181 bp and 172 
bp respectively. 
 
Table 2.5: Primer sequences used for sequencing bacteria isolated from bovine nasal swabs and purchased 
strains
Primer 
Name   Primer Sequence (5'-3') Target Reference and notes1 
337F GACTCCTACGGGAGGCWGCAG 16S 
Modified Wang and Qian 
(2009) [173] 
518R GTATTACCGCGGCTGCTGG 16S 




GG 16S  
Modified Lane (1991) 
[174] 
1100R GGGTTGCGCTCGTTG 16S  Lane (1991) [174] 
785F GGATTAGATACCCTGGTA 16S 
Modified Wang and Qian 
(2009) [173] 
907R CCGTCAATTCCTTTRAGTTT 16S Lane (1991) [174] 
1 Universal primers designed in other studies to detect conserved constant regions of the 16S rRNA gene 
of all bacterial species. Modifications included reduction in length to produce primers within a pair of 
similar melting temperatures or modification in reverse compliment.  
 
2.16.2 Preparation for sequencing of purchased bacterial strains 
DNA extracts were amplified using two sets of primers (PP3: 337F & 907R; PP4: 785F 
& 1100R as described in  
Table 2.5 under the following cycling conditions: 95°C for 10 minutes (1 cycle, hot start 
stage), followed by 40 cycles of 95°C for 60 s, 54°C for 60 s and 72°C for 120 s, followed 
by 1 cycle of 72°C for 10 minutes. Working concentrations of primers were 100 nM 
(diluted in AE buffer; Qiagen, Hilden, Germany) and purchased from Eurofins Genomics 
(Ebersberg, Germany). PCR runs were carried out using 96 well FrameStar® Break-A-
way plates and sealed with FrameStrips™ (Brooks Life Sciences, 4titude, UK) 
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performed on a SureCycler 8800 instrument (Agilent Technologies, Santa Clara, USA). 
The PCR was performed in a 25 µl reaction mix containing: 9.5 µl Nuclease-Free Water 
(Promega, UK), 12.5 µl Go Taq Hot Start (Promega, Madison, USA), 1 µl Forward 
Primer, 1 µl Reverse Primer and 1 µl nucleic acid template. 
PCR products were visualised on a 1% agarose gel; 10 µl product with 2 µl orange 
loading dye (Sigma Aldrich). Gels were run at 100 V for ~90 minutes and included 3 µl 
of a 50 bp and 100 bp ladder. PCR product sizes for PP3 and PP4 were expected at 141 bp 
and 328 bp respectively.  
 
2.16.3 Preparation for sequencing H. somni, M. haemolytica and P. multocida PCR 
products 
Representative PCR products generated from amplification of target species (H. somni, 
M. haemolytica and P. multocida) were sequenced to confirm their identity. DNA 
extracts from liquid broth culture for each species were used as template. PCR products 
with low Cq values (~12) were selected based on their presumptive high DNA template 
concentration. 
 
2.16.4 PCR product purification, sequencing and sequence analysis 
All PCR products intended for sequencing were purified using a QIAquick PCR 
purification kit (Qiagen, CA, USA) as per manufacturing protocols. A 15 µl aliquot of 
purified PCR product was mixed with 2 µl of forward primer and sent to Eurofins 
(Eurofins Genomics GmbH, Ebersbergm, Germany). Purified PCR products were 
independently mixed with 2 µl of forward and 2 µl of reverse primer. Files were supplied 
as .ab and used to visually inspect chromatograms using SnapGene® Viewer software 
(Version 1.4.5, GSL Biotech, available at snapgene.com). Sequences were cleaned 
accordingly, for example where peaks were not evenly spaced and overlapping these 
areas of sequences were clipped (occurring at the start of the sequence). Cleaned 
sequences were supplied as FAST-All (FASTA) format to Basic Local Alignment Search 
Tool (BLAST). Homology between unknown candidate sequences to known sequences 




2.17 Analysis of binary response variables 
Binary responses take only two values: 0 or 1. For example, bacterial carriage is either 
present (1) or absent (0). Binary response variables were analysed using either logit 
models or log-linear models where stated. When explanatory variables had no non-
unique values log-linear models were used by aggregating data into counts so that each 
count took a unique set of explanatory variables [175].  
 
2.18 Construction of log-linear models 
Log-linear models are generalised linear models used to analyse Poisson distributed data. 
They are commonly used for modelling cell counts in contingency tables; models specify 
how the number of counts within a cell depend on the levels of categorical explanatory 
variables for that cell. They are particularly useful when at least two variables in a 
contingency table are response variables; when one variable is the binary response and 
others are explanatory variables, certain log-linear and logit models are equivalent [176]. 
For all analyses using log-linear models count data was constructed in the form of a 
contingency table. A baseline model was then built which defined the overall structure 
of the data i.e. margins of the contingency table. To this baseline model explanatory terms 
were added in a sequence of increasing complexity until the saturated model, including 
all terms and the interactions between them was reached. Model parameters were 
interpreted by referring to the highest-order terms, relating directly to odds ratios. Model 
fit was assessed by comparing observed to fitted counts [176].  
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Chapter 3 Real-time PCR for detection and quantification of 
H. somni, M. haemolytica and P. multocida 
 
3.1 Introduction  
Bacterial carriage in the bovine upper respiratory tract has been detected most frequently 
by culture [135, 145-147, 153]. Difficulties have been reported due to the fastidious 
nature of organisms and overgrowth by faster growing species [149]. Bacterial 
involvement in bovine respiratory disease (BRD) frequently involves members of the 
Pasteurellaceae family. Pasteurellaceae normally inhabit the mucous membranes of the 
alimentary, genital and respiratory tracts of vertebrates [67]. Histophilus somni, 
Mannheimia haemolytica, Pasteurella multocida and to a lesser extent, Bibersteinia 
trehalosi are implicated in cases of BRD. The studies presented in this thesis focus on 
H. somni, M. haemolytica and P. multocida. The taxonomy of this family has frequently 
been revised: however, as molecular techniques have advanced, the differentiation 
between species has improved [78], consequently allowing in-depth investigation of 
organisms that are currently difficult or impossible to culture, for example by PCR [152] 
and sequencing [177-179]. 
 
Nucleic-acid-based amplification relies on sequence-based hybridisation chemistry using 
DNA (deoxyribonucleic acid) probes. Probes are short, labelled, single-stranded DNA 
segments which are designed to hybridise to complementary sequences of DNA. In 1980, 
use of probes to rapidly detect microbial DNA was demonstrated using a filter 
hybridisation assay method to detect enterotoxigenic Escherichia coli in stool samples 
[180]. The method showed enhanced performance as compared to culture. However, it 
relied on hybridisation of DNA probes to fixed target DNA (stool samples spotted onto 
filters), which increased the test time as compared to having both the probe and target 
sequence free in solution – this was the next advancement [181]. In 1983, Kary Mullis 
and colleagues invented PCR: a rapid, sensitive and simple technique to directly amplify 
target DNA. The capacity of PCR to amplify complete genomic sequences from tiny 
amounts of target molecules has led to its use in many analytical techniques and 
technological advances. Its profound effect within a range of fields has been recognised, 
and ten years after its invention, Mullis and colleagues were awarded the ‘Nobel Prize 
for Chemistry’. Figure 3.1 shows the principles of the reaction. In brief, the DNA 
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sequence of the target is used to design complementary oligonucleotide primers which 
hybridise to specific regions of the target DNA. The reaction is enzymatic, driven by a 
thermostable DNA polymerase, which amplifies the target sequence flanked by two 
primers in the presence of nucleotides. Repeat cycles of heating and cooling in a 
thermocycler allow DNA denaturation, primer hybridisation (annealing), and primer 
extension, resulting in exponential amplification of the target: the number of target DNA 




Figure 3.1: Schematic of the polymerase chain reaction: within a thermocycler DNA template is (1) 
denatured into single-stranded DNA; (2) primers anneal to complimentary sequence; (3) DNA polymerase 
extends primers to generate a new copy of the target DNA. The cycle is repeated, with newly synthesized 
strands of target DNA acting as further templates for subsequent cycles. Schematic unmodified from Yang 
et al. [182] 
 
Following widespread use of conventional PCR, real-time PCR or quantitative (qPCR) 
was introduced as a further development of this method for detection and quantification 
of nucleic acids. The technique was pioneered by Russell Higuchi, who first described 
its use in 1993 [183]. Higuchi and colleagues utilised the fluorescence enhancement 
produced when DNA-binding dye ethidium bromide binds to dsDNA, allowing 
monitoring of fluorescence corresponding to increasing cycles of amplification. During 
the PCR reaction process, as dsDNA is produced, instead of measuring the amount of 
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PCR product produced at the end of thermocycling using gel electrophoresis (e.g. 
competitive PCR) [184] [185]. Higuchi et al. employed kinetic analysis of fluorescence 
in real-time (continual monitoring during the annealing/extension phase). This real-time 
monitoring allowed calculation, by backward extrapolation, of the starting number of 
DNA targets and was advantageous for DNA detection over a wide dynamic range, 
including investigation into the effect of different reaction conditions on PCR kinetics 
[183]. The ability of qPCR to detect target sequences reliably from a range of samples 
has led to its widespread use, for example, in agricultural, forensic, medical and historical 
settings [186]. 
 
DNA detection systems in qPCR have subsequently evolved to include probes: molecular 
beacons [187], hydrolysis and scorpion probes, although dsDNA intercalating dyes, for 
example cyanine dyes such as SYBR® Green are still used in some settings.  
Probes are single-stranded nucleic acid molecules, with a sequence which is 
complementary to that of the target nucleic acid. A fluorescent moiety is attached to one 
end and a non-fluorescent quenching moiety to the other end. When the moieties are in 
close proximity to each other, the fluorescence of the fluorophore is quenched by 
fluorescence resonance energy transfer (FRET). When the fluorophore is not in close 
proximity to the quencher and is illuminated by ultraviolet light, it fluoresces [187]. 
 
In a TaqMan PCR assay a pair of primers and a non-extendable probe are used. The probe 
is a hydrolysis probe which binds to the target within the region delimited by the primers. 
As the probe is an oligonucleotide, its binding to its complimentary sequence can 
enhance an assay’s specificity. Typically, the 5’ terminus of the probe is labelled with a 
fluorophore (reporter) and the 3’ terminus with a quencher. Dyes such as FAM™ or 
VIC™ are popular choices for the reporter, with TAMRA™ used for the quencher dye. 
As the reaction proceeds, the TaqMan probe hybridises to the target sequence 
downstream of one of the primers (Figure 3.2). The upstream primer begins to be 
extended and the Taq polymerase-mediated 5’ to 3’ hydrolysis of the probe begins. This 
exonuclease activity of Taq polymerase results in removal of any sequences in the 
enzyme’s path. As a result, the probe is dissociated, and the fluorophore and quencher 
are no longer in close proximity to each other, disrupting the FRET and resulting in dye 
release. Upon subsequent illumination, fluorescence is detectable with a dye-specific 
wavelength and this fluorescence signal is proportional to the amount of accumulated 
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PCR product [188]. Quantification of DNA target may be achieved either through 
absolute or comparative quantification. Absolute quantification describes estimation of 
target copy numbers by reference to a standard curve constructed using a defined 
concentration of standards. Comparative (relative) quantification estimates the relative 
change in target copy numbers in relation to a reference (e.g. GAPDH); however, it relies 
on the assumption that the amplification efficiencies of the target and reference are very 
similar [189]. The fluorescence generated is reliant on complementarity between the 
TaqMan probe and the DNA template sequence, if there are mismatches between the 
sequences, failure appropriately to detect the DNA template may occur [190]. 
 
 
Figure 3.2: TaqMan 5’ nuclease activity [190] 
 
The typical workflow for PCR primer design consists firstly of defining the target and 
designing primers, then testing specificity in silico with primer BLAST and finally 
screening for dimers. Next, primers may be characterised to determine optimum 
annealing temperatures and concentrations by performing a gradient PCR and generating 
a concentration matrix, respectively. If there are several primer candidates, then the 
optimal primer combination is determined. Next, specificity for target is determined by 
testing a panel of related and common heterologous DNA extracts – known as a 
specificity panel. In the case of a PCR to detect a particular species of bacteria, this panel 
would typically consist of DNA extracts from cultures of genetically-related but distinct 
species and of species typically found in the same milieu or habitat as the target organism. 
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Finally, serial dilutions of template are used to generate a standard curve for evaluating 
assay operating parameters such as: amplification efficiency, limits of detection and 
quantification, linearity and dynamic range [191] [192]. PCR amplification efficiency is 
given by the slope of the standard curve from linear regression of cycle quantification 
(Cq) value against log[quantity DNA], or log[quantity DNA] vs Cq value, depending on 
the error term of interest. With a ten-fold dilution series of DNA, if perfect doubling 
occurs with each amplification cycle, then the efficiency will be 100%, given by a Cq 
value increase of 3.3 for every ten-fold dilution, or 0.3 when log[quantity DNA] is given 
as the response variable. Deviations from this workflow may occur depending on the 
purpose of the assay. For example, typically research assays do not require as stringent 
assessment of operating parameters as diagnostic assays.  
 
Historically, surveillance of Pasteurellaceae either from healthy animals or those 
suffering with BRD has largely relied on culture. PCR assays designed to detect 
H. somni, M. haemolytica and P. multocida and published prior to starting the studies 
presented in this thesis are shown in Table 3.1. Of these assays, only one was 
demonstrated to detect target species directly from clinical samples (trans-tracheal fluid) 
[148], whilst one other had the capability of quantification [151]. For the majority of 
assays described in Table 3.1, amplicon sizes were large and therefore primers were only 
suitable for use with conventional PCR. Generally, PCR assays have been developed to 
aid rapid detection of species from clinical cases, most commonly by culture-amplified 
PCR, which still requires initial culture of the clinical specimen and may employ 
transport media not suitable for PCR. Skim milk, tryptone, glucose, glycerol (STGG) 
broth is recommended by the World Health Organisation for studies investigating nasal 
carriage of Streptococcus pneumoniae [193] and is commonly used in human respiratory 
studies as a transport and storage medium suitable for bacterial culture and PCR [171] 
[83] [194] but, it has not been evaluated for use with Pasteurellaceae in veterinary 
settings. Cross-reactivity with closely-related species for M. haemolytica and 
P. multocida was reported for the assays presented in Table 3.1. However, published 




The objectives of the work presented in this chapter were to evaluate, optimise and 
validate three real-time PCR assays for detection and quantification of H. somni, 
M. haemolytica and P. multocida from pure cultures and directly from bovine nasal 
swabs.  
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Table 3.1: Published PCR assays for H. somni, M. haemolytica and P. multocida 
Species  Gene Target Amplicon 
size (bp) 
Comments Reference 
H. somni 16S rRNA 400  Angen et al. [152] 
 
H. somni 16S rRNA 160  Mahony and 
Horwood [195] 
M. haemolytica lkt 170 and 206 Multiplex PCR for: M. haemolytica, M. ruminalis, and M. 
glucosida. Two regions of the leukotoxin D gene were targeted. 
Unable to distinguish M. haemolytica from haemolytic M. 
ruminalis strains encoding segments of the leukotoxin operon 
Alexander et al. 
[48] 
M. haemolytica sodA 143 Multiplex SYBR-green PCR for: M. haemolytica, M. ruminalis,  
M. glucosida, M. varigena and M. granulomatis. Cross-reactivity 
between M. haemolytica and M. glucosida – resolvable by melt-
curve analysis. 
Guenther et al. 
[151] 
M. haemolytica lktC-artJ 385 Based on gene sequence upstream of the lineage-specific 
leucotoxin operon (lktCABD). Assay also recognised  
M. glucosida 
Angen et al [148] 
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Table 3.1 continued  
Species  Gene Target Amplicon 
size (bp) 
Comments Reference 
P. multocida kmt1 460 Targets outer membrane protein of all serogroups. Cross-
reactivity with P. canis biotype 2 was observed. 
Townsend et al. 
[150] 
P. multocida pm0762; 
pm1231 
567 and 601 
 
 
Putative transcriptional regulator genes Liu et al. [157] 
P. multocida 23S rRNA 1432 
 
Performed on colonies on primary isolation plates. Cross-
reactivity with P. canis biovar 2 and P. avium biovar 2 
Miflin et al. [196] 
P. multocida toxA 846 Differentiation between toxigenic and non-toxigenic isolates Lichtensteiger 
[197] 
P. multocida (A) hyaD-hyaC;  
(B) bcb; (D) 
dcbF; (E) ecbJ; 
(F) fcbD 
511 - 1,044 
 
 
Serogroup-specific multiplex-PCR for serogroups: A, B, D, E, F Townsend et al. 
[198] 
P. multocida 16S rRNA 74  Mahony and 
Horwood [195] 
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3.2 Materials and Methods 
3.2.1 Bacterial culture 
H. somni American Type Culture Collection (ATCC) 43625, M. haemolytica ATCC 
33396 and P. multocida ATCC 43137 were used as positive control strains for culture 
and PCR assay development. All reference strains used in the study (Table 3.2) for PCR 
assay optimisation and specificity testing were cultured on Columbia blood agar 
supplemented with 5% sheep blood (CBA; Thermo Fisher Scientific, Basingstoke, UK) 
overnight at 37°C with 5% CO2, except for H. somni and Haemophilus influenzae, which 
were cultured on Chocolate agar (E&O laboratories, UK) at 37°C, for 24 – 48 hours with 
5% CO2. All cultures were sub-cultured and Gram-stained to ensure purity. For long term 
storage, bacterial cells were harvested into Brain Heart Infusion broth or Haemophilus 
Test Medium (H. somni only) supplemented with 20% glycerol (Media Services, School 
of Cellular and Molecular Medicine, University of Bristol, UK) and stored at -70ºC. 
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Actinobacillus equuli NCTC† 8529 Equine, blood 
Actinobacillus ligieresii NCTC 4189  Bovine, sub-maxillary gland  
Actinobacillus 
pleuropneumoniae 
NCTC 11383  Ovine, arthritis  
Actinobacillus suis APHA‡ IS14-13758 Species unknown, liver 
Bibersteinia trehalosi APHA IS21-03264 Bovine, swab (location unknown) 
Enterococcus faecalis JH2-2 Unknown  
Escherichia coli ATCC®§ 25922 Species unknown, clinical isolate 
Fusobacterium necrophorum 
subsp. necrophorum 
APHA C977 Species unknown, foot  
Haemophilus parainfluenzae UoB¶, other carriage studies  Unknown  
Histophilus somni ATCC® 43625, type strain  Bovine, brain  
Mannheimia glucosida APHA IS14-07997* Bovine, lung 
(n = 5) CCUG¥ 38459 Ovine, lung 
 CCUG 38460 Ovine, lung 
 CCUG 38467 Ovine, lung 
 CCUG 38457, type strain  Ovine, lung 
Mannheimia granulomatis APHA IS14-13861* Bovine, lung 
(n = 2) CCUG 45422, type strain Bovine, subcutaneous granuloma 
Mannheimia haemolytica ATCC® 33396, type strain Ovine, location unknown 
(n = 4) V1-53-2 Bovine, nasal swab 
 V1-71-1-(19) Bovine, nasal swab 
 V1-37-1 Bovine, nasal swab 
Mannheimia ruminalis  CCUG 38470, type strain  Ovine, rumen  
(n = 2) APHA IS23-01503* Bovine, pericardium 
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Mannheimia varigena APHA IS12-04533 Bovine, lung 
Moraxella bovis NCTC 11013 Bovine, eye 
Moraxella bovoculi UoB, V1-26-1 Bovine, nasal swab 
Moraxella catarrhalis ATCC® 25240 Unknown 
Mycobacterium bovis BCG, Glaxo  Unknown 
Mycoplasma bovis  ATCC® 25523, type strain  Bovine, mastitis 
Pasteurella canis biotype 2 NCTC 11621, type strain  Canine, throat 
Pasteurella multocida ATCC® 43137, type strain  Porcine, location unknown 
(n = 4) UoB, V1-38-5 Bovine, nasal swab 
 UoB, V1-52-2 Bovine, nasal swab 
 UoB, V1-41-1 Bovine, nasal swab 
Pseudomonas aeruginosa UoB, other carriage studies  Unknown  
Rhodococcus equi  NCTC 10673 Unknown 
Salmonella dublin APHA R07571 Bovine, lung 
Salmonella typhimurium DT104 strain 30  Bovine, faeces 
Staphylococcus aureus ATCC® 25923 Clinical isolate 
Streptococcus agalactiae ATCC® 12403, type strain  Fatal septicaemia 
Streptococcus pluranimalium APHA C06551 Bovine, nasopharyngeal swab 
Streptococcus suis APHA 25  Bovine, lung 
Truepella pyogenes NCTC 5224 Porcine  
* Strains not included in final specificity panel testing 
† NCTC: National Collection of Type Cultures; ‡ APHA: Animal and Plant Health Agency;  
§ ATCC®: American Type Culture Collection; ¶ UoB: University of Bristol;  
¥ CCUG: Culture Collection University of Gothenburg  
 
3.2.2 Preparation of reference strains for DNA extraction 
To generate dilutions of reference strains used in specificity testing and as positive 
controls in PCR runs, frozen bacterial stocks (described above) were thawed, then ten-
fold serially diluted by taking 100 µl of starting suspension into 900 µl STGG broth.  
For H. somni (ATCC 43625), M. haemolytica (ATCC 33396) and P. multocida (ATCC 
43137), prior to DNA extraction a 300 µl aliquot of dilutions 10-1 to 10-10 were heat 
inactivated at 100°C for 10 minutes using a digital heat block (Grant Boekel, BBD, Grant 
Instruments, Cambridge, UK). Dilutions 10-3, 10-4 and 10-5 from the 
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Mannheimia haemolytica and Pasteurella multocida dilution series, and 10-2, 10-3 and 
10-4 from Histophilus somni were included in specificity panel testing and as positive 
controls in all PCR runs. All dilutions (10-1 to 10-10) were used in evaluating and 
informing selection of the optimum primer and probe combinations for H. somni, 
M. haemolytica and P. multocida assays described below in 3.2.5.  
Frozen stocks of reference strains used in specificity panel testing were ten-fold serially 
diluted in L6 lysis buffer (Public Health England, Bristol, UK). DNA extraction 
proceeded no later than 2 hours post preparation (see Chapter 2, section 2.13). Each 
bacterial species in the specificity panel was included at dilutions 10-3, 10-4 and 10-5. 
 
3.2.3 Validation of STGG broth as storage and transport media for Pasteurellaceae 
For comparison of Pasteurellaceae growth pre- and post-freezing in STGG broth 
bacterial reference strains representing H. somni, M. haemolytica and P. multocida were 
cultured according to conditions described above and Gram-stained to ensure purity. 
Approximately 8 well-isolated colonies of M. haemolytica and P. multocida were 
transferred to 1.5 ml STGG broth. A 50 µl aliquot of this neat inoculum was ten-fold 
serially diluted with STGG. Dilutions 10-1 to 10-10 were plated in triplicate by transferring 
50 µl of each dilution to the surface of an agar plate (CBA; Thermo Fisher Scientific, 
Basingstoke, UK) and spread evenly over the entire agar plate surface with a sterile 
plastic loop. Plates were incubated overnight at 37°C 5% CO2. 
For H. somni 8 well isolated colonies were transferred to Veterinary Fastidious Medium 
(VFM) (Oxoid, Basingstoke, UK) broth and incubated to log-phase of growth, described 
later in section 3.2.12. A 100 µl aliquot of this log-phase suspension was ten-fold serially 
diluted into STGG broth. Dilutions 10-4 to 10-7 were plated (100 µl) onto Chocolate agar 
(E&O laboratories, UK) and incubated overnight at 37°C 5% CO2. Immediately after 
plating, dilutions were transferred to -70°C. Dilutions were frozen for a minimum of 
24 hours, thawed on ice, and re-cultured under the same conditions as had been used for 
unfrozen aliquots. Colony counts were recorded after overnight incubation for all species. 
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3.2.4 Selection and design of primers and probes 
Primer and probe (PP) selection was informed by previously published targets.  
PPs used and designed in the development of each PCR assay are given in Table 3.3. PPs 
were designed to detect M. haemolytica by targeting the sodA gene encoding manganese-
dependent superoxide dismutase (Mn-SOD), as described previously by Guenther et al. 
[151]. Assays targeting sodA have shown improved ability to discriminate between 
species within the Mannheimia genus compared to corresponding 16S rRNA genes 
[151]. A novel probe (Mhae BVIP) was designed to work with published primers (Mhae-
SGF & Mhae-SGR) and a novel set of primers, again targeting sodA (Mhae-BV1F & 
Mhae-BV1R). For the development of the P. multocida assay, kmt1 encoding the outer 
membrane protein, described by Townsend et al. [150], was used as a target for which 
novel primers and probe sequences were designed. One forward primer (Pmulti-BV1F) 
and two reverse primers (Pmulti-BV1R & Pmulti-BV2R) were designed to work with a 
Taqman probe (Pmulti-BV1P) targeting kmt1. Published PP sequences targeting the 16S 
rRNA region of the P. multocida (Pmulti-TMF & Pmulti-TMR + Pmulti-TMP) and 
H. somni (Hsomni- TMF & Hsomni- TMR + Hsomni- TMP) bacterial genome were 
evaluated unmodified for both assays. No suitable published gene targets were found for 
H. somni at the time of development other than 16S rRNA.  Both novel and unmodified 
published PP sequences (shown in Table 3.3) were evaluated and optimized in silico 
using Primer Express Software 3.0 (Life Technologies). For each bacterial target, primers 
were aligned to all available complete genomes on Genbank. Specificity of PPs was 
assessed in silico by BLAST searches and using the National Center for Biotechnology 
Information database (NCBI). Following in silico analyses, the PPs shown in Table 3.3 
were synthesized by Sigma-Aldrich for wet lab analyses.
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Table 3.3: Primer and probe sequences used for qPCR assay development 
Target 





















Mh Mhae-BV1F GCGTGGTTAGTATTAGAAGAGGGTAAATTA 30 sodA 59.7 This Study  
2 144 
Mh Mhae-BV1R GAAACGCCTGCCACTTCTTT 20 sodA 58.1  This study  
  
Mh Mhae-SGF AGCAGCGACTACTCGTGTTGGTTCAG 26 sodA 65.6 
Guenther et al. 
2008  
3 92 
Mh Mhae-SGR AAGACTAAAATCGGATAGCCTGAAACGCC 29 sodA 68.7 






FAM AAGACTAAAATCGGATAGCCTGAAACGCCTG 26 sodA 68.4  This study  
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Table 3.3 continued 
Target 














Pm Pmulti-TMR GGCGCTCTTCAGCTGTTTTT 20 16S rRNA 58.3 
Mahony and 
Horwood 2007  
 
Pm Pmulti-BV1F CCGGCAAATAACAATAAGCTG 21 kmt1 56.2 This study 5 87 
Pm Pmulti-BV1R TGTTGAGCCAATCYGCTTCC 21 kmt1 
51.5 – 
56.6† This study  
 74 
84‡ 
Pm Pmulti-BV2R TGTTGAGCCAATCYGCTTCC 20 kmt1 
57.5 – 
62.0† This study 
6 
Pm Pmulti-BV1P  ATAAATAACGTCCAATCAGTTGCGCCGT 28 kmt1  67.4 This study 
  
 




* Hs: Histophilus somni; Mh: Mannheimia haemolytica; Pm: Pasteurella multocida 
† Wobble base in primer gives two Tm values; Y = T or C; ‡ BVIF and BVI2R additional primer pair evaluated 
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3.2.5 Viability of primer and probe combinations 
Following in silico primer design and evaluation, wet lab primer characterisation was 
undertaken. The M. haemolytica and P. multocida assays had more than one forward and 
reverse primer candidate, generating the PP combinations given in Table 3.3. There was 
one forward and reverse primer candidate as per Mahony and Horwood 2007 for 
H. somni. For each PP combination, assays were first run with molecular grade water 
(Sigma Aldrich) as template to ensure purity of PP stocks. PCR reactions were conducted 
as detailed in Chapter 2, section 2.14, with the exception of the M. haemolytica assay 
which was performed under standard Taqman cycling conditions: 95°C for 20 s hold 
stage, followed by 50 cycles of 95°C for 3 s and 60°C for 60 s. 
Next, for each bacterial target species, nucleic acid was extracted from dilutions 10-1 to 
10-10 of a ten-fold dilution series as detailed above in section 3.2.2. Nucleic acid was 
included in triplicate as template for evaluating the optimum PP combination for each 
PCR assay. The optimum PP combination for each target species was evaluated by 
assessing reproducibility between replicates, linearity of dilution series and dynamic 
range. 
 
3.2.6 Specificity panel 
To determine the specificity of the three assays, a panel of 40 bacterial strains (Table 3.2) 
were selected based either on genetic relatedness to target organisms, known 
involvement with respiratory disease in ruminants, or being common bacteria of different 
genera. Specificity panel bacteria were cultured overnight as described above and diluted 
10-3, 10-4, 10-5 in L6 lysis buffer (Public Health England, Bristol, UK), followed by 
automated DNA extraction using a QIAsymphony SP instrument (as described 
previously in Chapter 2, section 2.13.3). 
 
3.2.7 Sequencing Mannheimia spp. sodA gene 
Under standard TaqMan cycling conditions as described above, cross-reactivity was 
observed between Mannheimia haemolytica ATCC 33396 and Mannheimia glucosida 
CCUG 38457 T in specificity testing. The forward primer Mhae-SGF is located in a 
constant region of the sodA gene, therefore the specificity for this PP combination is 
generated by the reverse primer. It was hypothesized that inadequate divergence in the 
reverse primer region of sodA between M. haemolytica and M. glucosida was responsible 
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for the observed cross-reactivity. To test this hypothesis, a new reverse primer,  
Mhae-TCR (detailed in Chapter 2, Table 2.2), was designed to anneal upstream of Mhae-
SGR and work with Mhae-SGF, amplifying the corresponding partial sodA sequences of 
M. haemolytica and M. glucosida (Figure 3.3). 
 
 
Figure 3.3: Partial Mannheimia haemolytica sodA gene with primer positioning. Bases in red indicate 
where the partial sequences start and end. Yellow highlights the Mhae-SGF and Mhae-SGR primer 
positions. Green shows bases within primers at which M. haemolytica differs from M. glucosida. Blue 
highlights the position of primer Mhae-TCR, upstream of Mhae-SGR. 
 
3.2.8 Investigating divergence in partial sodA sequences of Mannheimia spp. 
Divergence in partial Mannheimia sodA sequences between all species of the genus was 
investigated using eleven representative strains of Mannheimia shown in Table 3.4 
(additional strain info given above in Table 3.2). Strains included Mannheimia spp. 
isolated from nasal swabs collected from healthy cattle housed on the North Wyke Farm 
Platform and confirmed through 16S rRNA sequencing (further details given later in 





















Table 3.4: Mannheimia strains used to investigate divergence in the sodA gene  
Species  Strain 
M. haemolytica  ATCC 33396 
M. varigena  APHA IS12-04533 
M. glucosida  CCUG 38457 T 
M. granulomatis  CCUG 45422 T 
M. ruminalis  CCUG 38470 T 
M. glucosida  CCUG 38459 
M. glucosida  CCUG  38460 
M. glucosida  CCUG 38467 
M. haemolytica  UoB, V1-53-2 
M. haemolytica  UoB, V1-71-1 
M. haemolytica  UoB, V1-37-1 
 
The Mannheimia species listed in Table 3.4 were PCR-amplified using the primer pair 
Mhae-SGF & Mhae-TCR (primer details given in Chapter 2, Table 2.2). PCR runs were 
carried out using 96 well Framestar® Break-A-way plates sealed with FrameStrips™ 
(Brooks Life Sciences, 4titude, UK), performed on a Mx3005P qPCR instrument 
(Agilent Technologies, Santa Clara, USA). The PCR was performed in a 2 µl reaction 
mix containing: 9.5 µl Nuclease-Free Water (Promega, UK), 12.5 µl Go Taq Hot Start 
(Promega, Madison, USA), 1 µl forward primer (Sigma Life Science), 1 µl reverse 
primer (Eurofins, Ebersberg, Germany) and 1 µl nucleic acid template. Working 
concentrations of primers were 100 nM (diluted in AE buffer; Qiagen, Hilden, Germany). 
Brain heart infusion (BHI) broth and L6 buffer were included as negative controls.  
Cycling conditions were performed using: 95°C for 10 minutes (1 cycle, hot start stage), 
followed by 40 cycles of 95°C for 1 minute 54°C for 1 minute, 72°C for 2 minutes and a 
final elongation step of 72°C for 10 minutes. PCR products were visualised on a 1% 
agarose gel; 10 µl product with 2 µl orange loading dye (Sigma Aldrich). Gels were 
prepared according to the recipe given in Appendix A. Gels were run at 100 V for ~70 
min and included 3µl of a 50 bp and 100 bp ladder (Bioline, London, UK). Gels were 
visualised using a UV transilluminator instrument (Ultra-Violet Products Ltd, 
Cambridge, UK). A PCR product of 212 bp was expected. PCR products were purified 
using a QIAquick PCR purification kit (Qiagen) as per manufacturing protocols. Purified 
 68 
products were sent to Eurofins Genomics (UK) for 16S rRNA sequencing. 
Chromatograms of respective returned sequences were inspected using SnapGene® 
Viewer software (Version 1.4.5, GSL Biotech, available at snapgene.com) and cleaned 
accordingly.  
 
3.2.9 Multiple alignment of Mannheimia spp. partial sodA gene sequences 
The neighbour-joining method from a multiple alignment analysis was performed in 
Clustal Omega software (Online version, accessed on 10/04/2017) [199]. A phylogenetic 
tree showing the relationship between Mannheimia partial sodA sequences was drawn. 
The sodA sequence of E. coli strain K-12 was used as an outgroup to root the tree [200]. 
Bootstrap values were estimated and shown on each branch.  
 
3.2.10 Thermal gradient PCR 
A thermal gradient PCR allows a range of annealing temperatures to be tested during the 
same PCR run. The lower and upper limits are specified by the user and the thermocycler 
software defines temperatures in-between these bounds. Thermal gradients can be used 
to ascertain optimum annealing temperatures.  
A thermal gradient PCR was performed to ascertain the optimum annealing temperature 
for M. haemolytica without observing cross-reactivity with M. glucosida. The aim was 
to identify a temperature at which M. haemolytica was successfully amplified but 
M. glucosida was not. Representative strains of Mannheimia spp. (as detailed in Table 
3.4) were used as nucleic acid templates in the PCR reaction. BHI broth and L6 buffer 
were included as “no template” negative controls. PCR runs were carried out as detailed 
above in section 3.2.8 with an alteration to cycling conditions, testing a range of 
annealing temperatures; between 54.4°C to 73.4°C (as shown in Figure 3.4). Cycling 
conditions were as follows: 95°C for 10 min (1 cycle, hot start stage), followed by 35 
cycles of 95°C for 30 s, 54.4°C to 73.9°C for 30 s, and a final elongation step of 72°C 
for 1 min (1 cycle). Amplicons produced from the thermal gradient PCR were visualised 
on a 1% agarose gel as described in 3.2.8.  
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  1 2 3 4 5 6 7 8 9 10 11 12 
A 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
B 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
C 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
D 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
E 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
F 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
G 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
H 54.4 54.9 56.6 59.1 61.0 62.9 65.0 66.7 68.8 71.1 73.4 73.9 
Figure 3.4: Thermal gradient PCR temperature layout in a 96 well plate format with rows labelled A to H 
and columns 1 to 12  
 
3.2.11 Sequencing H. somni, M. haemolytica and P. multocida PCR products  
PCR products generated from amplification of positive control reference strains for each 
assay were purified using a QIAquick PCR purification kit (Qiagen, CA, USA) according 
to the manufacturer’s instructions and sequenced (Eurofins Genomics, Ebersberg, 
Germany) with identification based on BLAST analysis of the target 16S rRNA gene.  
 
3.2.12 Growth curves in liquid broth culture 
Logarithmic-phase (log-phase) liquid cultures of H. somni, M. haemolytica and 
P. multocida were used to construct a 10-fold dilution series for each organism, 
quantified at each dilution by culture and colony counting. Log-phase cultures were used 
to construct standard curves as most bacterial cells are viable during the log-phase of 
growth: the number of target gene copies detected in a given broth sample are likely to 
equate reasonably accurately to the number of viable bacteria. Growth curves were 
repeated on three separate days for M. haemolytica and P. multocida and twice for 
H. somni (biological replicates). M. haemolytica and P. multocida reference strains were 
grown in liquid medium as described in [201] & [202]. In brief, 4–6 colonies from pure 
plate cultures were used to inoculate 20 ml Brain Heart Infusion (BHI) broth (Media 
Services, School of Cellular and Molecular Medicine, University of Bristol) and 
incubated overnight at 37°C with shaking at 200 rpm. An aliquot of overnight inoculum 
was transferred to fresh BHI broth the next morning to achieve a starting optical density 
(OD) measured at 600 nm (Thermo Spectronic Genesys 6, Thermo Electron Scientific 
Instruments LLC, WI, USA) of 0.05 (approximately 107 CFU/mL). After 1 hour, and at 
subsequent regular intervals, 1 ml aliquots were taken for further OD measurements until 
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stationary phase was reached. A final reading was taken at 24 hours. For H. somni, 
Veterinary Fastidious Medium (VFM) (Oxoid, Basingstoke, UK) was directly inoculated 
with 4–6 colonies from pure plate culture (starting OD of 0.05 at 600 nm, approximately 
107 CFU/ml) and incubated at 37°C, with shaking at 200 rpm and 5% CO2 [203]. For all 
3 bacterial species, at late log-phase, a 100 µl aliquot of liquid culture was taken and  
10-fold serial dilutions prepared in 900 µl STGG. For M. haemolytica and P. multocida, 
50 µl aliquots of dilutions 10-3 to 10-8 of the series were plated out in triplicate onto BHI 
agar.  For H. somni, 100 µl aliquots from dilutions 10-3 to 10-8 were plated onto Chocolate 
agar in triplicate. All plates were incubated for 12–24 hours at 37°C, in 5% CO2 for 
colony counts. Counts over 750 were considered too numerous to count and where 
necessary were extrapolated from higher dilutions yielding lower counts. Bacterial 
counts were performed in triplicate and the mean expressed as log10 colony count/ml. 
After plating, the dilution series was immediately cooled and held frozen at -70°C. 
 
3.2.13 Real-time PCR standard curves 
Liquid broth cultures of each bacterial species were used to generate qPCR standard 
curves [171] which were used to evaluate assay performance and to quantify template 
from bovine nasal swabs. Dilutions of liquid cultures for each organism (described 
above) were thawed on ice and a 300 µl aliquot of each dilution (10-1 to 10-10) was 
inactivated at 100°C for 10 minutes using a digital heat block (Grant Boekel, BBD, Grant 
Instruments, Cambridge, UK) [171]. Successful inactivation was confirmed through 
appropriate plate cultures for each species. Nucleic acid was extracted from all dilutions 
and PCR runs were conducted for each bacterial species as described above.  
Standard curves were generated by linear regression of cycle quantification (Cq) values 
versus log10 CFU/ml values for corresponding 10-fold serial dilutions of broth cultures. 
Five technical replicates of Cq values were performed at each dilution. The linear 
operating range, Cq cut-off value and amplification efficiency were determined for each 
assay. The amplification efficiency (E) was calculated based on the slope of the standard 
curve as follows: E (%) = (10-slope -1) × 100. The endpoint dilution of the standard curve 
at which tested samples were positive was used to determine Cq cut-off values. 
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3.2.14 Bacterial culture of bovine nasal swabs  
For validation of PCR assays, a subset (n = 60) of bovine nasal swabs (collected as part 
of the study detailed in Chapter 4) were cultured and assayed using the PCR assays 
developed in this chapter to detect H. somni, M. haemolytica and P. multocida. Both 
culture and sequencing were used to re-confirm PCR results.   
Nasal swabs were thawed on ice, vortexed and a 50 µl broth aliquot was spread over the 
entire agar surface for isolation of Pasteurellaceae [204] and were cultured onto CBA, 
Pasteurella selective agar and MacConkey agar with salt (Thermo Fisher Scientific, 
Basingstoke, UK) for detection of M. haemolytica and P. multocida. Haemophilus 
selective agar (Thermo Fisher Scientific, Basingstoke, UK) and Chocolate agar plates 
(E&O laboratories, UK) were used for the enumeration of H. somni. Plates were cultured 
in an atmosphere containing 5% CO2 at 37°C for 16 – 72 hours and were examined after 
16 hours. Colonies phenotypically resembling M. haemolytica or P. multocida were 
subcultured onto CBA and presumptive H. somni colonies were subcultured onto 
Chocolate agar. Prior to further testing, colonies were Gram-stained to ensure purity. 
Bacterial identification was done according to standard microbiological techniques for 
H. somni [205], M. haemolytica [206] and P. multocida [207]. Briefly, isolates’ species 
were confirmed based on characteristic colony morphology, Gram stain, oxidase, 
catalase, indole and growth on MacConkey agar. Further identification was performed 
using biochemical strips, either API 20NE (M. haemolytica and P. multocida) or API NH 
(H. somni) as per the manufacturer’s protocol (bioMérieux, Basingstoke, UK). The 
bacteriology workflow followed is summarised in Figure 3.5. For long term storage, 
bacterial cells were harvested into Brain Heart Infusion broth or Haemophilus Test 
Medium (H. somni only) supplemented with 20% glycerol (Media Services, School of 
Cellular and Molecular Medicine, University of Bristol, UK) and stored at -70ºC. 
 
For isolates giving doubtful biochemical results, phenol red carbohydrate fermentation 
tests were carried out to aid identification. Sucrose, trehalose, mannitol or lactose (0.5 
ml) were aseptically added to 4.5 ml peptone broth containing a Durham tube. The broth 
was inoculated with ~12 well-isolated colonies and incubated overnight aerobically at 
37°C. Broths were observed for a yellow colour change, indicating carbohydrate 





Figure 3.5: Flow chart illustrating identification of Pasteurellaceae species using culture. 
 
Clinical specimens:
Primary isolation plate 
Columbia blood agar 
(5% sheep blood) 




5-10% CO2 , 35 –
37°C 16 - 48h
Haemophilus selective agar 
Chocolate agar + bacitracin
Chocolate agar
5% CO2 , 35 – 37°C, 16 - 48h
Pasteurella sp. are 
regular, smooth, convex, 
grey, non-transparent and 
circular colonies. Rough 
irregular colonies may 
occur. No β-haemolysis
but sometimes greenish 
discoloration.
0.5 – 2 mm diameter
Mannheimia 































0.2 – 0.6 mm 
diameter. 
Gram-stain on pure culture: 
Gram-negative coccobacilli
Pasteurella sp. Spherical, ovoid 
or rod-shaped. Short chains, 
singularly or in pairs. Bipolar 
staining common. 
Mannheimia sp. small rods 
and coccobacilli   














ID kit: PM, MH: API 20 NE 
HS: API NH
Phenol red serum sugars: sucrose, 







selective agar,  5-
10% CO2 , 
35 – 37°C 16 - 48h
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3.2.15 Sequencing bacterial isolates  
Bacterial isolates cultured from nasal swabs and either classified as H. somni, 
M. haemolytica or P. multocida, or with presumptive but unconfirmed bacteriology were 
amplified using an in-house real-time SYBR green PCR assay, developed at University 
of Bristol (Bristol Veterinary School, Infection and Immunity Department). Two sets of 
universal primers (primer pair 1 and 2) designed to target two variable regions of 
16S rRNA were used. Full details are given previously in Chapter 2, section 2.16. PCR 
products were purified using a QIAquick PCR purification kit (Qiagen, CA, USA) 
according to the manufacturer’s instructions and sequenced (Eurofins Genomics, 
Ebersberg, Germany) with identification based on BLAST analysis of the target 
16S rRNA gene. 
 
3.2.16 Data analysis 
3.2.16.1 Variability in colony-forming units after freezing 
The coefficient of variation (expressed as a percentage; %CV) was calculated to estimate 
the variability observed in replicate colony-forming units obtained from triplicate plating 
of each ten-fold serial dilution series of reference strain in STGG broth. The difference 
between mean counts produced at each dilution of the series pre-and post-freeze was 
calculated as a percentage change. The %CV was calculated as follows: - 
!"#$$%&%#'(	"$	*+,%+(%"'	(%) = 1(+'2+,2	2#*%+(%"'3#+' 	× 	100 
 
3.2.16.2 Generation time of reference strains 
The generation time (doubling time) of each bacterial reference strain cultured in liquid 
medium was estimated during the exponential phase of growth. First, a logistic model 
was fitted to each bacterial growth curve (given by temporal reads of optical turbidity, 
OD600) using the R package ‘Growthcurver’ [208]. Growthcurver fits a basic form of the 
logistic equation commonly used to evaluate bacterial population dynamics. The logistic 
equation below gives the number of cells Nt at time t. Growthcurver finds the best values 
of: K, the maximum possible population size or carrying capacity; r, the population 
growth rate; and N0, the population size at the beginning of the growth curve: - 
78 =
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3.2.16.3 PCR variability  
Variability between cycle quantification (Cq) values was assessed by calculating the 
%CV. For the different primer and probe combinations evaluated, the variability between 
Cq values at each dilution between technical replicates was assessed. The inter- and intra-
assay variability between Cq values for both technical replicates and biological replicates 
of qPCR standard curves was also calculated. 
 
3.2.16.4 PCR standard curves 
At each dilution of the standard curve, bacterial counts were performed in triplicate and 
the mean expressed as log10 colony count/ml. A linear regression model was fitted to 
colony counts and Cq values obtained from liquid culture as described above. The 
log10 mean colony count/ml was considered as the response variable. Mean Cq value 
(n = 5) was an explanatory variable. The degree of linear correlation between the 
response and the explanatory variable was estimated for each standard curve by 
calculating the coefficient of determination (r2). A parallel lines model was fitted to allow 
for differences in the intercept between biological replicates of the growth curves, 
obtaining the best estimate of the slope by assuming an additive effect of each biological 
replicate. After fitting a parallel lines model, a predictive model was produced for each 
species using the mean intercept across the biological replicates. All analyses were 
performed in R version 3.5.0, using base functions. Cq values obtained from collected 
nasal swabs were converted to genome copies/ml by interpolation using the predictive 
models. In vivo, clinical samples are likely to contain both viable and non-viable bacterial 
cells. Accordingly, colony forming units/ml (CFU/ml) and genome copies/ml cannot be 




3.3.1 Bacterial culture 
Plate cultures for H. somni, M. haemolytica and P. multocida reference strains conformed 
to described and accepted macroscopic, microscopic and biochemical characteristics 
(characteristics used to differentiate isolates are given in Appendix B, Table B.1). 
  
3.3.2 Validation of STGG broth as storage and transport media for Pasteurellaceae 
Cells of H. somni, M. haemolytica and P. multocida were ten-fold serially diluted in 
STGG broth, quantified and frozen at -70°C. Post freezing, bacterial cells were thawed 
and quantified. Viability of bacterial cells after freezing was assessed by comparing plate 
counts of the ten-fold dilution series obtained before and after. All reference species were 
viable following freezing, evident through overnight growth on solid agar (Table 3.5). 
For all species, as the starting inoculum became more dilute the colony counts decreased 
(count data not shown), and the variability between replicate colony-forming units 
increased (evident though increasing %CV values). Colony-forming unit counts were 
similar for H. somni and M. haemolytica pre- and post-freeze, although a slight decrease 
was observed (Table 3.5). P. multocida was recovered from all dilutions which had viable 
colonies present pre-freezing; however, cell counts were reduced to a greater extent 
compared to H. somni and M. haemolytica (1 order of magnitude less post-freeze). In 
addition, variability in colony-forming unit counts between pre- and post-freezing was 
generally greatest for P. multocida (Table 3.5). 
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Table 3.5: Recovery of H. somni, M. haemolytica and P. multocida from skim milk, tryptone, glucose, glycerol broth: mean colony-forming unit (CFU) counts pre and post-
freezing of bacterial cells stored in STGG broth 
Species Dilution Pre-freeze Mean CFU* %CV‡ Post-freeze Mean CFU* %CV‡ Percent change§ 
H. somni 10-4 4.85 x106 9.1 4.16 x106 NA -14.2 
 10-5 5.87 x105 7.1 6.00 x105 NA 2.20 
 10-6 3.67 x105 56.8 5.00 x104 NA -86.4 
 10-7 3.33 x103 173.2 0 NA 100 
M. haemolytica† 10-6 1.50 x108 4.7 1.27 x108 7.3 -15.3 
 10-7 1.43 x108 10.7 1.50 x108 20 4.90 
 10-8 2.33 x108 24.7 2.33 x108 24.7 0 
 10-9 1.33 x109 43.3 6.67 x108 173 -49.8 
 10-10 0 NA 0 NA NA 
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Table 3.5 continued 
Species Dilution Pre-freeze Mean CFU* %CV‡ Post-freeze Mean CFU* %CV‡ Percent change§ 
P. multocida† 10-5 3.73 x107 11.7 1.27 x107 5.6 -70.0 
 10-6 5.33 x107 13.2 9.67 x106 41.8 -81.9 
 10-7 3.33 x107 45.8 6.67 x106 86.6 -80.0 
 10-8 1.00 x108 100 3.33 x107 173.2 -66.7 
 10-9 3.33 x108 173.2 3.33 x108 173.2 0 
 10-10 0 0 NA NA NA 
* Mean colony-forming unit (CFU); dilution series plated out in triplicate and colony counts performed. The H. somni dilution series post-freeze was plated out once 
without replication. 
† Colonies too numerous to count (>750 counts per plate) for dilutions 10-1 to 10-5 for M. haemolytica and for dilutions 10-1 to 10-4 for P. multocida. 
‡ Coefficient of variation (%): variability in CFUs obtained from colony counts performed in triplicate. 
§ Percent change: difference in mean CFUs pre- and post-freezing (%). 
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3.3.3 In-silico analysis of primer and probe combinations 
Primers and probes (PPs) for each bacterial assay were aligned to all available complete 
genomes on Genbank. All PPs were demonstrated as viable; amplicon sizes were well 
conserved, but primer positions were dependent on the particular strain used in the 
alignment (see Appendix B). No non-specific amplification of non-target strains in silico 
was detected by BLAST searches. 
 
3.3.4 Wet-lab analysis of optimum primer and probe combinations 
Primer and probe combinations for each qPCR assay were evaluated using a ten-fold 
dilution series of reference strains: H. somni ATCC 43625; M. haemolytica ATCC 
33396; P. multocida ATCC 43137. Prior to extraction, ten-fold dilutions of reference 
strains were heat-inactivated. Successful inactivation was confirmed after observing no 
overnight bacterial growth on solid agar. To ensure purity of PP stocks, molecular grade 
water was used as template and amplified under standard TaqMan cycling conditions for 
each assay. For each PP combination, no amplification signal was produced.  
 
One PP combination was evaluated for H. somni using type strain ATCC 43625. This PP 
showed high repeatability across Cq values obtained from assaying the dilution series in 
triplicate on the same run (%CV <3, shown in Table 3.6). Variation in Cq value was 
slightly increased at higher dilutions with less template. The dynamic range spanned 
across 6 dilutions.  
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Table 3.6: Inter-assay variability of Histophilus somni (ATCC 43625) amplification using primer and 
probe (PP) pair 1: TMF & TMR + TMP
PP Combination Dilution  Replicate 1 Replicate 2 Replicate 3 %CV* 
PP1: TMF & TMR + 
TMP 10-1 15.667 15.909 15.679 0.866 
 10-2 18.805 19.120 19.071 0.892 
 10-3 21.952 22.574 22.241 1.39 
 10-4 25.574 26.037 25.789 0.898 
 10-5 28.950 29.764 29.198 1.42 
 10-6 34.136 33.585 32.199 3.00 
 10-7 UN† UN UN NA‡ 
 10-8 UN UN UN NA 
 10-9 UN UN UN NA 
 10-10 UN UN UN NA 
* %CV: coefficient of variation  
† UN: undetermined. No template detected 
‡ NA: not applicable, no target nucleic acid detected for calculation of coefficient of variation  





Figure 3.6 shows the amplification plot for Histophilus somni PP1 combination. The 
threshold for detection was set at 0.01, illustrated above the background and in the 
exponential section of the amplification curve. As expected, Cq values increased as 
template became more dilute. Template was not detected in dilutions 10-7 to 10-10. 
Observed background was minimal. At lower starting template concentrations (Cq values 
of around 32), amplification curves at plateau phase were detected with lower 
absorbances compared to samples with higher quantities of template. 
 
 
Figure 3.6: Amplification plot for Histophilus somni strain (ATCC 43625) over ten dilutions amplified 
using primer pair Hsomni-TMF & Hsomni-TMR and probe Hsomni-TMP. Delta Rn represents adjusted 
absorbance; cycle number is shown on the y-axis. Setting of the threshold is shown by a horizontal line at 
0.01.  
 
Of the two PP combinations tested for Mannheimia haemolytica, both were shown to be 
viable candidates, with PP3 (Mhae-SGF & Mhae-SGR + Mhae-BV1P-FAM) 
demonstrated to be optimum (Table 3.7). Amplification with PP2 extended across 7 
dilutions, however amplification was not consistent between replicates of these dilutions, 
and inter-assay variability was higher (%CV < 22.3) compared to PP2 (%CV <1.82). 
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Table 3.7: Inter-assay variability of Mannheimia haemolytica (ATCC 33396) amplification using two 
primer and probe (PP) pairs: BVIF & BVIR + BVIP FAM and SGF & SGR + BVIP FAM
PP 
Combination Dilution  Replicate 1 Replicate 2  Replicate 3 %CV* 
PP2: BVIF & 
BVIR + BVIP 10-1 14.859 14.728 14.845 0.486 
 
10-2 17.763 17.926 22.086 12.7 
 
10-3 21.152 21.216 30.583 22.3 
 
10-4 24.777 24.512 UN 0.760 
 
10-5 27.855 27.979 28.582 1.38 
 
10-6 31.264 32.549 UN 2.84 
 
10-7 UN 33.251 UN NA‡ 
 
10-8 UN UN UN NA 
 
10-9 UN UN UN NA 
  10-10 UN UN UN NA 
PP3: SGF & 
SGR + BVIP 10-1 17.032 16.653 17.267 1.82 
 
10-2 20.268 19.972 20.478 1.26 
 
10-3 24.921 25.034 24.922 0.260 
 
10-4 28.277 28.345 27.713 1.23 
 
10-5 31.206 31.305 31.164 0.232 
 
10-6 31.590 UN† UN NA 
 
10-7 UN UN UN NA 
 
10-8 UN UN UN NA 
 
10-9 UN UN UN NA 
  10-10 UN UN UN NA 
* %CV: coefficient of variation.  
† UN: undetermined; no template detected. 
‡ NA: not applicable, no target nucleic acid detected for calculation of coefficient of variation. 
To determine Cq values a threshold value of 0.01 was set. 
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Figure 3.7 illustrates the amplification plot for Mannheimia haemolytica PP combination 
SGF & SGR + BVIP FAM. Cq values increased as starting template concentration 
decreased. Pronounced drop-off in absorbance at plateau phase for increasingly dilute 
samples was observed. Selection of the threshold at 0.01 is shown, the threshold was set 
above the background amplification and within the exponential phase.  
 
 
Figure 3.7: Amplification plot for Mannheimia haemolytica (ATCC 33396) using primer pair Mhae-SGF 
& Mhae-SGR + Mhae-BVIP. A ten-fold dilution series was run in triplicate, successful amplification was 
observed at dilutions 10-1 to 10-6. The threshold was set at 0.01 shown by a horizontal line. Delta Rn 
represents adjusted absorbance; cycle number is shown on the y-axis.  
 
Three different PP combinations were run against a ten-fold dilution of P. multocida type 
strain ATCC 43137. Of the three combinations tested all were shown to be viable (Table 
3.8). PP combination 4 (TMF & TMR + TMP) showed the best repeatability, 
demonstrated by lowest observed variability (%CV < 2.72). Template was detected 
across 8 dilutions for this PP, however in dilution 8 only one of the three replicates was 
positive. Given its low inter-assay variability PP4 was selected as the optimum PP 
combination for further validation. 
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Table 3.8: Inter-assay variability of Pasteurella multocida (ATCC 43137) amplification using three primer 
and probe (PP) pairs: TMF & TMR + TMP; BV1F & BV1R + BVIP; BV1F & BV2R + BVIP
PP Combination Dilution  Replicate 1 Replicate 2 Replicate 3 %CV* 
PP4: TMF & 
TMR + TMP 10-1 14.603 14.729 14.377 1.22 
 
10-2 17.176 17.041 17.392 1.03 
 
10-3 20.697 19.520 20.194 2.93 
 
10-4 23.989 23.710 23.915 0.605 
 
10-5 27.345 27.416 27.768 0.823 
 
10-6 30.309 31.482 30.823 1.90 
 
10-7 33.161 34.868 34.657 2.72 
 
10-8 UN UN 34.876 NA‡ 
 
10-9 UN UN UN NA 
 
10-10 UN UN UN NA 
PP5: BV1F & 
BV1R + BV1P 10-1 12.978 12.484 12.559 2.10 
 
10-2 15.855 15.313 15.385 1.90 
 
10-3 18.868 18.272 18.427 1.67 
 
10-4 22.253 21.902 21.869 0.967 
 
10-5 24.787 25.643 25.345 1.72 
 
10-6 28.776 28.617 28.536 0.426 
 
10-7 31.711 33.759 31.466 3.90 
 
10-8 UN UN 33.571 NA 
 
10-9 UN UN 33.896 NA 
 











Table 3.8 continued 
PP Combination Dilution  Replicate 1 Replicate 2 Replicate 3 %CV* 
PP6: BV1F & 
BV2R + BV1P 10-1 13.007 12.522 12.817 1.91 
 
10-2 15.270 15.141 14.955 1.05 
 
10-3 18.935 18.595 18.097 2.27 
 
10-4 21.857 21.697 21.622 0.553 
 
10-5 24.994 25.018 25.766 1.74 
 
10-6 29.319 28.832 28.829 0.973 
 
10-7 31.958 UN†  34.640 5.70 
 
10-8 UN  UN  UN  NA 
 
10-9 UN  UN  34.218 NA 
 
10-10 UN  UN  UN  NA 
* %CV: coefficient of variation. 
† UN: undetermined; no template detected. 
‡ NA: not applicable, no target nucleic acid detected for calculation of coefficient of variation. 
To determine Cq values a threshold value of 0.01 was set. 
 
Figure 3.8 shows the amplification plot for PP combination Pmulti-TMF & Pmulti-TMR 
+ Pmulti-TMP. Template was not detected at dilutions 10-9 and 10-10. Minimal 
background was observed for this assay. Selection of the threshold at 0.007 is shown, the 
threshold was set above background amplification and within the exponential phase.  
 
 
Figure 3.8: Amplification plot for Pasteurella multocida (ATCC 43137) amplified over ten dilutions using 
primer pair TMF & TMR and probe TMP. The threshold was set at 0.007 shown by a horizontal line. Delta 
Rn represents adjusted absorbance; cycle number is shown on the y-axis.  
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For all dilutions of each reference strain, the T4 internal amplification control assay Cq 
values were as expected, indicating successful DNA extraction with no evidence of PCR 
inhibition. Three dilutions from each reference strain’s dilution series were selected to 
act as positive controls when assaying bovine nasal swabs. Dilutions 10-3 to 10-5 were 
selected for M. haemolytica and P. multocida, dilutions 10-2 to 10-3 were selected for 
H. somni. These dilutions had high reproducibility between replicates and were 
positioned within the dilution series such that Cq values obtained would be likely to be 
similar to those obtained for nasal swabs.  
 
3.3.5 Specificity panel 
To determine the specificity of the three assays, a panel of bacterial strains (Table 3.2) 
was tested for each assay using the optimum PP combinations determined above. For 
H. somni and P. multocida assays, all 3 dilutions of the heterologous bacterial strains 
comprising the specificity panel yielded negative results. For all species, no amplification 
was observed using no-template controls. Cross-reactivity was observed for 
M. haemolytica with Mannheimia glucosida APHA IS14-07997, 
Mannheimia granulomatis APHA IS14-13861 and Mannheimia ruminalis APHA IS23-
01503. Sequencing of two variable regions of the 16S rRNA gene from strains revealed 
that the original identification of the isolates supplied was incorrect. The sequences were 
homologous to Mannheimia haemolytica when analysed using BLAST. Sequences for 
all ten strains supplied by APHA and amplified using primer pair 337F & 907R and 785F 
& 1100R are shown in Tables B.3 and B.4 of Appendix B, together with BLAST outputs. 
The specificity panel was repeated following replacement of these mis-identified type 
strains with Mannheimia spp. sourced from CCUG. However, cross-reactivity was again 
observed, this time with Mannheimia glucosida CCUG 38457 under standard TaqMan 
cycling conditions. Following optimization of annealing temperature (described later in 
section 3.3.7) no cross-reactivity with any heterologous species was observed. Successful 
inactivation using L6 lysis buffer prior to nucleic acid extraction of the reference strains 
used in the specificity testing was confirmed after observing no overnight bacterial 
growth on solid agar. 
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3.3.6 Sequencing Mannheimia spp. sodA gene 
To investigate divergence within the Mannheimia sodA gene, a phylogenetic tree was 
constructed from a multiple alignment analysis of the sodA partial sequences obtained 
for the PCR products generated using primer pair Mhae-SGF & Mhae-TCR. The 
phylogenetic tree showed clustering of sodA partial sequences into four clades (Figure 
3.9). Sequences relating to M. haemolytica appeared in their own clade and inspection of 
the reverse primer binding region revealed complete nucleotide homology among the 
four strains (Appendix B, Table B.5). Sequences relating to two strains of M. glucosida 
(38457T and 38459) occurred together and were a sister group to strains of 
M. haemolytica. M. glucosida 38460, M. ruminalis 38467 and M. glucosida 38460 
appeared in a separate clade, but confidence for M. glucosida 38460 within this clade 
was low (34). Finally, M. granulomatis 45422T and M. varigena APHA appeared in one 
clade: a sister group to all other clades. 
 
 
Figure 3.9: Phylogenetic tree showing the relationship among sodA gene sequences of Mannheimia 
species. The tree was constructed using the neighbour-joining method from a multiple alignment analysis 
of the sodA partial sequences obtained from amplification using primer pair SGF and TCR. The sodA 
sequence of Escherichia coli strain K-12 was used as an outgroup to root the tree. The value on each branch 

























3.3.7 Thermal gradient PCR: investigating Mannheimia spp. cross-reactivity 
Divergence between partial sodA gene sequences of Mannheimia spp. (Figure 3.9) 
prompted further investigation into assay optimisation for the PP combination SGF & 
SGR + BVIP, with the aim of eliminating previously observed cross-reactivity between 
members of the Mannheimia genus. 
A thermal gradient PCR was conducted, amplifying Mannheimia spp. over a range of 
temperatures. Gel electrophoresis of PCR products revealed a temperature range towards 
the upper end of the tested gradient (68.8 – 73.9 ºC) where PCR products were produced 
for M. haemolytica but not M. glucosida (Figure 3.10). Variability between 
M. haemolytica strains was observed (Figure 3.10, panels A - D), evident by PCR 
products produced at different temperatures for type strain M. haemolytica ATCC 33396 
and nasal swab isolates of M. haemolytica (V1-71-1, V1-37-1, V1-53-2) collected from 
cattle on the North Wyke Farm Platform as described in Chapter 4. No amplicons were 
produced from M. ruminalis or no-template negative controls (BHI broth and L6 buffer), 
consistent with qPCR specificity results. Based on these findings a new annealing 
temperature of 69°C was selected to discriminate between M. haemolytica and 
M. glucosida. Previously tested cycling parameter conditions remained the same. No 
cross-reactivity to non-target species following repeat specificity panel testing was 
observed at 69°C annealing.
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Figure 3.10: Agarose gel electrophoresis images representing Mannheimia spp.: (A) M. haemolytica ATCC 33396; (B) M. haemolytica V1-53-2; (C) M. haemolytica V1-71-
1; (D) M. haemolytica V1-37-1; (E) M. glucosida 38457T; (F) M. glucosida 38467; (G) M. glucosida 38460; (H) M. glucosida 38459; (I) M. granulomatis 38470 T;(J) M. 
varigena APHA. PCR products amplified over a range of temperatures are shown in lanes 1–12 as follows: lane 1 = 54.4°C, lane 2 =54.9°C, lane 3 = 56.6°C, lane 4 = 59.9°C, 
lane 5 = 61.0°C, lane 6 = 62.9°C, lane 7 = 65.0°C, lane 8 = 66.7°C, lane 9 = 68.8°C, lane 10 = 71.1°C, lane 11 = 73.4°C and lane 12 = 73.9°C. L1 = 50bp molecular weight 
ladder and L2 = 100bp molecular weight ladder.
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3.3.8 Growth curves in liquid culture 
Pure cultures were maintained throughout growth curve studies for each bacterial species 
(H. somni, M. haemolytica and P. multocida), as confirmed by well-isolated colonies and 
pure Gram-stains of overnight plate cultures. Ten-fold serial dilutions yielded 
appropriate colony counts for all three bacterial species. Growth rates of M. haemolytica 
and P. multocida determined by optical density measurements were similar for the first 
6 hours in liquid media. Thereafter the rise in optical density of M. haemolytica halted 
and then slowly declined, whilst P. multocida optical density continued to increase for a 
further 5 hours until stationary phase. Growth of H. somni reached the highest final 
optical density of the 3 (Figure 3.11). Using fitted logistic curves the estimated bacterial 
doubling times varied between species: M. haemolytica (27.9 minutes), H. somni 
(60.0 minutes) and P. multocida (80.4 minutes), see Appendix B, Figure B.1. 
 
 
Figure 3.11: Liquid broth cultures of Histophilus somni, Mannheimia haemolytica and Pasteurella 
multocida. Optical density at 600nm of the cultures of the three species was measured approximately every 
2 hours up to 24 hours. Timings of harvest of cells for generation of qPCR standard curves is shown in red 
at late log phase. The results are the mean optical density from two independent experiments (H. somni) 
and three independent experiments (M. haemolytica and P. multocida). Error bars represent the standard 
error of the mean. 
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3.3.9 Real-time PCR standard curves and assay performance 
Cultures of H. somni, M. haemolytica and P. multocida in liquid medium were used to 
construct standard curves for each organism (Figure 3.12 and values given in Table 3.9) 
using the same PCR conditions used to amplify DNA targets in nasal swabs stored in 
STGG broth. Linear regression of Cq value versus observed and extrapolated log10 mean 
colony count/ml for corresponding 10-fold serial dilutions of bacterial broth cultures 
provided equations for conversion of Cq values to CFU/ml [171]. These equations were 
later applied to Cq values obtained from nasal swabs to obtain genome copies/ml. For all 
standard curve dilutions, bacteriophage T4 internal amplification controls gave Cq values 
as expected, indicating successful DNA extraction and providing no evidence of PCR 
inhibition. 
 
All the assays were highly reproducible and repeatable for all bacterial species, producing 
consistent Cq values at each dilution of the standard curve for biological replicates tested 
on separate days (coefficient of variation, %CV <6), and for technical replicates 
performed on the same day of testing (%CV <4) (see Appendix B). For all standard 
curves, coefficient of determination values were high (r2 >0.99). Amplification efficiency 
was >95% for both M. haemolytica and H. somni and lower for P. multocida at 84% 
(Table 3.9). For all three assays, DNA extracts from three dilutions of all the heterologous 
bacterial strains comprising the specificity panel (Table 3.2) yielded negative results 




Figure 3.12: Standard curves for conversion of Cq values into genome copies/ml. Histophilus somni (panel 
A) liquid culture performed on two different days. Mannheimia haemolytica (panel B) and 
Pasteurella multocida (panel C) liquid culture performed on three different days. Mean Cq values were 
calculated from 5 technical PCR replicates at each dilution, for each biological replicate. Each biological 
replicate is represented by a symbol: circle, triangle or cross. Colony counts were performed in triplicate 
and expressed as the mean. 
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Table 3.9: Evaluation of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida qPCR assays on pure log-phase broth cultures of reference strains 
Assay characteristic  Histophilus somni Mannheimia haemolytica Pasteurella multocida 
Standard Equation*     
 Slope (standard error) -0.295 (0.00610) -0.292 (0.00688) -0.264 (0.00332) 
 Intercept 11.3 12.4 11.2 
 r2  0.995 0.991 0.998 
 Biological replicates 2 3 3 
 Degrees of freedom (total) 13 17 14 
Efficiency (%)†  97.5 96.0 83.5 
Linear dynamic range 
(log10) 
 
8 7 6 
Cq cut-off value‡  35 cycles 34 cycles 35 cycles 
* Linear regression of log10 colony count/ml against cycle quantification (Cq) value to generate standard equation for conversion of swab Cq value to genome copies/ml. 
† PCR Amplification Efficiency (%) = [(10-slope) -1] x100 
‡ The Cq value corresponding to the endpoint dilution of the standard curve at which samples tested positive. 
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3.3.10 Sequencing of reference strain PCR products 
PCR products of reference strains for each assay were sequenced and analysed using 
BLAST. All products had correct homology to target species (Appendix B, Table B.7). 
 
3.3.11 Comparison of PCR with culture of bovine nasal swabs 
Sixty nasal swabs collected from cattle (full details in Chapter 4) were cultured for the 
presence of H. somni, M. haemolytica and P. multocida and assayed by PCR. Culture 
results and their concordance to PCR are presented in Table 3.10. As only one swab was 
determined positive for H. somni by culture, PCR products from H. somni PCR-positive 
nasal swabs (n = 5) were sequenced to confirm identity. In all five, the sequences were 
representative of H. somni (Appendix B, Table B.7) as evident following Basic Local 
Alignment Search Tool (BLAST) searches: 100% homology to H. somni was seen for 3 
of 5 queried sequences, 99% to the fourth and 98% to the fifth. For all 5 queried swab 
sequences there was homology between 96–100% for sequences deposited as ‘uncultured 
bacterium clone’, probably representing H. somni. One swab had 93% homology to one 
sequence deposited as Actinobacillus capsulatus. The majority of these swabs (43/60) 
were determined positive for P. multocida both by culture and PCR, with a smaller 
number PCR-positive and culture-negative (14/60). Fewer swabs were determined 
positive for M. haemolytica (4/60) both by culture and PCR. Similarly, a number (5/60) 
were PCR-positive and culture-negative. No swabs for any species were determined 
culture-positive and PCR-negative.
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Table 3.10: Presence of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida 
determined by culture and qPCR of bovine nasal swabs (n = 60) 
Species PCR Culture Total 
H. somni + + 1 
H. somni - + 0 
H. somni + - 28 
H. somni - - 31 
M. haemolytica + + 4 
M. haemolytica - + 0 
M. haemolytica + - 5 
M. haemolytica - - 51 
P. multocida + + 43 
P. multocida - + 0 
P. multocida + - 14 
P. multocida - - 3 
 
Isolates obtained from culture of nasal swabs identified as M. haemolytica and 
P. multocida, or those with doubtful biochemistry were sequenced. Sequencing 
confirmed the identity of those identified as M. haemolytica and P. multocida by culture 
and consequently these isolates were included in the specificity panel. Biochemical 
testing of one isolate using API test strips suggested identification as Moraxella, 
sequencing confirmed this isolate to be M. bovoculi (Appendix B, Table B. B.2).  
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3.4 Discussion  
Three real-time quantitative PCR (qPCR) assays were developed, optimised and 
validated for the detection and quantification of Histophilus somni, Mannheimia 
haemolytica and Pasteurella multocida from bovine nasal swab specimens and bacterial 
cultures. Real-time quantitative PCR offers a rapid platform to detect and quantify 
closely-related bacterial species from a range of clinical samples reliably. TaqMan real-
time PCR assays use a probe alongside oligonucleotide primers to enhance an assay’s 
specificity [208]. To my knowledge this is the first demonstration of qPCR assays 
capable of detecting and quantifying bacterial species directly from bovine nasal swabs. 
 
Pre-existing published PCR assays may report potentially suitable primer targets and 
designed primer sets but their effective implementation across laboratories is not always 
reproducible. Between laboratories, extraction and purification methods, reagents and 
thermocyclers may differ. Consequently, if an assay has been published it may not work 
optimally in a different laboratory under different conditions [191] and optimisation is 
necessary. The sodA gene of M. haemolytica and 16S rRNA gene sequences of H. somni 
and P. multocida proved to be qPCR primer targets capable of separating these 
pathobionts from closely-related and common non-pathogenic bacterial species (Table 
3.2). Evaluating specificity ensures species-specific amplification signals and no cross-
reactivity to non-target bacterial species. Hitherto, discrimination between 
M. haemolytica and M. glucosida by PCR has generally relied either on analysis of 
melting curves following SYBR® green qPCR, or on the assumption that PCR positive 
samples are M. haemolytica because M. glucosida has not been implicated in clinical 
cases of bovine respiratory disease [148] [151]. The M. haemolytica qPCR assay 
presented here was able to discriminate successfully between all members of the 
Mannheimia genus using a TaqMan probe following optimisation of cycling parameters, 
in particular increased annealing temperature. Cross-reactivity with three isolates 
(Mannheimia spp.) provided by a UK reference laboratory was observed when first 
optimising the M. haemolytica assay: isolates were from clinical cases submitted to the 
reference laboratory and were identified as M. haemolytica using in-house culture 
techniques. Interestingly, following sequencing of these isolates their identification was 
not confirmed as M. haemolytica (Appendix B, Table B.3 and Table B.4). This further 
highlights the difficulty in accurately identifying this genus and adds value to using 
molecular techniques in addition to culture. Interestingly, microbiome publications 
 96 
reporting the use of 16S rRNA and metagenomics-based approaches between 1995–2017 
have been consistently increasing, whilst publications using culture were at their peak in 
1995 and have steadily decreased since. Despite these trends, citations made in 2018 to 
microbiome publications published prior to 2000, and hence those largely employing 
culture are not declining, suggesting that the conclusions from culture are still valued 
[209].  
 
For P. multocida, primers targeting the 16S rRNA gene sequence were shown to be 
superior over kmt1, targeting the outer membrane protein (Table 3.8). This was also true 
for H. somni, where the 16S rRNA gene sequence as described by Mahony and Horwood 
was suitable for detection and quantification in pure culture [195]. In accordance with 
these findings, 16S rRNA-dependent strain identification is regarded by most as the gold 
standard for molecular identification of bacterial species [210] [151] [211]. PCR 
amplification efficiencies estimated from standard curves were within the recommended 
ranges of  90–110% [212] for H. somni (97.5%) and M. haemolytica (96%). Lower 
efficiency for P. multocida (83.5%) was observed. This may reflect presence of primer 
dimers or pipetting error, although the latter is unlikely given the low inter- and intra-
assay variation (%CV <4). Optimising primer concentration and/or annealing 
temperature could also increase the amplification efficiency of the P. multocida assay, 
given that the maximum amount of primer bound to its target is defined by its annealing 
temperature [191]. However, given these assays were developed for research purposes, 
rather than diagnostic purposes, the lower efficiency for P. multocida is not a cause for 
concern with its application in this thesis.  
 
In human respiratory studies STGG broth has been widely used as a storage and transport 
medium for bacteria and viruses [193] but its use with members of the Pasteurellaceae 
has not been reported previously. For all 3 species (H. somni, M. haemolytica and 
P. multocida) minimal loss of viable bacterial cells stored in STGG was observed 
following one freeze-thaw cycle, suggesting its probable suitability as a transport 
medium capable of storing and recovering cells held at -70ºC for longer periods. As 
expected, colony counts decreased as inoculum became more dilute, and at higher 
dilutions (with fewer bacterial cells) the variability in the numbers of colony-forming 
units observed increased. Recovery of bacterial cells was possible for all species tested 
over a range of dilutions, validating usability of STGG broth for storage use following 
 97 
collection of bovine nasal swabs. Nevertheless, recovery of P. multocida cells after 
freezing was less efficient than recovery of H. somni and M. haemolytica. This evidence 
for suitability of STGG broth is supported by subsequent findings following collection 
of bovine nasal swabs which were held at -70ºC for several months and successful 
detection of bacterial species using culture, PCR and 16S rRNA sequencing (Table 3.10 
and Appendix B Table B.2, and in forthcoming chapters). 
 
A well-known limitation of PCR is that it does not distinguish viable from non-viable 
organisms. Cells were harvested from liquid cultures in the exponential phase of growth 
to maximise the probability that the bacterial cell populations used for production of 
calibration curves were likely to be viable [171]. While standard curves were calibrated 
using defined numbers of viable organisms, cycle quantification (Cq) values for unknown 
samples were expressed as genome copies/ml and not CFU/ml as, in biological mucosal 
samples it was uncertain what proportion of DNA detected by PCR came from viable 
organisms. A well-designed PCR assay will yield linearity of a ten-fold dilution series of 
target DNA, ideally over 5 dilutions [191]. For the species evaluated using standard 
curves, as the template concentration decreased, the variability among replicates 
increased, although linearity over at least 6 dilutions was observed for all species. In 
addition, coefficient of determination values were high (>0.99), suggesting that linear 
regression models fitted the data well. 
 
A high degree of genetic relatedness within P. multocida and between P. multocida-like 
organisms has been demonstrated using DNA-DNA hybridisation and 16S rRNA 
sequencing [73] [213]. Townsend et al. reported cross-reactivity between P. canis 
biotype 2 and P. multocida when targeting the kmt1 gene [150] and Miflin et al. observed 
cross-reactivity with biovar 2 strains of P. avium and P. canis biotype 2 when detecting 
a DNA fragment of unknown identity [196]. In addition, Scherrer et al. observed cross-
reactivity with a P. canis strain isolated from a cat wound with their qPCR detecting 
toxigenic P. multocida (toxA gene) [214]. Reclassification of biovar 2 strains of P. avium 
and P. canis to P. multocida has been proposed [213]. Interestingly, no cross-reactivity 
was observed with the PCR assay presented in this chapter between P. canis biotype 2 
and P. multocida. 
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The limit of detection (LOD), defined as the lowest amount of analyte detected at or 
above reasonable certainty (most commonly 95% confidence) [212] can be used to 
inform selection of an assays Cq cut-off value. The Cq cut-off represents the number of 
cycles at or below which Cq values from amplification of test samples are considered; 
values above the Cq cut-off are not deemed to reliably represent amplified target [215]. 
For the assays presented in this study, the lowest positive dilution of the standard curve 
was used to inform selection of the Cq cut-off value and provide insight into assay 
sensitivity. However, the limit of quantification (lowest amount of quantifiable analyte 
[212]) or LOD at a stated confidence was not determined for any of the three assays. As 
an approximation for the LOD, Cq values obtained from the lowest detectable dilution of 
each standard curve could be converted to genome copies/ml using the predictive 
regression models presented. However, this estimate relies on the accuracy of the original 
estimate quantifying standardised material used in the standard curve (i.e. colony counts). 
An alternative, and somewhat sophisticated approach could be to create a standard curve 
with known quantities of bacterial DNA, for example using a plasmid to standardise the 
approach [216]. In addition to these limitations, assay sensitivity using mixed cultures 
was not determined; in order to do this, cultures of target species could be spiked with 
non-target species at known dilutions [151].  
 
The optimum annealing temperature for primer combination SGF-SGR detecting  
M. haemolytica was determined empirically using a thermal gradient PCR. No 
amplification of non-target species was observed at 69°C. Incidentally, Guenther et al. 
noted cross-reactivity between M. haemolytica and M. glucosida using the primer 
combination SGF & SGR at 64°C annealing, subsequently differentiating between the 
two species using melt curve analysis after PCR amplification [151]. It is accepted that 
increased specificity will negatively impact on assay sensitivity and to some extent this 
was observed through the Cq cut-off value determined at 34 cycles for M. haemolytica 
compared to 35 cycles for both H. somni and P. multocida. Despite the reduced 
sensitivity at 69°C for this primer pair (SGF & SGR) a good dynamic range (7 orders of 
magnitude) and efficiency (96%) was observed. 
 
Partial sequences of the Mannheimia sodA gene revealed no nucleotide differences in the 
reverse primer (Mhae-SGR) binding region among the four M. haemolytica strains 
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assessed (Appendix B, Table B.5). These similarities were evident in phylogenetic 
analysis (Figure 3.9) where all M. haemolytica sequences were placed in the same clade 
with a high bootstrap value of 100 (estimated confidence). Of note, the clades identified 
were in concordance to those described for Mannheimia based on rpoB sequences, in 
particular, sequence similarities were observed for M. haemolytica, M. glucosida and 
M. ruminalis, whilst M. varigena and M. granulomatis were more similar to each other 
than the other Mannheimia species [200]. Differences of 19 to 21 nucleotides in the 
reverse primer binding region were seen between M. haemolytica and all other species 
in the genus (Appendix B, Table B.5). These mismatches were sufficient for divergence 
between Mannheimia spp. but their presence at lower annealing temperatures contributed 
difficulty in adequately distinguishing between M. haemolytica and M. glucosida. As no 
full genome sequence exists for M. glucosida, PCR assay development and 
troubleshooting was difficult. Such a sequence would facilitate novel and potentially 
improved PCR target and primer design. Diversity among the M. haemolytica bovine 
nasal isolates included in the phylogenetic analysis was evident following amplification 
using the thermal gradient PCR; gel electrophoresis revealed different amplification 
fingerprints for each strain (Figure 3.10). This raises questions about the genetic diversity 
of Mannheimia carried in a healthy population of animals. Future work could employ 
approaches such as pulse-field gel electrophoresis, multilocus sequence typing [217] and 
whole genome sequencing [218] to elucidate trends in diversity and transmission events. 
 
To validate detection of target bacteria using the qPCR assays presented in this study, a 
subset of nasal swabs collected from heathy cattle on the North Wyke Farm Platform 
(full experimental details given in Chapter 4) were cultured. In all cases, swabs negative 
by PCR were also negative by culture and detection of all species was enhanced using 
PCR, probably reflecting swabs with target DNA but too few viable organisms for 
successful culture. In contrast, a high proportion of oropharyngeal swabs collected from 
healthy school and university students were determined culture-positive but PCR-
negative for meningococcus. Greatest discordance between the two methods was 
observed at the lower limits of detection for both techniques. Although, at these lower 
limits a marginally greater number of samples were positive by qPCR, suggesting 
increased sensitivity than culture. It is likely that the culture-positive/PCR-negative 
samples reflect the poor sensitivity of PCR to detect very low numbers of organisms from 
mixed samples, whereas culture may detect single organisms [83]. Similar discordances 
 100 
between culture and PCR were seen for nasal swabs collected from healthy children for 
a number of bacterial species (Streptococcus pneumoniae, Moraxella catarrhalis, 
Haemophilus influenzae, Staphylococcus aureus and group A Streptococcus; GAS). 
Again, lowest concordance was seen at lower bacterial densities, where the number of 
samples positive by both culture and PCR was lower than the number of swabs positive 
by either method alone [171].  
 
During culture of nasal swabs 6 isolates were identified as either Moraxella or 
Pasteurella and a further 13 isolates could not be reliably identified based on 
biochemistry using API test strips. This reflects the difficulty in reliably identifying 
isolates based on phenotypic characteristics, especially when bacterial species are closely 
related. These results prompted the decision to perform 16S rRNA gene sequencing for 
reliable identification of isolates. To date, much of the focus surrounding BRD bacterial 
agents is directed at H. somni, M. haemolytica and P. multocida, but 16S rRNA gene 
sequencing also allows investigation of other bacterial species colonising the healthy 
bovine nasopharynx, these otherwise may be undetected when using targeted approaches. 
Sequencing successfully confirmed the identification of isolates cultured as  
M. haemolytica and P. multocida and these were then incorporated into the specificity 
panel. Of particular interest was one nasal isolate confirmed as Moraxella bovoculi which 
is the causative agent of infectious bovine keratoconjunctivitis along with M. bovis, 
although its precise role in pathogenesis is unclear [219]. Therefore, it would be 
interesting to know whether this isolate was an inhabitant of the nasal mucosa or 
conjunctiva and has migrated to/from the nasopharynx. In addition, this finding raises 
the question as to whether there are other Moraxella species carried in the bovine URT, 
given their role in respiratory disease in humans [220] [221]. 
 
In conclusion, qPCR is a rapid and reliable tool for studying the epidemiology of bovine 
respiratory disease and Pasteurellaceae colonisation dynamics in a range of settings. 
Colonisation with members of the Pasteurellaceae is not exclusive to respiratory biome 
of cattle. Pasteurellaceae have been found to colonise the mucous membranes of wild 
and domestic animals, for example, small ruminants, pigs, dogs, cats, and more recently 
were implicated in haemorrhagic septicaemia of Saiga antelopes [222] [223] [224]. The 
sample collection methods and qPCR assays described here could be applied to range of 
species to investigate the biology of Pasteurellaceae carriage.
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Chapter 4 Pasteurellaceae carriage dynamics in the nasal passages of 
healthy beef calves 
4.1 Introduction 
Respiratory microbiota are diverse communities in humans and livestock [225]. In 
humans, Staphylococcus aureus and Streptococcus pneumoniae are frequently carried in 
the nasal passages as commensals but are also significant pathogens on occasion [226]. 
Bacteria with this dual commensal-pathogen behaviour have been dubbed pathobionts, 
although key drivers between commensal and pathogenic states remain to be identified. 
Similarly, healthy cattle carry pathobionts in their nasal passages, most commonly 
members of the Pasteurellaceae family: Histophilus somni, Mannheimia haemolytica 
and Pasteurella multocida [179].  
 
Bacterial colonisation over a period of time is often referred to as carriage. Sometimes 
carriage may be persistent for long periods of time, thus uninterrupted, or it may be rare, 
or with low bacterial numbers, so that individuals studied may be misidentified as non-
carriers. Alternatively, carriage may be intermittent, and an individual may acquire, clear, 
and re-acquire the organism [227]. It is likely that persistent carrier types are responsible 
for maintaining carriage in a population [81], however it is not clear which carrier types 
are at increased risk of invasive disease [228]. However, it has been suggested that 
carriage is a prerequisite for invasive disease, and if organisms are carried at a high 
density there is increased risk of disease, for example by inhalation to the lower 
respiratory tract [229].  
 
Clearance of a bacterial organism can occur through immune mediated mechanisms, such 
as antibody opsonization and phagocytosis [130], or by displacement due to competition 
[230]. If adequate immune responses are triggered against an organism it is possible 
future colonisation may be prevented. In a healthy individual, most of the time, the 
respiratory microbiome is in homeostasis but following certain triggers dysbiosis may 
occur and alter the microbial niche such that certain members flourish and colonisation 
with others can no longer be sustained. This may lead to exclusion and potentially 
replacement by existing or new species [231].  
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Bacterial carriage in the bovine upper respiratory tract has generally been detected by 
culture of swabs [135, 145-147, 153], but this can be problematic due to the fastidious 
and often slow growth of Pasteurellaceae, which can be associated with over-growth by 
faster-growing species such as Proteus [149]. Advances in molecular techniques have 
allowed in-depth investigation of organisms that are currently difficult or impossible to 
culture, for example by PCR [152] and sequencing [177-179]. Real-time PCR (qPCR) 
can be used to detect and quantify bacterial species, as described in the previous chapter 
(Chapter 3). Density of carriage of bovine respiratory pathobionts has not previously 
been investigated and may be an important predictor or determinant of disease.  
 
Entrance to the nasal passages is through the nostrils but the exact sites of colonisation 
with Pasteurellaceae in the respiratory tract have been poorly described. Given the 
differences in temperature, cell type, gas exchange and pH, it is reasonable to assume 
colonisation may be different along the length of the respiratory tract. Historically, it has 
been noted by culture that M. haemolytica preferentially colonises deeper in the 
nasopharynx, at the palatine tonsil, as seen in Figure 4.1 [138] [139]. However, despite 
advances in molecular approaches, such as PCR, colonisation sites in the bovine upper 
respiratory tract have not been investigated. Characterisation of colonisation locations 
may reveal specific sites as reservoirs of infection, and these sites could be targeted to 
reduce shedding and transmission of clinically important species. In addition, 
determining colonisation locations may facilitate detection of organisms, which may 




Figure 4.1: Mid-sagitally sectioned adult bovine head with approximate locations of 1) palatine tonsil; 2) 
choana; and 3) external nasal meatus, as indicated by the arrows. Photo: Amy Thomas 
 
Bacterial carriage is often assessed over time by repeated sampling and assaying for the 
presence or absence of target organisms. This longitudinal approach provides rich data 
by following the same participant over time. By comparison, cross-sectional study 
designs sample participants at one point in time – there is no follow up and therefore no 
investigation into the influence of time on variables of interest. Cross-sectional studies 
can be repeated but the participants may be entirely or largely different on each occasion 
[232]. Compared to cross-sectional studies, longitudinal studies using sequential 
sampling are expensive and time-consuming, and inherently give rise to interval-
censored data; when an event of interest is known to occur within an interval [233]. In 
humans, upper respiratory tract pneumococcal carriage has been modelled using 
exponential interval-censored survival models to determine the rate of clearance and 
duration of carriage [234], but these approaches have rarely been used in veterinary 
research [233]. In survival analysis, the relationship between explanatory variables and 
the time-to-event is investigated. It can be performed using non-parametric, semi-
parametric or parametric methods. In medical settings, survival analysis is common, as 
the time to an event is often of interest. It’s also common that the data are censored – 
some of the participants may experience the event, other’s might not, and subsequently 
their survival times will be unknown. Right censoring occurs when an event has not 
occurred during the study, but it is assumed to occur beyond the follow-up period. If the 
event of interest has occurred before the study period begins, then that participant is said 
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to have left censoring. Finally, interval-censoring occurs when the time-to-event is not 
observed directly but is known to occur within a particular interval. This commonly 
occurs in monitoring for infectious diseases when discrete time points are chosen to 
monitor carriage/infection status [233].  
 
The survival function/survival probability is defined as the probability of the outcome 
‘event’ not occurring up to a specific point in time, including the time point of 
observation (t), and is denoted by S(t). When t = 0, the probability = 1; 100% survival at 
the onset. The median survival time is the point in time with 50% survival probability. 
An event refers to one of two responses of the binary categorical outcome variable. In 
the context of bacterial carriage, the event may be ‘acquisition’ or ‘loss of carriage’, and 
events may occur more than once e.g. recurrence of infection. In some instances, only 
the first event will be modelled but this ignores information. One approach is to model 
all recurrent events, preserving information, but account for clustering between events 
within the same individual (a cluster effect), using cluster robust standard errors. [235] 
[236] The hazard rate, denoted by h(t) is the probability that an individual at risk of 
having an event, will experience an event at time t. Survival and hazard are directly 
related. Examples of interval-censored analysis in veterinary medicine include: 
investigating bacterial dynamics in udder infections of dairy cows, using a gamma frailty 
model [237]; estimating the age at onset of Mycobacterium avium subsp. 
paratuberculosis  faecal shedding in cattle, using Weibull proportional hazards [238]; 
and Campylobacter infection dynamics in broiler flocks, using a proportional hazards 
model [239]. More recently, advances in regression analysis of interval-censored data 
have led to computationally efficient and easy-to-implement statistical methods. The 
package icenReg in R statistical software offers a flexible and easy-to-use environment 
for non-parametric, semi-parametric and parametric interval-censored regression 
analysis [240]. Given that interval-censored data is frequent in veterinary medicine, using 
these advances in statistical methods there is an opportunity for veterinary research to 
employ interval-censored survival analysis. Understanding bacterial colonisation 
dynamics in healthy individuals will improve our understanding of the fundamental 
biology of carriage, including transmission dynamics, in turn helping inform prevention 




The objectives of the work presented in this chapter were to investigate rates and 
densities of nasal carriage with Histophilus somni, Mannheimia haemolytica and 
Pasteurella multocida in heathy beef calves using the three real-time PCR assays 
described in Chapter 3. A secondary objective was to investigate differences in 
nasopharyngeal colonisation locations (posterior and anterior) using real-time PCR for 
these three bacterial species through collection of short and long nasal swabs.  
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4.2 Materials and Methods 
4.2.1 Longitudinal carriage study 
An observational cohort study was conducted to determine bacterial colonisation 
dynamics in the upper respiratory tract of healthy beef cattle bred and housed on the 
Biotechnology and Biological Sciences Research Council (BBSRC) North Wyke Farm 
Platform (NWFP) National Capability, Devon, UK [164]. Some information on the 
respiratory health status of these cattle was available from veterinary practice records.  
 
4.2.2 Cattle and husbandry 
Beef calves, either Charolais, Hereford or Limousin crosses, were bred at Rothamsted 
Research, North Wyke Farm, Devon, UK. In November 2015 at weaning, 60 calves aged 
5 to 7 months were transferred to the NWFP National Capability [167] and allocated to 
one of two identical, physically adjacent purpose-built cattle housing facilities, 
designated the ‘Green Barn’ and the ‘Red Barn’. Animals housed in the Blue barn were 
involved in a separate study not reported.  
 
Animals were allocated to housing, ensuring bodyweight, sire breed and sex were 
balanced between the two barns. In January 2016, within each barn, calves were 
separated into six pens each of five animals. Calves were housed on deep litter straw 
bedding with access to water and silage ad libitum. Animals were observed daily 
throughout all studies by animal technicians and any cattle showing abnormal behaviour 
that might have indicated poor health were examined in more detail by one of us (AT) 
using the Wisconsin scoring system for signs of respiratory disease (cough, nasal and 
ocular discharge, abnormal ear/head tilt and rectal temperature) [241]. 
 
4.2.3 Sample collection 
4.2.3.1 Nasal swabs 
Nasal swabs were collected from each calf housed in the Green and Red barns (n = 60) 
on five separate visits between January 2016 to April 2016, on days: 0, 33, 47, 62 and 
75. Swabs 15 cm in length were collected as described in Chapter 2, 2.9.5. On Day 62, 
deep guarded nasopharyngeal swabs were collected from a subset of animals 
predominately housed in the red barn (Red, n = 25; Green, n = 5) as described previously 
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in Chapter 2, section 2.9.5. Deep swabs were collected immediately after collection of 
short swabs to ascertain differences in detection rates by different swab lengths. 
 
4.2.3.2 Parasitological and serological sampling 
Shortly after housing, composite samples of 10 freshly deposited faecal pats collected 
from the floor of each barn were tested for the presence of respiratory nematode larvae 
(Dictyocaulus viviparus) using the Baermann technique. Following parasitological 
testing, all calves were treated once routinely with 200 mg ivermectin (Noromectin®, 
Norbrook) pour-on (40 ml of product) to control respiratory and gastrointestinal 
nematodes and external parasites. Paired blood samples were collected from all housed 
animals to detect evidence of infection by BRSV, BPIV-3, BHV-1, BVDV and 
Mycoplasma bovis. Jugular venous blood samples were collected into plain Vacutainers 
as described in Chapter 2, section 2.9.6 on Days 33 (Green, n = 30; Red, n = 30) and 47 
(Green, n = 29; Red, n = 29). 
 
4.2.4 ELISAs to detect serological responses to bovine respiratory pathogens 
Serum samples were tested to detect the presence of antibodies against BHV-1, BVDV, 
BRSV, BPIV-3 and Mycoplasma bovis using a multiplex indirect ELISA (BIOX K 284 
ELISA®, BioX, Belgium) according to the manufacturer’s instructions (see Chapter 2, 
section 2.12). Briefly, duplicate optical density (OD) results for test and control samples 
were imported into Microsoft® Excel for calculation of degree of positivity. According 
to the formulae specified in the kit instructions, each test sample OD was adjusted for 
control sample OD and categorised as either 0 (seronegative, having the lowest OD) or 
1, 2, 3, 4, or 5 (all seropositive, category 5 having the highest OD). Seroconversion was 
indicated to have occurred by an increase of at least two categories between paired (acute 
and convalescent) samples for all agents, as per kit instructions. Further details on the 
principle of the test and determination of degree of positivity are given in the Chapter 2, 
section 2.12.  
 
4.2.5 Real-time PCR for bacteria 
Real-time Taqman PCR (qPCR) assays targeting sodA and the 16S rRNA regions of the 
bacterial genome were performed for M. haemolytica, H. somni and P. multocida 
respectively, using methods as described in Chapter 2, section 2.14.  
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4.2.6 Data analysis 
4.2.6.1 Real-time PCR  
Cycle quantification (Cq) values obtained from qPCR analysis of nasal swabs were 
converted to genome copies/ml by interpolation using the predictive models described in 
Chapter 3.  
In vivo, clinical samples are likely to contain both viable and non-viable bacterial cells. 
Accordingly, colony forming units/ml (CFU/ml) and genome copies/ml cannot be used 
interchangeably for these assays, and genome copies/ml are presented. 
 
4.2.6.2 Carriage and co-carriage 
Rates of carriage of H. somni, M. haemolytica and P.  multocida were calculated as the 
numbers of animals positive by qPCR for each agent divided by the numbers of animals 
sampled on each occasion, unless stated otherwise. Carriage estimates for each bacterial 
species were calculated for each barn (Green and Red) and as an overall average. Co-
carriage rate, defined as carriage of either two or three of the bacterial species on the 
same occasion, was calculated as an overall average for the two barns. Confidence 
intervals for proportions and differences between proportions were calculated using the 
Wilson score [242] and Newcombe-Wilson hybrid score [243] methods respectively 
[244]. Levels of co-carriage of H. somni, M. haemolytica and P. multocida were assessed 
at each visit using Fisher’s exact test (because of expected values lower than 5) to assess 
for the independence of the carriage of pairs of different bacterial species, based on the 
counts of calves with different combinations of positive/negative qPCR results. Levels 
of P. multocida carriage were assessed for short and long swabs using Fisher’s exact test 
to assess for the independence of carriage between swab types. 
 
4.2.6.3 Interval-censored survival analysis 
Interval-censored survival analysis was used to estimate the rate (‘hazard’) of clearance 
of bacterial carriage. A parametric proportional hazards regression model for interval-
censored data with an exponential distribution was fitted to carriage episodes from all 
animals. Animals were combined into one cohort (n = 60) following insufficient evidence 
to suggest a difference in carriage between pens and barns (Appendix C, Effect of pen 
and barn on bacterial carriage rates). An episode was defined as a period of uninterrupted 
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H. somni or P. multocida carriage. Further details on rules defining carriage episodes and 
on dataset construction are provided in Appendix C, Interval-censored survival analysis). 
The number of carriage episodes for each bacterium contributing to the survival analysis 
was not equal to the number of animals observed; some animals experienced multiple 
carriage episodes whilst others were carriage-free. Adjustment for correlation between 
recurrent episodes of carriage within the same animal was made by including animal 
identity as a clustering variable and calculating cluster robust standard errors [235]. The 
effects of sex and density of carriage when first positive were considered as covariates 
in univariable analyses. To assess the relationship between log hazard ratio and density 
(log10 genome copies/ml) the observations were grouped into categories based on the 
density quartiles. Parameter estimates for each density category were plotted to assess 
the fit. The hazard for each sex and density category was estimated and expressed as a 
hazard ratio relative to the baseline category. Median carriage duration was calculated as 
-loge(0.5) divided by the estimated hazard value. Improvement in model fit between the 
unconditional model (no covariates specified) and the model with the covariate of interest 
was assessed by calculating the log-likelihood test ratio statistic. The strength of the 
relationship between categorical covariates (sex/carriage density) and hazard of 
clearance was assessed using the hazard ratio p-value. All analyses were performed in R 
version 3.5.0, using base functions and the following supplementary packages: ggplot2 
(version 2.2.1), longCatEDA (version 0.31 [245]), icenReg (version 2.0.7 [240]). 
 
4.2.6.4 Seroprevalence  
For each of the five respiratory disease agents tested, seroprevalences on Days 33 and 47 
were calculated as the number of animals seropositive by ELISA (i.e. results in categories 
1 to 5) divided by the total number of animals sampled. 
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4.3 Results 
4.3.1 Characteristics of the study animals and signs of respiratory disease 
A total of sixty mixed breed animals were included in the study. The nutritional plane of 
animals housed in each barn was similar (see Appendix C, Table C.1 for details on forage 
analysis) strengthening the consideration of housing arrangements as replicates. Animal 
characteristics (sex, sire breed, age and weight) are shown in Table 4.1. Animals were 
separated into groups of five per pen in both barns. Animals were monitored for signs of 
respiratory disease using the Wisconsin calf respiratory scoring system. Nasal discharges 
were observed on three occasions (scored between 1–3), two of which were in the same 
animal. Coughing was observed in one animal on one occasion. No 
Dictyocaulus viviparous larvae were detected in faeces of any animal. 
 
Table 4.1: Sex, sire breed, age and weight of calves in the observational study (n = 60) 
  Green Barn (n = 30) Red Barn (n = 30)  Total  
Sex     
Heifer  15/30 14/30 29/60 
Steer 15/30 16/30  31/60 
Sire Breed      
Charolais 20/30 21/30 41/60 
Hereford   4/30 3/30  7/60 
Limousin  6/30 6/30  12/60 
Median Age (Day 0)    
Days (range) 305 (276–319) 307 (258–324) 305 (258–324) 
Median Weight*    
Kilograms (range) 364 (266–441) 354 (277–455) 359 (266–455) 
* Weight 16 days before Day 0 
 
4.3.2 Carriage rates  
A total of 299 nasal swabs obtained during winter housing of calves were analysed by 
qPCR to determine carriage rates and densities of H. somni, M. haemolytica and 
P. multocida; 238 swabs were positive for at least one of these three target bacterial 
genes. P. multocida was most frequently detected (227/299; 75.9%), followed by 
H. somni (80/299; 26.8%) and M.  haemolytica (17/299; 5.7%). The overall proportions 
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of swabs positive in each barn were similar for P. multocida (Green Barn: 118/150; 
78.7%, Red Barn: 109/149; 73.2%; p = 0.327) and M. haemolytica (Green Barn: 7/150; 
4.7%, Red Barn: 10/149; 6.7%; p = 0.608). The proportion of swabs positive for H. somni 
was lower in the Green (20/150; 13.3%) than in the Red Barn (60/149; 40.3%; p < 0.001). 
In all cases, the T4 internal amplification control assay Cq values were as expected, 
indicating successful DNA extraction with no evidence of PCR inhibition. 
Target bacterial nucleic acid was detected in swabs from each of the sixty animals on at 
least one sampling occasion. Carriage rates were highest on the first occasion of sampling 
(Day 0), and declined for all bacterial species thereafter, with similar trends observed in 
both barns. P. multocida was carried at a higher rate than H. somni and M. haemolytica 
on all sampling occasions in the Green Barn, and on Days 0 and 47 in the Red Barn. 
Clearance of H. somni and M. haemolytica was observed in the Green barn from Days 
62 and 47, respectively (Figure 4.2 and Appendix C, Table C.2). Log-linear models 
provided insufficient evidence to suggest any difference in carriage rates between barns 
and pens (see Appendix C, Effect of pen and barn on bacterial carriage rates). 
 
 
Figure 4.2: Carriage of Pasteurellaceae during the observational study. Carriage of Pasteurella multocida 
(green circles), Histophilus somni (purple triangles) and Mannheimia haemolytica (orange squares) 
determined by qPCR on nasal swabs collected on five occasions from sixty calves housed in two identical 
barns (n = 30 Green Barn, n = 30 Red Barn). Error bars represent Newcombe 95% confidence intervals for 
the single proportion.  
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4.3.3 Colonisation at different locations within the bovine nasopharynx 
Paired short and long swabs were collected from a subset of calves (n = 29) on one 
occasion (Day 62) to investigate carriage of H. somni, M. haemolytica and P. multocida 
at different nasopharyngeal locations. H. somni was detected from 6/29 short and 2/29 
long swabs. No animal was positive for H. somni by both swab types. Conversely, 
P. multocida was detected using both swab types in six of 29 animals, with a greater 
proportion of animals found positive by sampling with short (17/29) than with long swabs 
(7/29). Carriage was not significantly associated with either swab type for P. multocida 
(p = 0.187; H. somni rates too low for statistical analysis). M. haemolytica was not 
detected in any sample on this occasion (Table 4.2). 
 
Table 4.2: Comparison of short and long swabs for detection of H. somni, M. haemolytica and P. multocida 
by qPCR 
  Short swab Long swab N 
H. somni + + 0 
 + - 6 
 - + 2 
 - - 21 
M. haemolytica + + 0 
 + - 0 
 - + 0 
 - - 29 
P. multocida + + 6 
 + - 11 
 - + 1 
- - 11 
 
 
Density of H. somni and P. multocida carriage determined using short and long swabs is 
given Table 4.3. P. multocida was detected at a higher median density by short compared 
to long swabs. Only two animals were positive for H. somni by long swab, with carriage 
at a lower density compared to short swabs.   
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Table 4.3: Density of Histophilus somni and Pasteurella multocida carriage determined by qPCR on short 
and long swabs 
  Short swab Long swab 
 Species 
Median density  
(genome copies/ml) N 
Median density  
(genome copies/ml) N 
H. somni 52.8 6 20.3 2 
P. multocida  3590 17 445 7 
 
4.3.4 Carriage patterns  
A carriage episode was defined as a period of carriage detected in consecutive samples 
without interruption. Forty-five (75%) of the 60 calves were positive for H. somni on at 
least one occasion: 36 of these calves had a single carriage episode and 9 had two 
episodes. H. somni was detected at the first visit in 29 calves, of which two remained 
positive at all subsequent study visits. Details of individual carriage trajectories are 
shown in Figure 4.3. 
 
Carriage of P. multocida was detected in 57 (95%) of the 60 calves at Day 0: 38 of these 
calves had a single carriage episode and 19 had two episodes. Carriage was detected in 
26 calves on all study visits. Of three calves negative for P. multocida on Day 0, carriage 
was detected in two at the subsequent visit, while the third remained negative throughout 
the study. Carriage of M. haemolytica was detected in 8 (13%) of the 60 animals at the 
first visit, of which 7 had one carriage episode and one had three. In three further calves, 
M. haemolytica was detected at the second visit, while this species of pathobiont was not 
detected in the remaining 49 animals at any visit.  
 
Co-carriage was defined as detection of more than one bacterial species in the same 
sample and co-carriage of two and three species was found in 47 and three animals 
respectively.  
Co-carriage with H. somni and P. multocida occurred most frequently and 
M. haemolytica was co-carried with P. multocida more commonly than with H. somni 
(see Appendix C, Table C.3 for co-carriage rates). No evidence of associations between 
pairs of species were apparent using Fisher’s exact test (p > 0.221). 
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Figure 4.3: Carriage patterns and density of Histophilus somni, Mannheimia haemolytica and Pasteurella determined by qPCR on nasal swabs collected on five sampling days 
(0, 33, 47, 62 and 75) from sixty calves. Animals housed in Green and Red barns are identified by G and R following ID numbers respectively. Density is represented as log10 
genome copies/ml. One animal (ID 23 R) had a missing sample at Day 47. 
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4.3.5 Carriage density  
For each bacterium, density values for all positive samples were plotted as histograms 
revealing distinct density profiles Figure 4.4. The modal value for H. somni carriage 
density accounting for the vast majority (82.5%) of swabs was 1–2 log10 genome 
copies/ml with fewer samples (13.8%) between 2–3 logs. Only two samples in two calves 
were in the 4–5 log range and one sample in the 3–4 log range. Although carriage rates 
were low for M. haemolytica, carriage density ranged between 2 and 6 logs when it 
occurred. Pasteurella multocida was also carried over a wide range of densities, most 
commonly between 3 and 5 log10 genome copies/ml, extending up to 6.08 (ID: 5G) logs 
in one sample. Although density of P. multocida carriage was also dynamic within and 
between calves, some animals maintained carriage at high densities in the 4–6 log range 
over several sampling visits, and only one sample in one calf (ID: 62G) was in the 1–2 
log range (Figure 4.3). 
 
 
Figure 4.4: Histograms for all positive swabs summarising density distribution profiles of Histophilus 
somni (n = 80), Mannheimia haemolytica (n = 17) and Pasteurella multocida (n = 227). 
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4.3.6 Duration of carriage and hazard of clearance  
Interval-censored exponential survival models for carriage (without inclusion of carriage 
density or host animal sex as covariates) estimated the median duration of H. somni 
carriage to be 14.8 days (CI95%: 10.6–20.9) and the hazard of clearance to be 0.0467 per 
day (CI95%: 0.0326–0.0634). For P. multocida, the median carriage duration was 
estimated to be 55.5 days (CI95%: 43.3–71.3) and hazard of clearance to be 0.0125 per 
day (CI95%: 0.00969–0.0159) (Figure 4.5). Carriage rates of M. haemolytica were too low 
for meaningful survival modelling. 
 
 
Figure 4.5: Fitted survival curves: proportion of carriage episodes still ongoing by time for 
Histophilus somni (panel A; 14.8 days median carriage duration) and Pasteurella multocida (panel B; 55.5 
days median carriage duration). Dotted lines represent 95% confidence interval. 
 
The effects of carriage density and host animal sex on carriage duration was modelled in 
univariable analyses. Log hazard ratio and density data were suggestive of a non-linear 
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trend for both H. somni and P. multocida, therefore the effect of density was modelled 
using categories based on density quartiles rather than continuously. For P. multocida, 
density of carriage significantly influenced subsequent carriage duration (p = 0.036, 
Table 4.5). Categories 2–4 of P. multocida density were significantly associated with 
increased carriage duration compared to the reference category (1) (Table 4.4). Density 
was not seen to influence H. somni carriage duration (Table 4.4) nor did the animals’ sex 
significantly influence carriage duration for either bacterium. 
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Table 4.4: Interval-censored exponential survival models: H. somni  
Species Model Covariate 
Hazard ratio 
[exp(bi)] 




H. somni  
(n = 54) M0: Unconditional  
 
0.0467* 0.0333 – 0.0655  -55.8 
 M1: Density† Category 1 (n = 14) 0.0556* 0.0261 – 0.112  -55.0 
 
 





Category 3 (n = 13) 0.610 0.219 – 1.69 0.342  
 
 
Category 4 (n = 14) 0.850 0.266 – 2.72 0.784   
 M2: Sex Heifer 0.0411* 0.0260 – 0.0617  -55.5 
  Steer 1.29 0.635 – 2.61 0.484  
H. somni log-likelihood ratio test statistic: (M0 vs. M1), χ2 (3 df) = 1.62, p = 0.655; (Model 0 vs. Model 2), χ2 (1 df) = 0.668, p = 0.414 
* Hazard for unconditional model and baseline category 
† H. somni density categories based on quartiles (log10 genome copies/ml): <1.26; ≥1.26 to 1.45; ≥1.45 to 1.96; ≥1.96 
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Table 4.5: Interval-censored exponential survival models: P. multocida 
Species Model Covariate 
Hazard ratio 
[exp(bi)] 




P. multocida  
(n = 78) M0: Unconditional 
 
0.0125* 0.00950 – 0.0164  -109 
 M1: Density† Category 1 (n = 20) 0.0280* 0.0145 – 0.0524  -104 
 
 
Category 2 (n = 19) 0.393 0.189 – 0.814 0.0119  
 
 
Category 3 (n = 19) 0.321 0.153 – 0.674 0.00267  
 
 
Category 4 (n = 20) 0.414 0.197 – 0.868 0.0196  
 M2: Sex Heifer 0.0108* 0.00791 – 0.0146  -108 
  Steer 1.33 0.464 – 1.23 0.255  
P. multocida log-likelihood ratio test statistic: (M0 vs. M1), χ2 (3 df) = 8.52, p = 0.036; (Model 0 vs. Model 2), χ2 (1 df) = 1.028, p = 0.311 
* Hazard for unconditional model and baseline category 
† P. multocida density categories based on quartiles (log10 genome copies/ml): <3.40; ≥3.40 to 3.99; ≥3.99 to 4.77; ≥4.77 
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4.3.7 Serological responses to bovine respiratory viruses and Mycoplasma bovis 
Among the bovine respiratory pathogens tested (BHV-1, BPIV-3, BRSV, BVDV and 
M. bovis), antibodies to BPIV-3 were detected most frequently (20/29 up to 30/30 
animals positive) with three animals also showing evidence of seroconversion. Exposure 
to BRSV was detected in slightly fewer animals (17/29 up to 24/30), and M. bovis in 
fewer still (7/29 up to 11/30). One calf had antibodies to BHV-1 at Day 33 and no animals 
had antibodies to BVDV (Table 4.6).  
 
Results for each agent were assigned either to a negative category or to one of 5 
categories of increasing seropositivity. The number of animals within each category for 
each agent is shown in Table 4.7. The number of calves with antibodies detected at 
varying degrees of seropositivity was similar between sampling days for all agents tested. 
The majority of calves positive for M. bovis had detectable antibodies between categories  
1–2. Antibodies were detected across a wider range of categories for BRSV (categories 
1–4) and BPIV-3 (categories 1–5); however, the majority of calves with detectable 
antibodies were within the lower category range (1–2).  
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Table 4.6: Serological status of calves in the study (n = 60) 
Barn Agent Day 33  Day 47  Seroconversion‡ 
   
Number of 
animals 








positive (n/N) † 
% 
BVDV Green 0/30 0.0 0 – 14.1 0/29 0.0 0 – 14.1 0/29 0.0 
 Red 0/30 0.0 0 – 14.1 0/29 0.0 0 - 14.1 0/29 0.0 
BHV-1 Green 1/30 3.3 0.174 – 19.1 0/29 0.0 0 – 14.6 0/29 0.0 
 Red 0/30 0.0 0 – 14.1 0/29 0.0 0 – 14.6 0/29 0.0 
M. bovis Green 11/30 36.7 20.5 – 56.1 9/29 31.0 16.0 – 51.0 0/29 0.0 
 Red 9/30 30.0 15.4 – 49.6 7/29 24.1 11.0 – 43.9 0/29 0.0 
BRSV Green 24/30 80.0 60.9 – 91.6 24/29 82.8 63.5 – 93.5 0/29 0.0 
 Red 19/30 63.3 43.9 – 79.5 17/29 58.6 39.1 – 75.9 0/29 0.0 
BPIV-3 Green 30/30 100 85.9 – 100 29/29 100 85.4 – 100 0/29 0.0 
 Red 22/30 73.3 53.8 – 87 20/29 70.0 49.4 – 83.8 3/29 10.3 
* Confidence intervals for single proportions were calculated using the Wilson score 
† Samples were considered seropositive in that calculated optical densities corresponded to categories 1 to 5 of the ELISA kit instructions (see Chapter 2 
for further details). 
‡ Seroconversion was considered to have occurred if there was an increase of at least two categories of seropositivity between paired samples. 
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Table 4.7: Number of calves seronegative and seropositive for BHV-1, BVDV, BRSV, BPIV-3 and Mycoplasma 
bovis, with 5 categories of increasing seropositivity. Serological status was determined by ELISA using a 
commercially available kit. Acute and convalescent blood samples were collected 14 days apart at Day 33 (visit 
2) and Day 47 (visit 3) respectively. 
    Green Barn Red Barn 









BVDV Negative 30 29 30 29 
   + 0 0 0 0 
   ++  0 0 0 0 
   +++ 0 0 0 0 
   ++++  0 0 0 0 
   +++++ 0 0 0 0 
BHV-1 Negative 29 29 30 29 
   + 1 0 0 0 
   ++  0 0 0 0 
   +++ 0 0 0 0 
   ++++  0 0 0 0 
   +++++ 0 0 0 0 
M. bovis Negative 19 20 21 22 
   + 8 7 7 6 
   ++  2 1 2 1 
   +++ 1 1 0 0 
   ++++  0 0 0 0 
   +++++ 0 0 0 0 
BRSV Negative 6 5 11 12 
   + 13 15 12 8 
   ++  8 7 6 7 
   +++ 2 1 0 1 
   ++++  1 1 1 1 
   +++++ 0 0 0 0 
BPIV-3 Negative 0 0 8 9 
   + 1 4 7 8 
   ++  14 13 12 7 
   +++ 9 8 2 2 
   ++++  6 4 1 2 




This is the first longitudinal investigation into nasal carriage patterns and densities of common 
bovine respiratory pathobionts in healthy animals using qPCR. The detailed quantitative 
profiles obtained over a typical housing period demonstrate marked differences between the 
bacteria studied in terms of frequency, duration of carriage and microbial density. These results 
provide methodological and biological information that could be useful for future study of 
bacterial carriage and transmission in housed animals, and of the impact of vaccines and viral 
infections upon respiratory disease. 
 
Cattle remained generally healthy throughout the study; on only a few occasions were mild 
signs of respiratory disease observed (nasal discharge and cough). No bovine lung worm 
(Dictyocaulus viviparous) larvae were detected. Surveillance data on diagnostic submissions to 
Veterinary Investigation Centres confirm that the bacterial species studied here are important 
in bovine pneumonia in the UK; most frequently Mannheimia spp. closely followed by 
P. multocida [246]. Although the prevalence of P. multocida as a commensal in the healthy 
bovine respiratory tract is unknown, the high carriage rates by PCR (61.7–95.0%; Figure 4.2, 
Table C.2) reported in this study in healthy animals suggest it may function as part of the core 
nasal microbiota. Using culture, nasal carriage of H. somni has been reported in healthy calves 
(6.6%) and those with respiratory disease (11.9%) [146]; however, rates reported by PCR in 
this study were higher (13.3% to 48.3%). This may reflect the increased sensitivity of detection 
by qPCR compared to culture, suggesting that H. somni may have been underreported 
previously. By contrast, M. haemolytica was rarely detected (carriage rates of up to 13.3%), 
although when carriage did occur it was over a wide range of densities (2–6 logs; Figure 4.4). 
It has been suggested that M. haemolytica is carried preferentially deeper in the nasopharynx at 
the palatine tonsil [139] [158]. To explore differences in colonisation locations, paired short 
and long swabs were collected. Unfortunately, M. haemolytica was not detected in any swab 
on the occasion that these paired samples were collected. Therefore, this warrants further 
investigation either through sampling a larger number of animals, or sampling animals where 
carriage rates of M. haemolytica are known to be higher in order to reduce the number of 
animals sampled using a more invasive method. Nevertheless, M. haemolytica was detected 
from short swabs on other sampling occasions. For both H. somni and P. multocida a greater 
proportion of short swabs were positive, however no pairs of short and long swabs from the 
same animal were both positive for H. somni. In addition, density of carriage tended to be higher 
 124 
in short swabs, although sample sizes were too small for meaningful statistical analysis. Only 
one animal had a negative short but positive long swab for P. multocida (6 animals with pairs 
of swabs both positive); this observation reflects a very small proportion of animals (1/29) 
likely to have carriage undetected if sampled solely with short swabs. Of note, short swabs were 
collected prior to long swabs in the same nostril, avoiding contamination of short swabs by 
material originally deeper in the nasopharynx pulled anterior by a longer swab. 
 
Seropositivity to BRSV and BPIV-3 was high for both viruses. This is unsurprising given other 
studies reporting their widespread occurrence [247] [248] [249], and reflects the likelihood of 
repeated exposure and viral infection in the absence of vaccination. Three animals showed 
evidence of seroconversion to BPIV-3; however, for all other agents seropositivity either 
declined or remained the same between paired samples (Day 33 and 47). 
Patterns of carriage for all three pathobiont species were similar between barns but not identical 
(clearance of H. somni was observed in the Green barn only). This suggests epidemiology may 
vary somewhat in different but overtly similar groups of animals. Furthermore, carriage rates 
for all species declined over the study period in both barns. This observation may reflect 
immunological maturation as animals become older or development of specific immune 
responses following exposure or both enabling them to clear bacteria more efficiently than 
younger animals. 
  
An episode of carriage was defined as a period when an animal was positive for any one 
bacterial species in consecutive samples without interruption. One animal experienced three 
such episodes of carriage with M. haemolytica and carriage was often transient for all three 
species. While such apparent transient carriage episodes may reflect genuine clearance and re-
acquisition, negative results could also be due to sampling error or intermediate and other 
sample(s) below the limit of detection of the assay, in the context of apparent large fluctuations 
in density over time (Figure 4.3).  
It is not known to what extent the bacteria are evenly distributed within the upper respiratory 
tract of colonised animals. Conversely, apparent continuous episodes of carriage in our study 
could also represent repeated acquisition and successive carriage episodes with the same or 
different strains of H. somni, M. haemolytica or P.  multocida. This is a limitation of repeated 
sampling studies which can be partially addressed by taking more frequent samples or 
undertaking more detailed characterisation of the bacteria detected. Approaches such as pulsed-
field gel electrophoresis, multilocus sequence typing [217] and whole genome sequencing can 
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be used to study transmission events, however their success is dependent on isolation by culture 
and adequate genetic diversity [218].  
Serotype displacement and replacement is known to occur following dysbiosis of the 
respiratory niche. For example reduction in carriage of pneumococcal vaccine serotypes 
following universal vaccination in childhood, suggesting that non-vaccine serotypes are 
outcompeted in the absence of vaccination [82]. In cattle, although differences in serotype 
prevalence have been suggested between healthy animals and those suffering with respiratory 
disease, this area of microbiology is relatively unexplored [154] [156].  
 
Interval-censoring occurs when the time-to-event is not observed precisely but is known to have 
occurred within a particular interval. This commonly occurs in monitoring for infectious 
diseases when discrete time points are chosen to monitor carriage/infection status [233]. Biased 
estimation can result if this imprecision is ignored and the midpoint or right end point of the 
observed interval is taken as the exact event/failure time [250]. Using interval-censored 
exponential survival analysis the median duration of H. somni carriage was estimated at 14.8 
days (hazard; 0.0467 per day) and at 55.5 days for P. multocida (hazard; 0.0125 per day), 
concordant with the increased prevalence observed for P. multocida. However, prevalence 
depends on acquisition and clearance rates also. Increasing P. multocida carriage density was 
significantly associated with increased carriage duration. One explanation for reduced carriage 
duration at lower densities could be the requirement of a certain number of bacteria for 
colonisation [251]; however, at higher densities (over a threshold) the opportunity for naïve 
individuals to become exposed increases. Incidentally, H. somni was predominately carried at 
lower densities (1–2 logs) and was not significantly associated with carriage duration (Figure 
4.4). M. haemolytica carriage episodes were too few (prevalence 1.7–13.3%) to model using 
survival analysis but carriage density did extend transiently up to 6 log10 genome copies/ml. 
Given the infrequency of observed second episodes for both bacterial species, it was not 
possible to generate precise estimates for the median duration of carriage per episode type. Only 
two animals had sustained carriage of H. somni for the entire study, but twenty-six had 
sustained carriage of P. multocida. It would be of interest to define factors which predict and 
determine persistence of carriage with these pathobionts.  
 
A greater incidence of respiratory disease has been reported in male calves than in female calves 
[28], suggesting sex may influence respiratory pathobiont colonisation dynamics. Sex was 
included as a covariate in exponential survival models but was not found to be significantly 
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associated with carriage duration for either H. somni or P. multocida. Furthermore, when 
carriage rates and densities observed at each occasion were stratified by sex there was no 
difference between the two proportions carrying on any occasion (data not presented). This may 
indicate that reported differences in disease rates may not be due to marked differences in 
carriage biology but instead to other factors [82]. 
 
Between the three bacterial species studied, unexpected marked differences in prevalence, 
carriage duration and density were observed. These observed differences provide evidence for 
genuine differences in the carriage biology of these organisms and do not reflect sampling 
artefact. Quantitative molecular techniques have identified increased nasal bacterial carriage 
and density following respiratory viral infection in the upper respiratory tract of healthy mice 
and children [252, 253]. One hypothesis is that density may be important for transmission of 
bovine pathobionts between herd members and may affect the likelihood of invasive disease. 
Moreover, respiratory viral infection may influence bacterial colonisation dynamics. The 
methodological approaches and carriage patterns presented in this chapter lay the foundation 
for exploring transmission models of bovine respiratory disease and intervention studies 
exploring the effects of respiratory viral infection on bacterial colonisation dynamics.  
 127 
Chapter 5 Pasteurellaceae colonisation in early-life of cattle 
5.1 Introduction 
Work investigating the role of microbiota in health of humans and rodents, and more recently 
of livestock has exploded since the advent of culture-independent and novel technologies [254] 
[177]. Microbiota have been demonstrated to play an important role in immune maturation, 
metabolism, mucosal barrier functions and colonisation resistance for pathogens [254] [255] 
[256]. At birth, calves are exposed to microbiota from the dam directly and from the maternal 
environment [257]. Traditionally it has been considered that initial colonisation by the 
microbiome occurs during birth and that subsequent colonisation proceeds through a dynamic 
succession of stages. This process leads to a complex host microbiome that continues to change 
during life [160] [257]. Recent evidence in humans suggests that colonisation can occur in utero 
[258] but the evidence is controversial [259].  
 
Biesbroek et al. reported that the respiratory microbiomes of children aged between 6 weeks 
and 2 years fell into distinct clusters. Children with microbiomes characterised either by 
Moraxella or by Corynebacterium combined with Dolosigranulum at 6 weeks old tended to be 
more stable up to 2 years old, in that these individuals tended to maintain microbiomes 
dominated by these organisms, whereas children with microbiomes dominated by, for example, 
Staphylococcus tended to be more variable over time. Notably, children with microbiomes 
dominated by Corynebacterium in combination with Dolosigranulum went on to develop fewer 
upper respiratory tract infections [160]. Studies in humans, therefore, seem to suggest that the 
composition of the respiratory microbiota in early life may be important for determining 
subsequent respiratory health. 
 
There has been considerable interest in characterising colonisation patterns in the neonatal calf 
rumen, with a view to manipulating microbiomes for enhanced health and productivity [260] 
[261]. In addition, mucosal immune responses in the gastrointestinal tract of neonatal pigs have 
been shown to be influenced by changes in rearing environment [262]. However, despite 
respiratory disease frequently occurring in calves <6 months of age, there is little known about 
the patterns of bacterial colonisation of the respiratory tract of bovine neonates. One study used 
culture to report the nasal and tracheal microbiota of calves from the first day of life up to 3.5 
months. Calves were housed in controlled environments experiencing different climatic 
conditions (varying temperature and relative humidity). The authors reported colonisation 
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within the first days of life with M. haemolytica regardless of climatic differences [137]. Only 
one study [149] has surveyed carriage of P. multocida in a UK farm setting and reported 
prevalence of P. multocida in the nasal passages of 637 Scottish calves based on culture-
amplified PCR. The median age of calves sampled was 22 days, and carriage was detected in 
17% of calves: however, carriage rates stratified by age were not reported [149]. From the 
literature, then, it is not clear when healthy beef suckler calves become colonised with common 
respiratory pathobionts. Such information on bacterial colonisation is essential for detailed 




The objective of the work presented in this chapter was to characterise colonisation with 
H. somni, M. haemolytica and P. multocida from shortly after birth and up to weaning by 
collection of short nasal swabs and analysis using real-time PCR. 
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5.2 Materials and methods 
5.2.1 Calves and husbandry  
Healthy beef suckler calves born from dams resident at the North Wyke Farm Platform during 
spring 2016 were included in the study. Calves (n = 28) were purebred Stabiliser or were 
crossbred from Hereford-Friesian dams by either Charolais or Limousin sires. Soon after 
calving, dams and their respective calves were housed in penned groups: 5 dams with their 
respective calf. Pen 1 contained six calves as one cow had twins, but neither of these calves 
were sampled. One other set of twins which were sampled were located in Pen 10 (Figure 5.3). 
Bull calves were castrated at 1–2 days of age by elastration. Disbudding was performed between 
4–8 weeks of age. Calves remained with dams up to, and during spring/summer turnout. 
Weaning occurred at the time of housing in November 2016. All calves remained apparently 
healthy throughout the course of the study. None were either diagnosed with or treated for 
respiratory infections. 
 
5.2.2 Sample collection  
Nasal swabs were collected from calves on four occasions: within their first week of life; at 
approximately 2 months; approximately 3 months; and approximately 7 months of age. The 
swabs collected at 2 and 3 months of age were taken when calves were brought in temporarily 
from pasture for management purposes. At 7 months of age swabs were collected shortly after 
weaning and housing (16 days). Swabs 15 cm in length were collected as previously described 
in Chapter 2, section 2.9.5 into skim milk, tryptone, glucose, glycerol (STGG) broth and kept 
at -70ºC until further processing. Sampling points for detecting Pasteurellaceae during early 
life are illustrated in Figure 5.1. 
 
Figure 5.1: Collection of nasal swabs from calves aged approximately 1 week to 7 months for detection 
Pasteurellaceae.  
 
5.2.3 Real-time PCR for bacteria 
Real-time PCR (qPCR) assays targeting sodA and the 16S rRNA regions of the bacterial 




















methods as described in Chapter 2, section 2.14. In all cases, the T4 internal amplification 
control assay Cq values were as expected, indicating successful DNA extraction with no 
evidence of PCR inhibition. 
 
5.2.4 Data analysis 
5.2.4.1 Real-time PCR 
Cycle quantification (Cq) values obtained from collected nasal swabs were converted to genome 




Rates of carriage of H. somni, M. haemolytica and P. multocida were calculated as the numbers 
of animals positive by qPCR for each bacterium divided by the total number of animals sampled 
on each occasion, unless stated otherwise. 
Confidence intervals for proportions and differences between proportions were calculated using 
the Wilson score [242] and Newcombe-Wilson hybrid score [243] methods, respectively [244]. 
Association of H. somni and P. multocida carriage at 7 months of age was compared to carriage 
previously using Fisher’s exact test (because expected values were fewer than 5) to assess for 
the independence of carriage, based on the number of calves with different combinations of 
positive/negative qPCR results. Association between carriage (H. somni, M. haemolytica and 
P. multocida) and sex was assessed using Fisher’s exact test. All statistical analyses were 
performed in R version 3.5.0 using base functions. Figures were generated using the 
supplementary package ggplot2 (version 2.2.1). 
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5.3 Results  
5.3.1 Study animal characteristics  
Characteristics of the animals sampled in this study are shown in Table 5.1. The majority of 
calves were Charolais-cross (18/28). There were equal numbers of heifers and steers. 
 
Table 5.1: Sex, sire breed and age of calves sampled shortly after birth to 7 months of age on four occasions to 
determine patterns of bacterial colonisation. 
 Breed*  
  CHX LIMX ST Total 
Sex      
Heifer  10 4 0 14 
Steer† 8 3 3 14 
Median Age   
Visit Days (range) Months (range) 
1 4 (1–9) 0.1 (0.03–0.3) 
2 68 (54–81) 2.3 (1.8–2.7) 
3 103 (89–116) 3.4 (3.0–3.7) 
4  218 (204–231) 7.2 (6.8–7.7) 
* CHX: Charolais cross; LIMX: Limousin cross; ST: Stabiliser 




5.3.2 Carriage rates and patterns  
Carriage rates for H. somni, M. haemolytica and P. multocida were determined by qPCR for 
the calves at all time points sampled. Carriage with H. somni was observed from 1 week of age 
and carriage rates at the group level remained similar up to 3 months of age (Figure 5.2). The 
proportion of calves positive for H. somni was not dissimilar between 1 week [8/28, (29%); 
CI95%: 13.9–48.9], 2 months [5/28 (18%); CI95%: 6.8–37.6] and 3 months [9/28 (32%); 
CI95%: 16.6–52.4]. However, at the individual level, carriage was transient, and no calves 
positive at 1 week of age maintained carriage to 2 months although two calves, positive at 1 
week, had detectable levels again at 3 months. At 7 months of age, carriage rates were increased 
[12/28 (43%); CI95%: 25.0–62.6; Figure 5.2], although there was no association between the 
carriage of H. somni at 7 months and carriage at any age sampled previously (p ≥ 0.687). 
 
 
Figure 5.2: Patterns of nasal bacterial carriage for healthy calves at 1 week, 2 months, 3 months and 7 months of 
age.Carriage of Histophilus somni (top panel; purple), Mannheimia haemolytica (middle panel; orange) and 
Pasteurella multocida (bottom panel; green) determined by qPCR. Error bars represent 95% confidence intervals 
calculated using the Wilson score. 
 
In contrast to H. somni, carriage of M. haemolytica was not detected in any animals until the 
age of 7 months [8/28 (29%); CI95%: 14.0–48.8; Figure 5.2]. Similarly, carriage of P. multocida 
was not detected until the age of 3 months, at which point only two calves were colonised [2/28 
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(7%); CI95%: 1.2–25.0], both of them also carrying H. somni. At 3 months, carriage of H. somni 
was significantly higher than both P. multocida (p = 0.044) and M. haemolytica (p = 0.00361). 
At 7 months, P. multocida carriage was the highest of all bacterial species at any age [22/28 
(79%); CI95%: 58.5–91.0%; Figure 5.2]. However, as for H. somni, carriage at 7 months was 
not significantly associated with carriage previously (p = 1). The two animals colonised with 
P. multocida at 3 months of age had detectable carriage again at 7 months but no co-carriage 
of H. somni or M. haemolytica. 
 
5.3.3 Spatial distribution of positive calves 
Calves at 1 week of age were co-housed in pens of 5 with their respective dams. The spatial 
distribution of calves colonised with H. somni at 1 week of age is given in Figure 5.3. There 
was no obvious clustering of calves positive for H. somni in the same pen.  
Of those positive, 2/8 and 3/8 were housed in pens 1 and 9 respectively. The remaining 3/8 
positive calves were housed in adjacent pens. 
 
Figure 5.3: Spatial distribution of housed calves positive for Histophilus somni at approximately 1 week of age. 
Each pen contains 5 calves (pen 1 with 6 calves). Cells shaded purple represent calves positive for H. somni; blue 
shaded cells represent calves negative for H. somni; grey shaded cells represent calves in pens that were not 
sampled but co-housed with sampled calves; white shaded cells show no calf present. Each row of seven pens is 





















































5.3.4 Association of early life colonisation patterns with sex 
Carriage for all three bacterial species stratified by sex is given in Table 5.2. On four of the 
seven occasions when carriage was observed, carriage rates were marginally higher in steers 
compared with heifers. However, for H. somni, colonisation was not significantly associated 
with sex at any age (p ≥ 0.209). This was also true at 7 months of age for M. haemolytica 
(p = 0.678) and P. multocida (p = 0.648), and for P. multocida at 3 months (p = 0.482). 
 
Table 5.2: Early life carriage with Histophilus somni, Mannheimia haemolytica and Pasteurella multocida 
stratified by sex 
 Species Age Carriage rate  
  Heifer (%) Steer (%) P-value‡ 
H. somni 1 week 2/14 (14.3) 6/14 (42.9) 0.209 
H. somni 2 months 4/14 (28.6) 1/14 (7.14) 0.326 
H. somni 3 months 3/14 (21.4) 6/14 (42.9) 0.420 
H. somni 7 months 6/14 (42.9) 6/14 (42.9) 1 
M. haemolytica* 7 months  3/14 (21.4) 5/14 (35.7) 0.678 
P. multocida† 3 months 0/14 (0.0) 2/14 (14.3) 0.482 
P. multocida† 7 months 10/14 (71.4) 12/14 (85.7) 0.648 
* Carriage of M. haemolytica was undetected prior to 7 months of age 
† Carriage of P. multocida was undetected prior to 3 months of age 
‡ P-values shown are for the null hypothesis of no association between carriage and sex as assessed 




5.3.5 Density of colonisation  
Density values for all positive swabs for each bacterium were plotted as histograms and showed 
distinct density profiles for each species (Figure 5.4 and Figure 5.5). The distribution of density 
of H. somni carriage remained similar as calves aged (Figure 5.4). H. somni carriage density 
was observed most frequently between 1–2 log10 genome copies/ml. At 7 months of age, one 
animal had higher carriage density between 4–5 log10 genome copies/ml.  
 
 
Figure 5.4: Density distribution profiles of Histophilus somni. Histograms for all positive swabs collected in early 
life summarising density of H. somni determined by qPCR at ages 1 week (n = 8), 2 months (n = 5), 3 months (n 
= 9) and 7 months (n = 12). Density given as log10 genome copies/ml. 
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Carriage density for M. haemolytica at 7 months of age ranged between 2 and 6 log10 genome 
copies/ml. P. multocida was also carried over a wide range of densities at 7 months of age (1–
6 log10 genome copies/ml), most commonly between 3–4 log10 genome copies/ml (Figure 5.5). 
At 3 months of age two calves carried P. multocida at 4.5 and 4.8 log10 genome copies/ml.  
 
 
Figure 5.5: Density distribution profiles of Mannheimia haemolytica and Pasteurella multocida.Histograms for 
all positive swabs summarising density of M. haemolytica (top panel; orange; n = 8) and P. multocida (bottom 




5.4 Discussion  
Using targeted molecular approaches, this work has provided novel insights into the 
colonisation patterns of important bovine respiratory pathobionts in early life in apparently 
healthy calves. Marked differences between bacterial species in the frequency of colonisation 
were observed as calves aged. Histophilus somni was detected in the first week of life and at 
subsequent sampling points (2 m, 3 m and 7 m), with carriage consistently at low densities  
(1–2 log10 genome copies/ml). This suggests H. somni may function as part of the core 
respiratory microbiota, in which case it may be that it was also present in animals determined 
to be carriage-negative, but below the limit of detection for this assay. Conversely, P. multocida 
was not detected until 3 months of age and, even then, in only two calves also carrying H. somni. 
Dowling et al. detected high antibody titres to P. multocida and respiratory viruses in calves 
sampled under 56 days of age [263]. However, Dowling et al. did not culture P. multocida from 
any nasal swab sample from the same animals. Unfortunately, no details of colostrum intake 
were given but these reportedly high titres, although possibly antibody produced by the calf, 
probably reflect maternal antibody and as such provide only weak evidence for colonisation 
within the first week of life. This study has echoes of the observation that P. multocida is not 
an early coloniser of the bovine URT niche, possibly as a result of protective maternally-derived 
antibody.  
 
In the studies reported here, M. haemolytica was not detected until 7 months of age. This finding 
differs from that of Woldehiwet et al. who isolated M. haemolytica from both nasal and tracheal 
swabs collected from 1-day-old Friesian male calves, purchased directly from nearby farms 
[137]. These differences could be due to breed (dairy versus beef) or to increased transmission 
from the maternal environment at birth. Interestingly, Woldehiwet et al. reported that 
M. haemolytica constitutes a very small proportion of the total flora cultured (0.5–8.5%) at one 
day of age. However, as calves aged, M. haemolytica was isolated with increased abundance 
relative to the total flora.  
 
As discussed, predominance of certain bacterial species in human infants in early life has been 
suggested to have a protective role in later respiratory health [160]. Evidence is more limited 
for domesticated animals, but next-generation sequencing of 16S rRNA performed on nasal 
swabs collected from Holstein calves revealed the total bacterial load of 3-day-old calves to be 
higher in animals that developed pneumonia than in healthy animals. Differences in the relative 
abundance of genera were noted between healthy calves and those diagnosed with pneumonia: 
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abundance of Mannheimia and Moraxella was significantly higher in sick calves at 14 days old 
compared to healthy calves. Similarly Mannheimia and Mycoplasma were higher in sick calves 
at 28 days old than healthy calves [264].  
 
When carriage of M. haemolytica and P. multocida at 7 months occurred, it was over a wide 
range of densities (up to 6 log10 genome copies/ml) although the majority of calves carrying 
M. haemolytica were colonised at lower densities (2–3 log10 genome copies/ml). In the studies 
reported in Chapter 4 a longer duration of P. multocida carriage in individuals was significantly 
associated with higher density carriage. Higher rates of P. multocida carriage (22/28; 79%) in 
older calves aged 7 months may be a consequence of increased potential for onward 
transmission as a result of higher carriage density: animals carrying for longer periods have 
potentially increased opportunity to transmit and acquire bacteria. It may also be that both the 
higher rates of carriage in the population and the higher density reflect a change with age in the 
upper respiratory environment, creating an increasingly favourable niche for P. multocida. 
 
Carriage rates for all three bacterial species were highest after weaning and housing at  
7 months of age. This may be a simple consequence of age (increased probability of acquisition 
over time, or changes in the function of the respiratory mucosa with age) or of weaning, 
transportation and housing, all of which are thought to enhance bacterial proliferation in the 
nasal passages [19] [23]. Since animals were sampled 16 days after weaning, the increased 
carriage rates observed at this age could be a consequence of several factors: stress of weaning 
and/or housing i.e. change in diet and social re-organisation; the increased stocking-density in 
a housed environment in turn increasing the likelihood for transmission; or change in climate 
from warmer spring/summer weather at pasture to a cooler less ventilated housed environment 
in winter. Similar carriage rates were also seen in the previous year’s cohort of animals while 
housed at 10 months of age (see Chapter 4). Calves carrying H. somni in the first week of life 
were clustered either in the same or adjacent pens, possibly reflecting transmission between in-
contact animals. However, carriage rates were low (18%) and a relatively small number of 
animals were studied, and thus meaningful inference is difficult; highlighting a limitation to 
this study. Although it is possible that carriage rates could be higher in housed environments 
compared to that at pasture as a result of increased transmission. 
 
Aside from changes in environment, differences in colonisation among individuals during early 
life may be the result of differences in maturation rates of the immune system, particularly the 
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mucosal immune system in the respiratory tract. As discussed in Chapter 1, colostrum is 
essential for transfer of maternal antibodies in ruminants due to lack of transfer of 
immunoglobulins from cow to calf in utero, with IgG1 the predominant immunoglobulin of 
colostrum [29]. In beef calves, it has been shown that maternally acquired antibodies against 
P. multocida and M. haemolytica wane to baseline values at 60–120 days of age. Calves appear 
to start producing their own antibodies against these bacterial species at 60–90 days of age, 
with IgG1 demonstrated as the predominant antibody isotype against both of these bacterial 
species [106]. However, IgG2a is thought to protect against H. somni: cattle with low titres of 
IgG2a against H. somni have shown increased susceptibility to disease associated with H. somni 
infection and animals with infection have higher titres of IgG2a specific to H. somni compared 
to other immunoglobulin isotypes [265]. Furthermore, protective IgG2 responses have been 
found to develop at different ages, with IgG2a expressed early (<60 days) and IgG2b expressed 
later (3–4 months) [266]. It may be that colonisation during different stages of life differs as a 
result of waning maternally-derived antibody and differences in the timing of production of 
antibody by the calf. 
 
The respiratory microbiota of calves is likely to reflect that of the dam and maternal 
environment. Yeoman et al. described the influence of maternal sources (udder skin, 
colostrum, and vaginal microbiomes) on the early succession of the calf gastrointestinal tract. 
Overall they found 46% of luminal and 41% of mucosal operational taxonomic units seen 
throughout the calf gastrointestinal tract were present in at least one of the maternal sources 
investigated [267]. However, similar detailed studies of the source of the respiratory microbiota 
has not been carried out in calves, and the role of H. somni, M. haemolytica and P. multocida 
as commensals within the respiratory microbiome remains to be elucidated. Recent indirect 
evidence suggests that colonisation with Mannheimia in early life may be protective against 
subsequent respiratory disease. Lima et al. reported calves born from dams with a high 
abundance of Mannheimia in their vaginal microbiome are less likely to experience URT 
disease [268]. Interestingly, differences in gut microbiota have been reported between vaginally 
and Caesarean-delivered infants. Infants delivered vaginally acquire gut bacterial communities 
similar to the mother’s vaginal microbiota whereas those delivered via Caesarean acquire 
communities more similar to those found on the skin, in addition to demonstrating delayed 
colonisation [269]. Furthermore, children up to 36 months of age delivered by Caesarean have 
been found to have a higher incidence of wheezing, asthma and recurrent lower respiratory tract 
infection compared to vaginally delivered children [270]. It is not clear from human studies 
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whether the effects observed on respiratory ‘health’ are a direct consequence of the respiratory 
microbiome or an indirect consequence of the gut microbiome on, for example, the common 
mucosal immune system. However, it seems that the maternal vaginal microbiota may be 
important for determining bovine neonatal respiratory health, whether directly or indirectly. 
Future studies could be designed to sample the calf, dam and maternal environment. Such 
samples could potentially provide sequential information to determine the patterns of bacterial 
transmission to neonatal calves.  
 
Together, these results suggest that bacterial colonisation in the upper respiratory tract is 
dynamic, with different organisms predominating as cattle age. While it is not yet clear how 
these colonisation dynamics affect or are affected by host mucosal immune responses, early life 
colonisation could be an important factor in determining later respiratory health. Logical next 
steps would be to conduct longitudinal studies employing high-throughput sequencing 
approaches to determine bovine neonatal respiratory profiles, to identify how those profiles 
may differ as a consequence of environment and management practices, and how they may 




Chapter 6 A double-blind, randomised controlled trial of the effect of 
respiratory viral infection on bacterial carriage in the bovine nasopharynx 
 
6.1 Introduction 
The effect of viral infection on upper respiratory tract carriage of bacteria remains poorly 
understood in both humans and livestock. However, recent evidence in humans suggests that 
viral infection can affect bacteria carried in the URT [256] [271] [272]. Infections with 
respiratory viruses in cattle, most commonly bovine respiratory syncytial virus (BRSV), bovine 
parainfluenza virus-3 (BPIV-3) and bovine herpesvirus-1 (BHV-1) are usually transient and in 
temperate climates, outbreaks of infection typically occur during autumn and winter months 
[273] [274] [275]. Viral infection may alter the environment for bacteria colonising the 
respiratory tract. As discussed previously in Chapter 1, viruses can modify innate and adaptive 
immune responses, in turn promoting secondary bacterial infection [22] [19]. Viral infection 
may also cause physiological disruption to the respiratory mucosa, for example compromising 
mucociliary apparatus to favour migration of bacteria to the lower respiratory tract (4) (6). In 
addition, viral infection can cause nasal discharge promoting opportunity for transmission of 
viruses and bacteria to susceptible individuals within a herd. Consequently, understanding viral 
involvement may be pivotal in improving understanding of bacterial transmission dynamics 
and successful implementation of bovine respiratory disease (BRD) prevention and control 
strategies [21] [19]. 
 
Both BRSV and BPIV-3 are in the family Paramyxoviridae, BRSV belonging to the genus 
Pneumovirus within the subfamily Pneumovirinae and BPIV-3 belonging to the genus 
Respirovirus; both are single-stranded, negative sense RNA-viruses [276] [274]. These viruses 
are widespread and have been detected in cattle herds worldwide [276] [277]. Reinfection with 
BRSV in calves is common and viruses from recurrent infections have been reported to vary 
up to 11% in nucleic acid sequence analysis of the genes coding for the glycoprotein and the 
small hydrophobic protein in closed herds [273]. Clinical signs of BRSV include serous to 
mucopurulent nasal discharge, slightly to moderately increased respiration rate, tachypnoea and 
coughing in moderate infections, and severe dyspnea with subpleural and interstitial 
emphysema and emphysematous bullae in severely affected calves [278]. Interlobular 
emphysema and bullae are differentiating features of BRSV infection and have not been 
reported with BPIV-3 [274]. While both BRSV and BPIV-3 may act in synergy with other 
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agents to cause disease, infection with BRSV alone can induce severe respiratory disease and 
be fatal [115] [279]. In comparison, infection with BPIV-3 alone is either subclinical or usually 
associated with mild clinical illness [274]. Transmission of both viruses can occur via 
aerosolised droplets, direct animal-to-animal contact or indirectly via fomites [140].  
 
Work presented in previous chapters has demonstrated the utility of real-time PCR (qPCR) for 
detection and quantification of bacteria from bovine nasal swabs. In healthy cattle of various 
ages, bovine respiratory pathobionts were detected over a wide range of densities and at 
different rates depending on the bacterial species. However, it is not known whether or how 
patterns of carriage and/or density are influenced by respiratory viral infection in cattle. It can 
be hypothesised that animals suffering respiratory viral infection carry bacterial pathobionts at 
higher densities. Mina et al. recently showed that vaccination with an intranasally administered 
live attenuated influenza vaccine (LAIV) to significantly increases bacterial carriage densities 
of clinically important bacterial pathogens within the upper respiratory tract of mice 
(Streptococcus pneumoniae and Staphylococcus aureus) [252]. Thors et al. later demonstrated 
that administering LAIV increases bacterial carriage densities of S. pneumoniae and 
Haemophilus influenzae in healthy pre-school children [253]. These findings raise the 
possibility that the short-term effects of viral vaccination could modulate onward transmission 
of a range of non-target bacterial opportunistic pathogens, while inducing beneficial acquired 
immune response to vaccination resulting in protection against the target pathogen. Similarly, 
it can be hypothesised that wild-type viral infection may have similar and possibly more marked 
effects [280]. Together, these findings suggest it may be rewarding to study bacterial 
colonisation dynamics of nasal bacteria using vaccination as a model viral infection system. 
 
Live attenuated vaccines contain a version of the pathogen that has been changed such that it 
does not elicit serious disease but is processed by the immune system nevertheless. This occurs 
because vaccine pathogens can replicate in the host, mimicking a natural infection, and as such 
do not require an adjuvant [281]. However, it should be noted that live attenuated vaccines may 
have the potential to revert back to virulence and cause disease [281]. Vaccines for protection 
against respiratory infections should ideally induce both local and systemic immunity; however, 
the effectiveness of immune responses hinges partly on the immunisation route [282]. Beef 
calves have been estimated to possess maternal antibody against BRSV and BPIV-3 for 
approximately 6 months [49]. During this period when maternal antibody wanes and antibody 
is starting to be produced by the calf, rates of BRD are high, with outbreaks typically occurring 
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in calves under 6 months of age. It is therefore desirable to vaccinate calves early to protect 
against disease later on, but this can be challenging in the presence of maternally derived 
antibody which can interfere with vaccination strategies. In youngstock, intranasal delivery of 
a bivalent live attenuated respiratory vaccine (Rispoval® RS + PI3 Intranasal, Zoetis UK Ltd ) 
has been demonstrated to replicate in the presence of maternally derived antibody[278] [283].  
 
In cattle, several live attenuated intranasal respiratory viral vaccines are available in the UK, 
including bivalent BRSV and BPIV-3 (Bovalto Respi Intranasal, Boehringer Ingelheim Animal 
Health UK Ltd; and Rispoval® RS + PI3 Intranasal; Zoetis UK Ltd), bivalent BPIV-3 and IBR 
(Imuresp RP; Zoetis UK Ltd), and monovalent BRSV (Rispoval® RS; Zoetis UK Ltd). 
Rispoval® RS + PI3 Intranasal is administered as a single dose to calves from 9 days of age 
with onset of immunity from 5 days for BRSV and 10 days for BPIV-3 – immunity lasting for 
12-weeks. However, immunity against BPIV-3 may be reduced in calves with maternally 
derived antibody before 3 weeks of age [284]. Vangeel et al. demonstrated vaccine efficacy 
through reduced BRSV and BPIV-3 nasal shedding after viral challenge, following intranasal 
vaccination with Rispoval in calves with and without maternal antibody. It is uncertain how 
viral replication may be inhibited following vaccination, although several mechanisms have 
been proposed: virus specific antibody produced in the respiratory tract (predominately IgA), 
cell-mediated immune responses, viral-specific IFN-g and enhanced production of neutrophil 
chemotactic factors from alveolar macrophages resulting in enhanced clearance through 
neutrophils [278] [283].  
 
Randomised controlled trials (RCTs) are robust research designs used to establish a cause-effect 
relationship between an intervention and outcome [285]. In cluster randomised trials (CRTs) 
clusters are randomised to receive the intervention, rather than randomisation at the individual 
level as in RCTs. CRTs are often more feasible than conventional RCTs when evaluation of an 
intervention needs to be pragmatic [285]. In settings where interventions are delivered at the 
group level, for example in health care settings such as a hospital, hospital ward, or general 
practice, randomisation at the individual level often is not feasible, so these scenarios lend 
themselves well to CRTs. When the intervention under investigation is an infectious agent or 
live-attenuated vaccine, then rolling out an intervention to clusters can be favourable to reduce 
the threat of cross-contamination between intervention and control arms of the study. 
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A stepped wedge trial is an extension of a CRT. In stepped wedge trials, the intervention is 
rolled out to different clusters successively. Each cluster acts as a control providing 
observations before and after implementation of the intervention, and data are collected from 
all clusters throughout the study. Clusters are randomised so as to first receive the intervention 
at different staggered timepoints (crossover points) - eventually all clusters will have switched 
from the control to receiving the intervention phase. The timing of these different crossover 
points gives rise to the name stepped wedge; the ‘shape’ of the intervention rollout is apparent 
in illustrations as seen in Figure 6.1 [286]. The number of clusters per group, the number of 
groups, and the time between crossover points are key aspects of the allocation strategy [287].  
 
 
Figure 6.1: Diagrammatic illustration showing characteristics and terminology of stepped wedge cluster 
randomised controlled trials. Clusters are shown in grey once exposed to the intervention. Illustration as in Copas 
et al. [288] 
  
Copas et al. classified stepped wedge trials into three types of design: i) continuous recruitment 
with short exposure, where participants are recruited as the trial begins, with others participating 
once eligible overtime; ii) closed cohort with participants recruited at the start and remain until 
the study end and iii) open cohort with participants recruited from the start but some may leave 
during the study, whilst others become eligible [287]. The proportion of clusters exposed to the 
intervention gradually increases over time; consequently, control clusters will contribute 
observations earlier than intervention clusters and therefore time is a potential confounder 
 145 
during longitudinal (horizontal) analysis of outcomes, particularly if secular trends in the 
measured outcome exist [289]. 
One of the earliest examples of a stepped wedge trial was the Gambia hepatitis study in 1980 
[290]. However, its popularity has grown only in recent years, particularly within human health 
service evaluation [291] [292]. As such, there are challenges for sample size calculations, 
analysis and reporting, for which there are not yet agreed standard protocols [293] [287]. 
Nevertheless, this pragmatic design boasts several advantages over the conventional CRTs 
outlined above, particularly when study constraints may exist. For example, it may be ethically 
unacceptable to deliver the intervention to only one group of participants if there is existing 
evidence for its effectiveness. As most participants in stepped wedge studies experience both 
the control and intervention phase this constraint can be overcome [294]. Staggered 
implementation of the intervention might also be preferable due to logistical, practical and 
financial constraints [285].  
 
In stepped wedge trials the treatment or intervention effect is estimated by comparing data from 
participants within the control (unexposed) to exposed (intervention) phase. This can be 
achieved through within-cluster comparisons and between-cluster comparisons, referred to as 
‘horizontal’ and ‘vertical’ analyses respectively. Unlike parallel CRTs, in stepped wedge trial 
designs, statistical power can be increased by estimating the intervention effect using both 
horizontal and vertical analysis approaches simultaneously [285]. Analysis of stepped-wedge 
trials has largely been conducted using mixed effect models following the seminal paper by 
Hussey and Hughes in 2007 [293]. Using a mixed modelling framework allows for a more 
nuanced error structure than is possible with a simple fixed effects model with a single error 
term, including, for example the possibility of specifying random effects for individuals nested 
within clusters or specific correlation structures [295]. 
 
6.1.1 Objectives 
The objectives of the work presented in this chapter were to determine the effect of viral 
infection (live-attenuated viral vaccination) on nasal carriage and density of H. somni, 
M. haemolytica and P. multocida in healthy beef suckler calves. 
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6.2 Materials and Methods 
6.2.1 Study design 
Calves were vaccinated intranasally with bivalent BRSV and BPIV-3 (Rispoval® RS+PI3 
Intranasal, Zoetis) as a model viral infection system using a double-blind cluster randomised 
controlled trial following a stepped wedge design. Outcomes 2 and 4 weeks after viral infection 
were of primary interest. Figure 6.2 shows the design pattern matrix [292] for the study design 
implemented. Each barn represents a cluster (n = 29 calves per cluster). All clusters entered the 
trial at the same point (November 2016, Week 0) and acted as a control until the intervention 
(vaccination) was introduced by random allocation to one cluster at a time, at regular intervals. 
All clusters eventually received the intervention. 
 
 Time (Week) 
 0 2  4 6  8  10  12  
1 (Red) 1 0 2 0 2 0 0 
2 (Blue) 2 0 1 0 2 0 0 
3 (Green) 2 0 2 0 1 0 0 
Figure 6.2: Study design pattern matrix showing collection of nasal swabs (0), collection of nasal swab and 
administration of vaccine (1), and collection of nasal swab and administration of diluent (2). Clusters in the 
intervention phase are shown in darker shading.  
 
6.2.2 Power calculation 
Sample size calculations for stepped-wedge trials have been a rapidly expanding area of 
research during the course of designing and implementing this study. Suitable methods were 
not available at the outset for this particular study design (closed cohort).  
Given the population size (n = 90) and considering a study design of 540 observations, with an 
average cluster size of ten animals and an intracluster correlation coefficient (ICC) of 0.01 [296] 
the study had 80% statistical power to detect an effect size of 16% (i.e. an increase in 
colonisation from 30 to 46%) at p < 0.05 significance level. Power was calculated using Stata 
Statistical Software, using the Stata command ‘stepped-wedge’ [297]. This analytical method 
did not allow for repeated measures on the same animals and therefore is approximate in this 
case [298]. Methods have since been proposed to calculate sample sizes for stepped-wedge 
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trials under closed cohort designs and as such this study has for the same population (n = 90), 
assuming an ICC of 0.01, a minimum detectable effect size of 10% (increase in colonisation 
from 30 to 40%) at 80% power, p < 0.05 significance level [299].  
 
6.2.3 Cattle and husbandry 
Beef calves, either Charolais or Limousin crosses, or pure bred Stabiliser, were bred at 
Rothamsted Research, North Wyke Farm, Devon, UK. In November 2016, at weaning, 87 
calves aged 5 to 9 months were transferred to the Biotechnology and Biological Sciences 
Research Council (BBSRC) North Wyke Farm Platform National Capability [167] and 
randomly allocated to one of three identical, physically adjacent, purpose-built cattle housing 
facilities, designated the ‘Blue Barn’, ‘Green Barn’ and the ‘Red Barn’ (barns are respective to 
the three farmlet treatments as described previously Chapter 2, section 2.2). Calves were loose-
group housed (n = 29 per barn) on deep litter straw bedding with access to water and silage ad 
libitum. The nutritional plane of animals housed in each barn was similar (see appendix D for 
details on forage analysis). Calves were acclimatised to their surroundings for 16 days prior to 
starting the study i.e. the period between the first day of housing (and weaning) and Week 0. 
Animals were observed daily throughout the study by animal technicians and any cattle 
showing abnormal behaviour that might have indicated poor health were observed in more 
detail for signs of respiratory disease and health scored using a standardised scoring system that 
included cough, nasal and ocular discharge, abnormal ear/head tilt, rectal temperature and 
faecal consistency [37] [36] [241]. During the weeks of sample collection, calf respiratory 
health was scored on the day immediately prior to sampling, on the day of sampling and one 
day later. 
 
6.2.4 Allocation of animals to clusters 
Animals were allocated to clusters (i.e. barns) following a modified covariate-based 
randomisation [170] to maximise balance in three categorical variables (breed, sex and sire) 
and three continuous covariates (age, weaning weight, average daily growth rate) across the 
three treatment groups. Covariate-based randomisation in medical studies conventionally uses 
cluster- or group-based covariates to determine a balanced allocation of clusters or groups of 
patients to treatments – in this study, it is the individual animals that are being allocated to the 
treatment groups, and so animal-level covariates are considered. Units are allocated to treatment 
by randomly selecting one potential allocation from several which meet a specified level of 
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balance on relevant covariates [170] [300]. The study statistician (Andrew Mead; AM) 
determined the random allocation of the 87 calves to three clusters. First, constraints on 
breed/sex/sire combinations were selected to give as balanced allocation across the three 
treatment groups as achievable. The majority of calves (69/87) were cross-bred Charolais, the 
remaining animals were cross-bred Limousin (12/87) and Stabiliser (6/87). Given this 
demographic, 7 groups of breed/sex/sire combinations were identified (see Appendix D) with 
a total of 2.3 x1033 permutations possible for the allocation to three treatment groups based on 
these breed/sex/sire combinations. In a conventional covariate-based randomization all possible 
permutations would be considered. However, the size of the problem made this unfeasible. 
Therefore, an arbitrary and manageable 50,000 random permutations were constructed based 
on separate permutations of each of the 7 breed/sire/sex groups to allocate 29 animals to each 
of the 3 clusters. Summary statistics were calculated for each possible permutation assessing 
the mean and standard deviation of the three continuous covariates for the 3 clusters. Of these 
50,000 permutations, only 423 satisfied the following criteria: daily growth rate (range of mean 
and standard deviation less than 0.05 kg between clusters), most recent weight (range of mean 
and standard deviation less than 5 kg between clusters) and age (range of mean and standard 
deviation less than 10 days between clusters). Finally, one permutation of the 423 was selected 
at random as the final allocation of animals to clusters. The principles describing this 
randomization approach were presented as a poster at the 29th International Biometric 
Conference in Barcelona, 2018 [300]. 
 
6.2.5 Study blinding 
The rollout order of vaccination was determined prior to starting the stepped wedge study, by a 
‘blinding team’ who were privy to this information, unlike those involved in running the cattle 
experiment, recording data and collecting and testing samples. The Blinding Team comprised: - 
1.) Andrew Mead (AM) – Statistician, RR 
2.) Hannah Fleming (HF) - Farm Animal Technician, RR 
3.) Mark Eisler (ME) - Project Licence Holder, UoB 
4.) Robert Orr (RO) – NWFP manager, RR 
5.) Melanie Mils (MM) – Named Information Officer (NIO), RR 
 
Clusters (barns) were assigned numbers 1 to 3 randomly, determining their order of vaccination 
by AM in October 2016. AM was neither involved in sample collection nor processing, did not 
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have access to subsequent results before the trial was unblinded and shared the blinding key 
(intervention rollout order) directly with other members of the Blinding Team. 
HF was responsible for reconstitution of the vaccine and preparation of syringes with nasal 
applicators for administration (see 2.9) and for ensuring all doses were adequately administered 
by AT. AT collected nasal swabs from cattle, rectal temperatures, jugular bloods, performed 
respiratory calf health scoring, and monitored the temperature and humidity of the barns. Cattle 
were assigned a randomly-generated identification number separate to their management tag. 
Samples were labelled with new identification numbers for laboratory analysis by AT.  
AT remained blinded until all data had been collected and analysed. 
ME and RO were given the blinding key in case of any unforeseen need relating to animal 
health and welfare, although no such need arose. This rationale applied to MM, whose role as 
NIO at the NWFP also demanded records of procedures and administered medicines for each 
calf kept on regulated procedures. No farm animal staff involved in handling animals and their 
day to day management had access to the blinding key. 
Key details to the study design, study outcomes, methodology and raw data obtained were 
published as an unblinding protocol [301]. Following publication of the unblinding protocol 
the study was unblinded.  
 
6.2.6 Concealing preparation of vaccine and diluent  
Preparation of either vaccine or diluent was performed for each cluster on weeks 0, 4 and 8 by 
HF. Vaccine was reconstituted in a room out of sight from the cattle-handling facilities whilst 
calves were brought into the handling area. As saline was pre-prepared, no reconstitution was 
necessary: however, for continuity the same protocol was followed for saline, whereby HF 
remained in the same room out of sight for the same amount of time (15 minutes). Contents of 
syringes were concealed from all other personnel during administration and sample collection 
periods. Concealment was essential as the vaccine had a slight pink colour compared to diluent 
(colourless saline). Concealment was achieved by keeping vials containing prepared vaccine 
and saline in a covered box, all vials were covered in tape to conceal the contents, and prepared 
syringes were further concealed with a black sheath (Figure 6.3).  
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Figure 6.3: Intranasal applicator device for delivery of saline and vaccine, front and back of device pictured 
respectively 
 
6.2.7 Administration of vaccine and diluent 
Following an assessment to ensure calves were in good health, vaccine and diluent doses were 
administered intranasally. The vaccine (Rispoval RS+PI3 IntraNasal, Zoetis Animal Health) 
contained bovine parainfluenza type 3 (BPIV-3) thermosensitive strain RLB103, between 105.0 
and 108.6 cell culture 50% infective doses (CCID50) and modified live bovine respiratory 
syncytial virus (BRSV) strain 375, between 105.0 and 107.2 CCID50, as supplied by the 
manufacturer with sterile diluent (water for injection and sodium chloride, 18 mg per 2 ml) for 
reconstitution.  
Vaccine and diluent were stored in a temperature-monitored box during administration. 
Vaccine was administered to calves as a 2 ml dose with an intranasal applicator supplied by the 
vaccine manufacturer and modified to ensure blinding, see section 6.2.6. Diluent (saline; 0.9% 
w/v sodium chloride, Zoetis Animal Health) was administered as a 2 ml dose by an identical 
route as a placebo. Gloves and applicators were changed between animals. 
 
6.2.8 Biosecurity measures to avoid cross-contamination between barns 
Stockman coats and overalls worn by individuals directly handling animals or collecting 
samples were changed between barns to prevent transmission of infectious material. Personnel 
directly handling animals wore gloves and changed these between barn groups. In addition, 




6.2.9 Nasal swabs and rectal temperatures  
Nasal swabs (dual-tipped) were collected from each animal as described previously in Chapter 
2, section 2.9.5. Rectal temperatures were recorded on the same day as nasal swab collection 
using a livestock rapid read digital thermometer (Nettex, UK).  
 
6.2.10 Parasitological sampling  
Shortly after housing of cattle, composite samples of 10 freshly deposited faecal pats collected 
from the floor of each barn were tested for the presence of respiratory nematode larvae  
(Dictyocaulus viviparus) using the Baermann technique. Following parasitological testing, all 
calves were treated once routinely with 200 mg ivermectin (Noromectin®, Norbrook) pour-on 
(40 ml of product) to control respiratory and gastrointestinal nematodes and external parasites.  
 
6.2.11 Serological sampling 
Paired blood samples were collected into plain Vacutainers as described in Chapter 2, section 
2.9.6 on Week 0 (n = 78) and Week 12 (n = 86) for evidence of natural infection by common 
bovine respiratory viruses (BRSV, BPIV-3 and BHV-1), BVDV and Mycoplasma bovis.  
 
6.2.12 Measurement of barn temperature and relative humidity  
Temperature and relative humidity was monitored in each barn and recorded every 4 hours 
using a Perfect-Prime TH0165WH Micro USB High Accuracy Temperature Humidity Data 
Logger Meter (Perfect-Prime, London, UK).  
 
6.2.13 Laboratory analyses  
6.2.13.1 ELISAs to detect serological responses to bovine respiratory pathogens 
Serum samples were tested in duplicate microplate wells using a multiplex indirect ELISA 
(BIOX K 284 ELISA®, BioX, Belgium) to detect presence of antibodies against BHV-1, 
BVDV, BRSV, BPIV-3 and Mycoplasma bovis as described previously in Chapter 2, 2.12. 
 
6.2.13.2 Real-time PCR for bacteria 
Real-time PCR (qPCR) assays targeting sodA and the 16S rRNA region of the bacterial genome 
were performed for M. haemolytica, H. somni and P. multocida respectively, using methods as 
described in Chapter 2, 2.14. 
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6.2.14 Data analysis 
6.2.14.1 Barn temperature and relative humidity  
Pearson correlation coefficients were computed for the relationships between the barns for i) 
relative humidity and ii) temperature. Correlograms (graphical representations of correlation 
matrices) for Pearson correlation coefficients were computed using the R function ‘corrplot’.  
 
6.2.14.2 Seroprevalence  
For each of the five respiratory disease agents tested, seroprevalences on Week 0 and 12 were 
calculated as the number of animals seropositive by ELISA (i.e. results in categories 1 to 5, see 
Chapter 2, section 2.12) divided by the total number of animals sampled. 
 
6.2.14.3 Real-time PCR 
Cycle quantification (Cq) values obtained from qPCR reactions on nasal swab samples were 
converted to genome copies/ml using the equations derived from predictive models fitted to 
standard curves for each assay as described in Chapter 3. 
 
6.2.14.4 Carriage and co-carriage 
Rates of carriage of H. somni, M. haemolytica and P. multocida were calculated as the numbers 
of animals positive by qPCR for each agent divided by the numbers of animals sampled on each 
occasion, unless stated otherwise. Carriage estimates for each bacterial species were calculated 
for each cluster/barn and as an overall average. Co-carriage rate, defined as carriage of either 
two or three of the bacterial species on the same occasion, was calculated as an overall average 
for each of the three barns. Confidence intervals for proportions and differences between 
proportions were calculated using the Wilson score [242] and Newcombe-Wilson hybrid score 
[243] methods respectively [244]. 
 
6.2.14.5 Differences between clusters in carriage rates at Week 0 
Pearson’s c2 test was used to assess for differences in carriage at Week 0. Counts of the number 




6.2.14.6 Effect of viral infection on bacterial carriage rate 
6.2.14.6.1 Bacterial carriage combining 1st and 2nd crossover points 
A preliminary analysis was conducted to compare bacterial carriage rates in animals in the 
control phase with those in the intervention phase. Each cluster (barn) received the vaccine at 
one of three different time points, subsequently referred to as crossover points. This analysis 
did not consider differences in the timing of vaccination or clustering of animals within barn, it 
simply treated the first two crossover points as replicates by combining comparisons as follows: 
Red Barn vs Blue and Green barns (replicate 1); Blue Barn vs Green Barn (replicate 2), as 
shown in Figure 6.4. The Red Barn was excluded from replicate 2 as animals had already been 
exposed to the intervention for 4 weeks; if included in analyses then the two replicates would 
not be comparable in terms of exposure time since vaccination. Generalised linear logistic 
models of the rates of carriage of M. haemolytica and P. multocida were used to estimate the 
odds ratios for the effect of vaccination 2 and 4-weeks after it was administered. Models 
included vaccination as a predictor and replicate (1 and 2 as above) as a covariate. H. somni 
was not detected from animals housed in the Green Barn from Week 2 (based on PCR), 
therefore the first vaccine crossover period excluding observations from the Green barn was 
considered (i.e. Red vs Blue).  
 
 
Figure 6.4: Illustration showing analysis of bacterial carriage rates combining the 1st and 2nd crossover points. 
Clusters in the control phase (solid shading) and clusters in the intervention phase (diagonal shading) are 
illustrated. Replicate 1: At Week 0 all clusters are in the control phase and Red receive the vaccine, at Week 2 the 
Blue and Green clusters remain in the control phase with Red in the intervention phase. Replicate 2: At Week 4, 
the Blue cluster is vaccinated and subsequently at Week 6 and Week 8 is in the intervention phase – the Green 
cluster remains in the control phase.  
 
Week 0 Week 2 Week 4 
Replicate 1





6.2.14.6.2 Vertical analysis of bacterial carriage following each crossover point 
For each bacterial species, at each crossover point, the odds ratio of carriage was estimated for 
animals in the intervention phase 2 and 4-weeks post vaccination compared to those remaining 
in the control phase. Analysis at each of the crossover points was conducted as follows:  
1.) 1st crossover: carriage at Week 2 & Week 4; Red (n = 29) vs Blue and Green (n = 58) 
2.) 2nd crossover: carriage at Week 6 & Week 8; Red and Blue (n = 58) vs Green (n = 28) 
3.) 3rd crossover: carriage at Week 10 & Week 12; Green (n = 28) vs Red and Blue (n = 58) 
At the 3rd crossover all animals had received the vaccine, therefore this analysis assessed 
whether the carriage rate in the most recently vaccinated (Green) cluster differed from that in 
the other two clusters (Red and Blue) vaccinated two or four weeks previously.  A sequence of 
nested general linear models with a Poisson error distribution and log-link function were fitted 
to constructed count data using the base ‘glm’ function of R version 3.5.0 (see Chapter 2, 
section 2.18 for an introduction to these models). Datasets were constructed by counting the 
number of calves positive and negative for carriage at Week 2 to Week 12 (response), for each 
level of the explanatory variables: treatment (vaccine/control), prior carriage of the response 
bacterium at day of vaccination (positive/negative) and cluster (blue/green/red). The nested 
term of cluster within treatment assessed for differences in carriage between two clusters in the 
same intervention phase. Nested models of increasing complexity were built from the simplest, 
baseline model to investigate the effect of explanatory variables on carriage post vaccination 
(see Appendix D, Table D.1 for sequence of models). The impact of additional terms included 
in a more complex model was assessed by comparing the change in residual deviance from a 
nested, simpler model with the upper-tailed critical value (p < 0.05) of the appropriate chi-
squared distribution (as identified by the change in the residual degrees of freedom between the 
models). The odds ratios for the main effect terms of vaccination and prior carriage on 
subsequent carriage (2 and 4 weeks post vaccination) were estimated by exponentiating the 
coefficient for interaction terms between carriage and the term of interest for the parsimonious 
model (see Appendix D for details on model selection and evaluation of fit). Profile confidence 
intervals for odds ratios were estimated using the ‘confint’ function in R (version 3.5.0) [302].  
 
6.2.14.6.3 Longitudinal assessment of bacterial carriage: mixed effect models  
Generalized linear mixed effect models were used to estimate the odds ratio of carriage for 
animals in the intervention phase compared with the control phase. For each bacterial species, 
presence or absence of carriage was considered as the response variable. Two cross-classified 
multilevel models [303] were fitted to assess either the overall effect of viral infection on 
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bacterial carriage (Model 1) or a transient effect of viral infection on carriage (Model 2). In 
Model 1, vaccination was included as a fixed effect with two levels: unvaccinated (control) or 
vaccinated. In Model 2, vaccination was included as a fixed effect (‘vaccination status’) with 
four levels: unvaccinated (control), vaccinated 2 weeks previously, vaccinated 4 weeks 
previously, or vaccinated 6 or more weeks previously. Model 2 was simplified to Model 3 
where appropriate to include fewer categories of vaccination status: unvaccinated (control), 
vaccinated 2 weeks previously or vaccinated 4 or more weeks previously. In all models, once 
animals received the vaccine, they remained in the intervention phase. As proposed by 
Hooper et al. for the analysis of closed cohort stepped wedge trials [303] a nested random effect 
of calf within cluster (barn), and a crossed random effect of time within cluster was included. 
Random effects accounted for correlation between observations assessed in the same calf within 
a given cluster at different time points and differences in conditions experienced by a given 
cluster i.e. experiencing the control or intervention condition at different time points [303]. The 
nested effect of calf within cluster and crossed-random effect of time within cluster can be seen 
in Figure 6.5. The significance of viral infection on bacterial carriage was assessed by 
comparing the simpler unconditional model (no fixed effect of viral infection) with the model 
including a fixed effect of viral infection (vaccination/vaccination status). Models were 
compared by calculating the likelihood ratio test (LRT) statistic by comparing the change in 
residual deviance between models with the upper-tailed critical value (p < 0.05) of the 
appropriate chi-squared distribution (with degrees of freedom equal to the change in the residual 
degrees of freedom between the models). Similarly, the fit of both random effects was assessed 
by sequentially removing each effect from the model containing no fixed effects and calculating 
the LRT statistic between competing models. The Akaike Information Criterion (AIC) was also 
used to compare model fit, with a lower AIC value indicating a better fit.  
 
Figure 6.5: Nested random effects structure of calves within clusters (random variation among spatial blocks) and 
cross-classified random effects structure of clusters with time (each cluster is observed at each time; random 
variation among temporal blocks).   
Cow: 1  2 3  4  5  6  7  8  9  10 ………87
Cluster: Blue         Green        Red
Time: 1       2      3      4      5      6      7 
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6.2.14.7 Effect of viral infection on bacterial carriage density 
6.2.14.7.1 Bacterial density combining 1st and 2nd crossover points 
Vertical analysis of density was performed in a manner analogous to the logistic regression 
models of bacterial carriage (see above, section 6.2.14.6) comparing unvaccinated cluster(s) 
with vaccinated cluster(s) pre- and post-vaccination. In brief, replicate 1 for this analysis 
compared unvaccinated animals in the Blue and Green Barns with vaccinated animals in the 
Red Barn and for replicate 2 compared vaccinated animals in the Blue Barn to unvaccinated 
animals in the Green Barn. A gamma general linear model was fitted to estimate the difference 
in mean density of P. multocida carriage (genome copies/ml) between animals positive in the 
control and intervention condition. P. multocida carriage density (genome copies/ml) was the 
response variable, with vaccination as a predictor and replicate (1 and 2 as above) as a covariate. 
Density of carriage 2 and 4-weeks after vaccination was assessed. Gamma regression, using a 
log link was chosen because density was positively skewed. 
 
6.2.14.7.2 Horizontal analysis of P. multocida density within barn 
The density of P. multocida determined by PCR was natural log transformed for positive swabs 
collected in each barn on the day of vaccination, 2 weeks post vaccination and 4 weeks post 
vaccination. The difference in log density between paired swabs positive on two occasions was 
calculated for i) the day of vaccination and 2 weeks post vaccination and, ii) the day of 
vaccination and 4 weeks post vaccination. The mean of the differences in log P. multocida 
carriage was exponentiated to obtain a ratio of geometric means [304]. To assess whether the 
mean log P. multocida density before and after vaccination (2 and 4 weeks) was significantly 
different within each barn a paired t-test was performed on paired swabs positive on the 
occasions outlined above.  
 
6.2.14.7.3 Vertical analysis of P. multocida density following each crossover point 
The mean of the differences for swabs positive for P. multocida as described above (section 
6.2.14.7.2) was calculated for each barn. To assess for differences in P. multocida density 2 and 
4-weeks following vaccination between barns, a one-way ANOVA was fitted with a fixed effect 
of cluster (barn) and the natural log change in P. multocida density as the response variable. 
For significant effects, a Tukey test was used to determine which barns were different. 
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6.2.14.7.4 Horizontal and vertical analysis of H. somni and M. haemolytica density 
Too few animals were positive for H. somni or M. haemolytica for meaningful statistical 
analysis. 
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6.3 Results  
6.3.1 Monitoring barn climate 
The internal climate (temperature and relative humidity) of each barn was monitored during the 
housing period. Both parameters fluctuated over the study period (Week 0 to 12) with similar 
trends observed across barns (Figure 6.6). Temperatures ranged from -2.3ºC to 14.8ºC; relative 
humidity ranged from 53.4% to 100%. The lowest temperature recorded occurred in the Green 
barn at Week 7.6 with a corresponding humidity of 91.3%. The lowest humidity occurred at 
Week 10 in the Green barn, with a corresponding temperature of 6.8ºC. Peak temperature 
occurred in the Green barn at Week 4 with a corresponding humidity of 79%. Peak humidity 
occurred at Week 11.8 in the Blue barn (100%) with a corresponding temperature of 7.3ºC. 
Barn temperature and humidity were similar between the three barns at the 1st and 2nd crossover 
points (Week 0, Blue: 10.2ºC; Green: 10.2ºC; Red: 9.9ºC and Week 4, Blue: 12.8 ºC; Green: 
12.6ºC; Red: 12.7ºC). However, at the 3rd crossover point (Week 8) the temperature was lower 
(~6ºC) for all barns (Blue: 5.2ºC; Green: 5.1ºC; Red: 5.3ºC) than at prior crossover points 
(Week 0 and 4). 
 
 













































Temperature and relative humidity were positively correlated among barns (Figure 6.7). 
Temperature was more similar between the Blue and Green (r = 0.965) barns than between the 
Red and Green (r = 0.102) or Red and Blue (r = 0.101) barns. Similarly, humidity was highly 
correlated between the Blue and Green barns (r = 0.920), but less so between Red and Green (r 
= 0.190), and Red and Blue (r = 0.223). 
 
 
Figure 6.7: Correlograms depicting Pearson correlations between the barns for temperatures (left) and relative 
humidity levels (right) monitored in each barn. Positive correlations are displayed in blue. The colour intensity 
and the size of the circle are proportional to the correlation coefficients, which are shown in the legend on the 
right-hand side of the correlogram. 
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6.3.2 Characteristics of the study animals  
Characteristics of the animals following covariate-based constrained randomisation at the start 
of the study are shown in Table 6.1. 
 
Table 6.1: Sex, sire breed, age and weight of calves (n = 87) housed in the Blue, Green and Red barns during the 
stepped-wedge study 









    Total 
Sex      
Heifer  15 15 15 45 
Steer 14 14 14 42 
Sire Breed        
Charolais 23 23 23  69 
Limousin 4 4 4  12 
Stabiliser 2 2 2  6 
    All clusters 
Age at Week 0 (days)     
Median 228 231 224 228* 
Min 154 147 164 147 
Max 274 249 260 260 
Weight at Week 0 (kg) 
   
 
Median  308 315 313 312* 
Min 198 159 177 159 
Max 417 435 418 435 
* Median age and weight of all animals (n =87) 
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6.3.3 Signs of respiratory disease 
Animals remained healthy over the course of the study apart from three individuals. One animal 
died during the second study week (ID: 160). The animal presented with colic/abdominal 
symptoms. At post-mortem a distinct length of small intestine was dark purple in colour and 
almost gangrenous, but adjacent intestine was normal and further abdominal findings were 
unremarkable, as were the lungs and heart. Although Clostridial disease or Salmonella was 
suspected on the basis of post-mortem examination, laboratory tests proved negative. Intestinal 
torsion was given as the likely cause of death. At Week 10, one animal (ID: 177) presented with 
increased respiration rate, elevated temperature and dry adventitious lung sounds detected on 
auscultation, clinical signs highly suggestive of pneumonia. No nasal discharge was observed. 
The animal was treated with tulathromycin (Draxxin, Zoetis UK Limited) and the non-steroidal 
anti-inflammatory drug meloxicam (Metacam, Boehringer Ingelheim Animal Health UK Ltd). 
Another animal (ID: 140) was diagnosed with infectious keratoconjunctivitis one week before 
starting the study and was treated with oxytetracycline hydrochloride (Engemycin 10% DD, 
MSD Animal Health). Transient bouts of coughing were observed in animals on a few 
occasions only. This largely occurred following bedding down with fresh straw. 
 
6.3.4 Serological results for respiratory disease agents  
Serological results for the five respiratory disease agents tested are shown in Table 6.2. For all 
5 agents tested and in all three barns, some cattle were serologically positive on at least one 
occasion. No cattle were serologically positive for all five agents on the same day of testing. 
Antibodies to BRSV were detected in more than half the animals at Week 0 (57.5–75.0 %), and 
the rate of seropositivity increased still further by Week 12 (85.7–100.0 %). Only four animals 
had detectable antibodies to BPIV-3 at Week 0, with much higher levels of seropositivity at 
Week 12 (75–89.7%). Few animals (<4) had detectable antibodies to BVDV or BHV-1 at Week 
0 and Week 12. Seropositivity to Mycoplasma bovis was similar among the three barns at Week 
0 (21.4–37.5%); by Week 12, the proportion of animals with detectable antibodies to M. bovis 
in the Red Barn (72%) was significantly higher (p = 0.0229), although similar increases were 
not seen in the Blue (17.2%) or Green (25%) barns. Laboratory analysis of collected bloods 




Table 6.2: Serological results for BVDV, BHV-1, M. bovis, BRSV and BPIV-3 at Week 0 and Week 12 of the stepped wedge study 
Barn Agent Week 0  Week 12  Seroconversion‡ 















BVDV Blue 2/26 7.7 1.3 – 26.6 0/29 0.0 0.0 – 14.6 0/26 0.0 
 Green 1/28 3.6 0.2 – 20.2 1/28 3.6 0.2 – 20.2 1/28 3.6 
 Red 0/24 0.0 0.0 - 17.2 1/29 3.4 0.2 – 19.6 1/24 4.2 
BHV-1 Blue 2/26 7.7 1.3 – 26.6 0/29 0.0 0.0 – 14.6 0/26 0.0 
 Green 2/28 7.1 1.2 – 25.0 2/28 7.1 1.2 – 25.0 1/28 3.6 
 Red 1/24 4.2 
0.02 – 
23.1 
0/29 0.0 0.0 – 14.6 0/24 
0.0 
M. bovis Blue 9/26 34.6 
17.9 – 
55.6 
5/29 17.2 6.5 – 36.5 2/26 
7.7 
 Green 6/28 21.4 9.0 – 41.5 7/28 25.0 11.4 – 45.2 2/28 7.1 
 Red 9/24 37.5 
19.6 – 
59.2 


















Table 6.2 continued 
Barn Agent Week 0  Week 12  Seroconversion‡ 















BRSV Blue 15/26 57.7 
37.2 – 
76.0 
29/29 100.0 85.4 –100.0 15/26 
57.7 
 Green 21/28 75.0 
54.8 – 
88.6 
24/28 85.7 66.4–95.3 5/28 
17.9 
 Red 19/24 71.2 
57.3 – 
92.1 
29/29 100.0 85.4–100.0 12/24 
50.0 
BPIV-3 Blue 1/26 3.8 0.2 – 21.6 24/29 82.8 63.5–93.5 19/26 73.1 
 Green 3/28 10.7 2.8 – 29.4 21/28 75.0 54.8–88.6 19/28 67.9 
 Red 0/24 0.0 0.0– 17.2 26/29 89.7 71.5–97.3 20/24 83.3 
* Confidence intervals for single proportions were calculated using the Wilson score 
† Samples were considered seropositive in that calculated optical densities corresponded to categories 1 to 5 of the ELISA kit 
instructions (see Chapter 2 for further details). 




6.3.5 Carriage of Pasteurellaceae  
6.3.5.1 Carriage at Week 0  
A total of 604 nasal swabs were analysed using qPCR for the presence of H. somni, 
M. haemolytica and P. multocida. Carriage rates for all three bacterial species at each week are 
shown in Table 6.3. All three species of Pasteurellaceae were detected in all three barns at 
Week 0. P. multocida was carried at high prevalences in the Green (93.1%), Red (86.2%) and 
Blue (69%) barns. Carriage rates of H. somni were very similar at Week 0 in all three barns: 
Blue (41.4%), Green (44.8%) and Red (37.9%). Similar rates of M. haemolytica carriage were 
observed in the Blue and Red barns at 48.3% and 44.8% respectively, with a lower rate in the 
Green barn (24.1%). There was very little evidence to suggest a difference between barns 
in H. somni (p = 0.867; c2) or M. haemolytica (p = 0.125; c2) carriage at Week 0. However, 
there was evidence to suggest a difference in P. multocida carriage between barns at baseline 
(p = 0.0432; c2). 
 
6.3.5.2 Overall rates of bacterial carriage and co-carriage   
Bacterial nucleic acid was detected in 472 of 604 samples. Nucleic acid of more than one 
bacterial species (i.e. co-carriage) was detected in 168 of these 472 samples. P. multocida was 
detected the most frequently (399/604; 66.1%;), followed by M. haemolytica (154/604; 25.5%) 
and H. somni (109/604; 18.0%). Of the 168 samples with co-carriage detected, P. multocida 
and M. haemolytica was the most frequent combination recorded (86/168; 51.2%), followed by 
P. multocida and H. somni (53/168; 31.5%). Co-carriage with H. somni and M. haemolytica 
was detected in seven samples (7/168; 4.2%) and co-carriage with all three species was detected 
in 22/168 samples (13.1%). 
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Table 6.3: Carriage rates of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida in the Blue, Green and Red barns over the course of the study 
    Number (%)* 
 Week 0 2 4 6 8 10 12 
H. somni Red 11 (37.9) 2 (6.9) 4 (13.8) 3 (10.3) 6 (20.7) 3 (10.3) 1 (3.4) 
 Blue 12 (41.4) 9 (31.0) 6 (20.7) 17 (58.6) 10 (34.5) 4 (13.8) 8 (27.6) 
  Green 13 (44.8) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
M. haemolytica Red 13 (44.8) 6 (20.7) 6 (20.7) 7 (24.1) 12 (41.4) 5 (17.2) 5 (17.2) 
 Blue 14 (48.3) 7 (24.1) 6 (20.7) 5 (17.2) 5 (17.2) 1 (3.4) 9 (31.0) 
  Green 7 (24.1) 3 (10.3) 8 (28.6) 12 (42.9) 14 (50.0) 2 (7.1) 7 (25) 
P. multocida Red 25 (86.2) 13 (44.8) 19 (65.5) 16 (55.2) 28 (96.6) 22 (75.7) 13 (44.8) 
 Blue 20 (69.0) 14 (48.3) 16 (55.2) 13 (44.8) 19 (65.5) 10 (34.5) 12 (41.4) 
  Green 27 (93.1) 21 (72.4) 19 (67.9) 23 (82.1) 27 (96.4) 26 (92.9) 16 (57.1) 
Shaded cells indicate the intervention phase of the stepped wedge study  
*n = 29 for all barns at all sampling occasions apart from Weeks 4–12 in the Green Barn where n = 28 (one animal died) 
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6.3.5.3 Trends in bacterial carriage over the study period at the barn level  
6.3.5.3.1 H. somni 
Carriage rates of H. somni within clusters over the study period are shown for each barn 
in Figure 6.8. Prevalence of carriage at Week 0 was very similar in all three barns: 
between Week 0 and Week 2 carriage decreased for all barns, but thereafter there were 
barn differences. At Week 2 and at subsequent sampling points until the end of the study, 
H. somni was not detected from any animal in the Green Barn. Carriage peaked in the 
Blue Barn at Week 6, two weeks post vaccination (58.6%) and declined thereafter. 
Carriage was maintained at similarly low rates in the Red Barn between Week 2 to 12 
following vaccination at Week 0. 
 
 
Figure 6.8: Carriage rates of Histophilus somni within clusters over the study period. Timing of vaccination 
for each barn marked with a ‘V’ in the corresponding colour.  
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6.3.5.3.2 M. haemolytica  
Trends in M. haemolytica carriage for each barn are shown in Figure 6.9. Carriage rates 
were highest at Week 0 for both the Blue (48.3%) and Red (44.8%) barns. The highest 
carriage rate observed for any barn occurred at Week 8 in the Green barn (50.0%). 
Carriage rates for vaccinated animals fell following vaccination in each barn. Following 
vaccination in the Red barn at Week 0, carriage decreased and was maintained at a similar 
rate between Week 2 and 6. Carriage fell slightly 2 and 4-weeks post vaccination in the 
Blue Barn (only 1 animal lost carriage). Between Week 2 and 8, carriage in the Green 




Figure 6.9: Carriage rates of Mannheimia haemolytica within clusters over the study period. Timing of 
vaccination for each barn marked with a ‘V’ in the corresponding colour. 
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6.3.5.3.3 P. multocida  
Over the study period, similar fluctuations in carriage of P. multocida were observed 
between barns. In general, carriage was maintained at higher rates in the Green Barn and 
lower rates in the Blue Barn (Figure 6.10). The highest colonisation rates (~96%) were 
observed at Week 8 (Green and Red barns), with colonisation lowest in the Blue Barn at 
Week 10 (35%). For all barns, carriage decreased to some degree 2 weeks post 
vaccination. 
 
Figure 6.10: Carriage rates of Pasteurella multocida within clusters over the study period. Timing of 
vaccination for each barn marked with a ‘V’ in the corresponding colour. 
 
6.3.5.3.4 Trends in bacterial carriage over the study period at the animal level 
Detected carriage of H. somni, M. haemolytica and P. multocida was transient across the 
study period with the majority of animals experiencing both apparent acquisition and loss 
of carriage (Figure 6.11). Neither carriage with H. somni nor M. haemolytica was 
sustained throughout the whole study duration by any animal. Conversely, twelve 
animals sustained carriage across all visits with P. multocida, the majority (nine) being 
housed in the Green Barn. Only one animal did not experience colonisation with 
P. multocida at any observation (ID: 139; Blue Barn). In the Green Barn, around half of 
the animals (13/29) were colonised with H. somni at Week 0, but these infections were 
cleared from Week 2 onwards and no others were detected (Figure 6.11c). Totals of 30 




Figure 6.11: Carriage patterns of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida over the study period in the Red (panel a), Blue (panel b) and Green 
(panel c) barns determined by qPCR on nasal swabs. Time of vaccination indicated by an arrow. One animal (ID: 160) died, as shown by no coloured shading from Week 4 in 
the Green Barn. Animals ordered with respect to carriage patterns: those with persistent, uninterrupted carriage appear at the top of the figure; animals with increasingly 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.3.6 Effect of viral infection on bacterial carriage rate 
6.3.6.1 Bacterial carriage rates combining 1st and 2nd crossover points 
Rates of carriage of H. somni, M. haemolytica and P. multocida for animals in the control 
and vaccine groups are shown in Figure 6.12. For the three bacterial species, carriage 




Figure 6.12: Between cluster analysis of Pasteurellaceae carriage rates combining data from the 1st and 
2nd crossover points as if they were replicates. Carriage of Pasteurellaceae for animals in the control or 
vaccine group at 0, 2 and 4-weeks post vaccination. Confidence intervals for single proportions were 
calculated using the Wilson score. 
 
Results from logistic regression are given in Table 6.4. There was evidence to suggest 
that the odds of bacterial carriage were significantly lower in vaccinated compared with 
control animals 2-weeks post vaccination for P. multocida (OR: 0.351, CI95: 0.170–
0.709) and H. somni (OR: 0.165; CI95%: 0.0234–0.725). At 4 weeks, similar trends were 
observed for both bacteria, albeit with little evidence to suggest a difference in carriage 
rates between vaccinated and unvaccinated animals (P. multocida: OR: 0.165; CI95%: 
0.0234–0.725; H. somni: OR: 0.613; CI95%: 0.141–2.42). For M. haemolytica, again, the 
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odds of carriage were lower for animals in the vaccine group compared with those in the 
control group at 2-weeks post vaccination (OR: 0.591; CI95%: 0.247–1.35), and 
significantly so at 4-weeks post vaccination (OR: 0.417; CI95%: 0.177–0.929).  
 
Table 6.4: Pasteurellaceae carriage rates combining data from the 1st and 2nd crossover points as if they 
were replicates 
  Carriage rate    





H. somni 0 12/29  (41.4) 11/29  (37.9) 1.08  0.518–2.23 0.788 
 2 9/29  (31.0) 2/29  (6.90) 0.165  0.0234–0.725 0.0308 
 4 6/29 (20.7) 4/29  (13.8) 0.613  0.141–2.42 0.489 
M. haemolytica 0 29/86  (33.7) 19/58  (32.8) 1.08  0.518–2.23 0.840 
 2 22/86  (25.6) 11/58  (19.0) 0.591  0.247–1.35 0.221 
 4 28/85  (32.9) 11/58  (19.0) 0.417  0.177–0.929 0.038 
P. multocida 0 66/86  (76.7) 41/58  (70.7) 0.877  0.401–1.95 0.745 
 2 58/86  (67.4) 26/58  (44.8) 0.351  0.170–0.709 0.00398 
 4 62/85  (72.9) 38/58  (65.5) 0.585  0.272–1.25 0.165 
* Week post vaccination  
† Odds ratio of carriage and its 95% confidence interval (CI95%) of the odds for carriage in the vaccine group 
compared with the control group calculated at 0, 2 and 4-weeks post vaccination using logistic regression adjusting 
for number of replicate determinations. 
 
6.3.6.2 Vertical analysis of carriage rates following the 1st crossover point  
Following the 1st crossover point (of vaccination) the rates of carriage of Pasteurellaceae 
were generally less in the vaccinated animals (Red Barn) compared with controls (Green 
and Blue barns). There was no evidence for a difference between vaccinated and 
unvaccinated animals in terms of carriage rate for any of the three bacterial species at 
Week 2 or Week 4 (2 and 4-weeks post vaccination respectively) as shown in Table 6.5, 
Table 6.6 and Table 6.7. Prior carriage of H. somni was significantly associated with 
subsequent carriage, where the odds of carriage were 4.5 times greater (CI95%: 1.18–22.0) 
given prior carriage at Week 0. There was no significant interaction between vaccination 
and prior carriage for any bacterium at either Week 2 or Week 4.  
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Table 6.5: Vertical analysis of Histophilus somni carriage following the 1st crossover point 
(a) Carriage at Week-2, following vaccination at Week-0 
   Carriage Total Odds Ratio   
   No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 14 6 20 3 6 9 29     
 Green 16 13 29 0 0 0 29     
  Subtotal 30 19 49 3 6 9 58     
Vaccinated Red 18 9 27 0 2 2 29 0.403 0.417‡ 0.059–1.84 0.233 
Total   48 28 76 3 8 11 87 4.571 4.5† 1.18–22.0 0.024 
(b) Carriage at Week-4, following vaccination at Week-0 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 15 8 23 2 4 6 29     
 Green 15 13 28 0 0 0 28     
  Subtotal 30 21 51 2 4 6 57     
Vaccinated Red 17 8 25 1 3 4 29 1.360 1.5‡ 0.346–6.01 0.659 
Total   47 29 76 3 7 10 86 3.782 3.89† 0.990–19.3 0.056 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 2 (M5 vs. M2), χ2 (1 df) = 14.1, p < 0.001 and 
Week 4 (M5 vs. M2), χ2 (1 df) = 8.79, p = 0.00303; Likelihood ratio test statistic for evidence of interaction between vaccination and prior carriage:  
Week 2 (M4 vs. M3), χ2 (1 df) = 1.62, p = 0.203 and Week 4 (M4 vs. M3), χ2 (1 df) = 0.282, p = 0.596 
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Table 6.6: Vertical analysis of Mannheimia haemolytica carriage following the 1st crossover point 
(a) Carriage at Week-2, following vaccination at Week-0 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 14 8 22 1 6 7 29     
 Green 19 7 26 3 0 3 29     
  Subtotal 33 15 48 4 6 10 58     
Vaccinated Red 13 10 23 3 3 6 29 1.252 1.25‡ 0.386–3.81 0.698 
Total   46 25 71 7 9 16 87 2.366 2.37† 0.790–7.36 0.124 
(b) Carriage at Week-4, following vaccination at Week-0 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 13 10 23 2 4 6 29     
 Green 16 4 20 6 2 8 28     
  Subtotal 29 14 43 8 6 14 57     
Vaccinated Red 12 11 23 4 2 6 29 0.801 0.8‡ 0.255–2.29 0.686 
Total   41 25 66 12 8 20 86 1.093 1.09† 0.381–3.02 0.151 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 2 (M5 vs. M2), χ2 (1 df) = 1.98, p = 0.160 and 
Week 4 (M5 vs. M2), χ2 (1 df) = 0.479, p = 0.489; Likelihood ratio test statistic for evidence of interaction between vaccination and prior carriage:  
Week 2 (M4 vs. M3), χ2 (1 df) = 0.640, p =  0.424 and Week 4 (M4 vs. M3), χ2 (1 df) = 0.851, p = 0.356 
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Table 6.7: Vertical analysis of Pasteurella multocida carriage following the 1st crossover point 
(a) Carriage at Week-2, following vaccination at Week-0 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 5 10 15 4 10 14 29     
 Green 0 8 8 2 19 21 29     
  Subtotal 5 18 23 6 29 35 58     
Vaccinated Red 3 13 16 1 12 13 29 0.534 0.534‡ 0.214–1.31 0.171 
Total   8 31 39 7 41 48 87 1.512 1.51† 0.492–4.745 0.468 
(b) Carriage at Week-4, following vaccination at Week-0 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Control§ Blue 4 9 13 5 11 16 29     
 Green 1 8 9 1 18 19 28     
  Subtotal 5 17 22 6 29 35 57     
Vaccinated Red 2 8 10 2 17 19 29 1.194 1.19‡  0.475–3.11  0.709 
Total   7 25 32 8 46 54 86 1.610 1.61†  0.510–5.01 0.044 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 2 (M5 vs. M2), χ2 (1 df) = 3.57, p = 0.0587 and 
Week 4 (M5 vs. M2), χ2 (1 df) = 0.971, p = 0.324; Likelihood ratio test statistic for evidence of interaction between vaccination and prior carriage:  
Week 2 (M4 vs. M3), χ2 (1 df) = 0.283, p = 0.595  and Week 4 (M4 vs. M3), χ2 (1 df) = 0.0982, p = 0.754 
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6.3.6.3 Vertical analysis of carriage rates following the 2nd crossover point  
Following the 2nd crossover point at Week 4, odds ratios were estimated comparing 
bacterial carriage rates in intervention phase animals housed in the Blue and Red barns 
to control phase animals housed in the Green Barn. There was moderate evidence to 
suggest the carriage rate of M. haemolytica was reduced in vaccinated animals compared 
to controls 2 weeks post vaccination (Week 6; OR: 0.355;  CI95%: 0.122–1.00) and weak 
evidence to suggest carriage rates were reduced further still 4 weeks post vaccination 
(Week 8; OR: 0.432; CI95%: 0.162–1.14, Table 6.8). There was strong evidence to suggest 
a difference in P. multocida carriage rates between the vaccine and control group 2 weeks 
post vaccination (OR: 0.219; CI95%: 0.065–0.628, Table 6.9), with weaker evidence at 4 
weeks post vaccination (OR: 0.164; CI95%: 0.00862–0.947). For both bacterial species, 
the odds of subsequent carriage were significantly higher given prior carriage either 2 or 
4-weeks earlier. As carriage rates of P. multocida were very similar between the Red and 
Green barns at Week 8 these two barns were combined and considered as an alternative 
analysis (Table 6.9c). Again, there was evidence to suggest that carriage rates were 
significantly reduced in the Blue (vaccine group) compared to Red and Green (control 
group), and the odds of subsequent carriage were significantly higher given prior carriage 
4-weeks earlier. There was no significant interaction between vaccination and prior 
carriage for either species at Week 6 or Week 8. Carriage of H. somni was not observed 
in the Green barn from Week 2 onwards, so vertical analysis could not be conducted for 
this bacterial species following the second or third crossover point. 
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Table 6.8: Vertical analysis of Mannheimia haemolytica carriage following the 2nd crossover point 
(a) Carriage at Week-6, following vaccination at Week-4 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




        
    No Yes No Yes         
Control Green 14 2 16 6 6 12 28         
Vaccinated§ Blue 21 3 24 2 3 5 29 
    
 
Red 18 4 22 5 2 7 29 
    
  Subtotal 39 7 46 7 5 12 58 0.348 0.355‡  0.122–1.00  0.0505 
Total   53 9 62 13 11 24 86 4.983 4.91†  1.65–15.3 0.00423 
(b) Carriage at Week-8, following vaccination at Week-4 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




        
    No Yes No Yes         
Control Green 11 3 14 9 5 14 28         
Vaccinated§ Blue 22 2 24 1 4 5 29     
 Red 14 3 17 9 3 12 29     
  Subtotal 36 5 41 10 7 17 58 0.415 0.432‡  0.162–1.14 0.0886 
Total   47 8 55 19 12 31 86 3.711 3.59† 1.26–10.8 0.0167 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 6 (M5 vs. M2), χ2 (1 df) = 0.421, p =  0.516 and 
Week 8 (M5 vs. M2), χ2 (1 df) = 4.17, p = 0.0411; Likelihood ratio test statistic for evidence of interaction between vaccination and prior carriage:  
Week 6 (M4 vs. M3), χ2 (1 df) = 0.230, p =  0.632 and Week 8 (M4 vs. M3), χ2 (1 df) = 0.671, p = 0.413. 
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Table 6.9: Vertical analysis of Pasteurella multocida carriage following the 2nd crossover point 
(a) Carriage at Week-6, following vaccination at Week-4 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




        
    No Yes No Yes         
Control Green 1 4 5 8 15 23 28         
Vaccinated§ Blue 6 10 16 3 10 13 29 
    
 
Red 6 7 13 4 12 16 29 
    
  Subtotal 12 17 29 7 22 29 58 0.217 0.219‡  0.065–0.628 0.00399 
Total   13 21 34 15 37 52 86 1.527 2.44†  0.953–6.45 0.06287 
(b) Carriage at Week-8, following vaccination at Week-4 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




        
    No Yes No Yes         
Control Green 11 3 14 9 5 14 28         
Vaccinated§ Blue 6 4 10 7 12 19 29     
 Red 1 0 1 9 19 28 29     
  Subtotal 7 4 11 16 31 47 58 0.158 0.164‡  0.00862–0.947 0.0332 
Total   8 4 12 24 50 74 86 4.167 4.05†  1.12–16.8 0.025 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 6 (M5 vs. M2), χ2 (1 df) = 0.622, p = 0.430 and 
Week 8 (M5 vs. M2), χ2 (1 df) = 10.3, p = 0.00134; Likelihood ratio test statistic for evidence of interaction between vaccination and prior carriage:  
Week 6 (M4 vs. M3), χ2 (1 df) = 2.94, p = 0.0865 and Week 8 (M4 vs. M3), χ2 (1 df) = 0.964, p = 0.326 
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Table 6-9: Vertical analysis of Pasteurella multocida carriage following the 2nd crossover point (continued) 
(c) Carriage at Week-8, following vaccination at Week-4 – alternative analysis 
    Carriage Total Odds Ratio   
    No Yes  Univariable Model CI95% P-value 




        
    No Yes No Yes         
Control§ Green 1 0 1 8 19 27 28 
    
 
Red 1 0 1 9 19 28 29 
    
  Subtotal 2 0 2 17 38 55 57         
Vaccinated Blue 6 4 10 7 12 19 29 0.069 0.070‡ 0.0099-0.307 0.00021 
Total   8 4 12 24 50 74 86 4.167 4.05† 1.02-18.7 0.047 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine compared to those that 
did not. § Likelihood ratio test statistic for evidence of differences in carriage rates between barns in the same phase: Week 8 (M5 vs. M2), χ2 (1 df) = 0.000638, p = 0.980; 








6.3.6.4 Vertical analysis of carriage rates following the 3rd crossover point  
After the 3rd crossover point all barns had received the vaccine, therefore, there was no 
comparison between vaccinated and unvaccinated animals. Instead, differences in 
bacterial carriage rates were assessed for animals in the most recently vaccinated (Green) 
cluster compared to the other two clusters (Red and Blue) vaccinated two or four weeks 
previously. The rate of carriage of M. haemolytica (Table 6.10) in the most recently 
vaccinated animals (Green Barn) was compared with that of animals vaccinated on 
earlier occasions (Red and Blue barns); two weeks after vaccination of the Green Barn 
animals, the carriage was lower in those animals than in the other two barns (Week 10; 
OR = 0.667; CI95%: 0.0933–3.13), but after 4 weeks the rates were similar (Week 12; OR: 
1.05; CI95%: 0.352–2.92). There was no evidence to suggest carriage at Week 8 was 
significantly associated with subsequent M. haemolytica carriage either 2 or 4-weeks 
later (Table 6.10).  
The carriage rate of P. multocida (Table 6.11) was greater 2 weeks post vaccination 
(approximately 8-fold higher) in the late vaccine cluster compared to the early vaccine 
cluster, but the confidence interval for this estimate was very large (OR: 8.68; 
CI95%: 2.21–58.7). The odds of subsequent carriage were significantly increased given 
prior carriage 2 weeks earlier, but again the confidence interval for this estimate was 
large (OR: 6.48; CI95%: 1.62–34.1). At Week 12, the odds of carriage were slightly higher 
for animals vaccinated at Week 8 and for animals with prior carriage at Week 8 (Table 
6.11). There was no significant interaction between vaccination and prior carriage for 
any bacterium at either Week 10 or Week 12.  
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Table 6.10: Vertical analysis of Mannheimia haemolytica carriage following the 3rd crossover point 
(a) Carriage at Week-10, following vaccination at Week-8 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Early vaccine§ Blue 23 5 28 1 0 1 29 
    
 Red 13 11 24 4 1 5 29 
    
  Subtotal 36 16 52 5 1 6 58         
Late vaccine Green 14 12 26 0 2 2 28 0.667 0.667‡ 0.0933–3.13 0.625 
Total   50 28 78 5 3 8 86 1.071 1.07† 0.207–4.70 0.929 
(b) Carriage at Week-12, following vaccination at Week-8 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Early vaccine§ Blue 16 4 20 8 1 9 29 
    
 Red 14 10 24 3 2 5 29 
    
  Subtotal 30 14 44 11 3 14 58         
Late vaccine Green 9 12 21 5 2 7 28 1.048  1.05‡ 0.352–2.92  0.931 
Total   39 26 65 16 5 21 86 0.469  0.467† 0.140–1.36  0.169 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine at Week-8 (late vaccine 
group) compared to those that received the vaccine 2 or 4 weeks earlier (early vaccine group) § Likelihood ratio test statistic for evidence of differences in carriage rates 
between barns in the same phase: Week 10 (M5 vs. M2), χ2 (1 df) = 3.22, p = 0.0728 and Week 12 (M5 vs. M2), χ2 (1 df) = 1.52, p = 0.217; Likelihood ratio test statistic for 
evidence of interaction between vaccination and prior carriage: Week 10 (M4 vs. M3), χ2 (1 df) = 3.46, p = 0.0629 and Week 12 (M4 vs. M3), χ2 (1 df) = 0.315, p = 0.575 
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Table 6.11: Vertical analysis of Pasteurella multocida carriage following the 3rd crossover point 
(a) Carriage at Week-10, following vaccination at Week-8 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Early vaccine§ Blue 8 11 19 2 8 10 29 
    
 Red 1 6 7 0 22 22 29 
    
  Subtotal 9 17 26 2 30 32 58         
Late vaccine Green 0 2 2 1 25 26 28 10.563 8.68‡  2.21–58.7 0.00104 
Total   9 19 28 3 55 58 86 8.684 6.48† 1.62–34.1 0.00748 
(b) Carriage at Week-12, following vaccination at Week-8 
    Carriage Total Odds Ratio   
    No Yes  Univariate Model CI95% P-value 




     
    No Yes No Yes      
Early vaccine§ Blue 5 12 17 5 7 12 29 
    
 Red 1 15 16 0 13 13 29 
    
  Subtotal 6 27 33 5 20 25 58         
Late vaccine Green 1 11 12 0 16 16 28 1.760 1.76‡  0.712–4.45 0.222 
Total   7 38 45 5 36 41 86 1.326 1.33† 0.389–4.84 0.654 
† Odds ratio for carriage in animals that had prior carriage compared to those that did not. ‡ Odds ratio for carriage in animals that received the vaccine at Week-8 (late vaccine 
group) compared to those that received the vaccine 2 or 4 weeks earlier (early vaccine group)  § Likelihood ratio test statistic for evidence of differences in carriage rates 
between barns in the same phase: Week 10 (M5 vs. M2), χ2 (1 df) = 1.73, p = 0.188 and Week 12 (M5 vs. M2), χ2 (1 df) = 10.4, p = 0.00128; Likelihood ratio test statistic for 
evidence of interaction between vaccination and prior carriage: Week 10 (M4 vs. M3), χ2 (1 df) = 0.0703, p =  0.791 and Week 12 (M4 vs. M3), χ2 (1 df) = 0.837, p = 0.360 
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6.3.6.5 Longitudinal assessment of bacterial carriage rates 
Results from mixed effects models estimating the odds ratio of bacterial carriage for animals 
in the intervention phase compared with those in the control phase are shown in Table 6.12. 
Model 1 assessed for a lasting effect of vaccination on bacterial carriage rate. There was strong 
evidence that the odds of M. haemolytica carriage were reduced after vaccination [OR: 0.48, 
CI95%: 0.27–0.85; change in deviance on removing the term ‘vaccination’, χ2 (1 df) = 5.49, p = 
0.0191]. Model 2 assessed for a transient effect of vaccination on bacterial carriage rate, 
assessing differences in carriage between control and intervention phase animals either 2, 4 or 
≥6 weeks post vaccination. There was weak evidence to suggest a transient effect of 
vaccination on rates of M. haemolytica carriage [change in deviance on removing the term 
‘vaccination status’, χ2 (3 df) = 6.53, p = 0.0887]. There was little evidence for a lasting (Model 
1) or a transient (Model 2) effect of vaccination on carriage rates of P. multocida or H. somni 
although the odds of carriage were reduced following vaccination. Estimates for the odds of 
carriage 4 or ≥6 weeks post vaccination (Model 2) were similar for M. haemolytica and 
P. multocida, so Model 2 was simplified to Model 3 by combining 4 and ≥6 weeks into one 
category. For both bacterial species, the Akaike information criterion was slightly lower for 
the simpler model, suggesting an improved fit. In addition, there was no evidence that Model 
2 was a better fit when models were compared by performing a likelihood ratio test 
(M. haemolytica p = 0.931 and P. multocida p = 0.412). When evaluating Model 3 there was 
evidence for a transient effect of vaccination on M. haemolytica carriage [change in deviance 
on removing the term ‘vaccination status’, χ2 (2 df) = 6.51, p = 0.0384]. However, there was 
no evidence for a transient effect of vaccination on P. multocida carriage. Simplification of 
Model 2 for H. somni was not justified (M2 vs M3, χ2 (2 df) = 6.99, p = 0.0303). Likelihood 
ratio test statistics showed that for all three bacterial species model fit was significantly 
improved by including the two random effects (calf within cluster and time within cluster). For 
M. haemolytica, nesting calf within cluster resulted in a singular fit, hence this random effect 
of was not nested.
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Table 6.12: Results from mixed effect models assessing the overall and transient effect of viral infection on bacterial carriage rates 
Species Model Covariate Odds ratio CI95% P-value AIC§ 
H. somni  
 
M1: Lasting effect Vaccination 0.48 0.12 – 2.00 0.317 493 
 M2: Transient effect 2 wpv* 0.63 0.09 – 4.35 0.638 496 
  4 wpv 0.52 0.08 – 3.60 0.509  
  ≥6 wpv 0.39 0.07 – 2.12 0.276  
M. haemolytica M1: Lasting effect Vaccination 0.48 0.27 – 0.85 0.012 671 
 M2: Transient effect 2 wpv 0.34 0.14 – 0.82 0.016 674 
  4 wpv 0.52 0.23 – 1.21 0.130  
  ≥6 wpv 0.54 0.28 – 1.07 0.077  
 M3: Transient effect (b) 2 wpv 0.34 0.14 – 0.82 0.016 672 
  ≥4 wpv  0.54 0.29 – 0.98 0.041  
       


















Table 6.12 continued 
Species Model Covariate Odds ratio CI95% P-value AIC§ 
P. multocida M1: Lasting effect Vaccination 0.49 0.21 – 1.16 0.103 716 
 M2: Transient effect 2 wpv 0.51 0.15 – 1.73 0.283 720 
  4 wpv 0.49 0.15 – 1.62 0.243  
  ≥6 wpv 0.47 0.16 – 1.36 0.163  
 M3: Transient effect (b) 2 wpv 0.49 0.13 – 1.88 0.300 718 
  ≥4 wpv  0.44 0.17 – 1.14 0.090  
* wpv: weeks post vaccination; § Akaike information criterion 
H. somni likelihood ratio test statistic: - 
unconditional model (no covariate) vs. M1, χ2 (1 df) = 0.916, p = 0.339; unconditional model vs M2, χ2 (3 df) = 1.127, p = 0.771; 
M2 vs M3, χ2 (2 df) = 6.99, p = 0.0303 
M. haemolytica likelihood ratio test statistic: - 
unconditional model (no covariate) vs. M1, χ2 (1 df) = 5.49, p = 0.0191; unconditional model vs M2, χ2 (3 df) = 6.53, p = 0.0887;  
unconditional model vs M3, χ2 (2 df) = 6.51, p = 0.0384; M2 vs M3, χ2 (1 df) = 0.01, p = 0.931 
P. multocida likelihood ratio test statistic: - 
unconditional model (no covariate) vs. M1, χ2 (1 df) = 2.47, p = 0.116; unconditional model vs M2, χ2 (3 df) = 2.49, p = 0.476; 
unconditional model vs M3, χ2 (2 df) = 0.713, p = 0.398; M2 vs M3, χ2 (2 df) = 1.78, p = 0.412 
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6.3.7 Overall bacterial carriage density 
For each bacterium, density values for all positive samples were plotted as histograms 
revealing distinct density profiles (Figure 6.13). The modal value for H. somni carriage 
density accounting for the vast majority (78.0%) of swabs was 1–2 log10 genome 
copies/ml with fewer samples (11.0%) between 2–3 log10 genome copies/ml and fewer 
still between 3–4 log10 genome copies/ml (5.5%). Only four samples were in the 4–5 log 
range and two samples in the 5–6 log range (highest value observed at 5.27 logs in one 
sample). Carriage density for M. haemolytica ranged between 2 and 6 log10 genome 
copies/ml when it occurred, with the majority of swabs occurring between 3–4 
log10 genome copies/ml (40.9%), the highest density observed in one sample was 6.05 
log10 genome copies/ml. Pasteurella multocida was also carried over a wide range of 
densities, most commonly between 2–3 log10 genome copies/ml (40.0%), with the 
proportion of swabs positive steadily decreasing as density increased; density extended 
up to 6.26 log10 genome copies/ml in one sample. 
 
 
Figure 6.13: Histograms for all positive swabs summarising density distribution profiles of Histophilus 
somni (n = 109), Mannheimia haemolytica (n = 154) and Pasteurella multocida (n = 399). 
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6.3.8 Trends in bacterial carriage density at the barn level 
Carriage densities for all swabs positive for each bacterium over the study period are 
shown in Figure 6.14. Carriage density for all three bacterial species varied among calves 
on the same day and between days. There was a transient increase in the mean carriage 
density of H. somni following vaccination in the Red Barn, but a decrease was observed 
following vaccination in the Blue Barn (no H. somni was detected in the Green Barn 
from Week 2 onwards). The mean carriage density of M. haemolytica was relatively 
constant for the first 6 weeks in the Red Barn following vaccination at Week 0. 
M. haemolytica carriage density in the Blue and Green barns fluctuated overtime, 
regardless of vaccination status. Similarly, density of P. multocida fluctuated over the 




Figure 6.14: Boxplots and scatterplots showing density of Pasteurellaceae carriage. H. somni (panel a), 
M. haemolytica (panel b) and P. multocida (panel c) determined by qPCR on positive nasal swabs collected 
over the study period. Each black dot represents an animal. White crosses show the geometric mean density 
(log10 genome copies/ml). The middle line (hinge) corresponds to the median. The lower and upper hinges 
of the boxplots correspond to the first and third quartiles respectively. The upper and lower whiskers extend 
from the upper and lower hinges to the largest and smallest value (no further than 1.5 times the interquartile 
range) respectively. Outliers are shown in grey and are greater than 1.5 times the interquartile range. 
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6.3.9 Trends in bacterial carriage density at the animal level 
6.3.9.1 Red Barn 
Trends in bacterial carriage density for each animal following vaccination in the Red 
Barn are shown in Figure 6.15, panel a. Only two out of nine animals with H. somni 
carriage at Week 0 sustained carriage two weeks later, of which density was similar (ID: 
153) or decreased (ID:110). Five calves not colonised with H. somni at Week 0 acquired 
carriage from Week 4, with density commonly between 1–2 log10 genome copies/ml. 
Similar trends were seen for M. haemolytica: 10 out of 13 calves that were colonised at 
Week 0 lost carriage 2 weeks later and only 3 sustained carriage over a range of densities 
until Week 2. A further 3 initially uncolonized animals acquired carriage 2 weeks later, 
with carriage maintained for a maximum of three consecutive visits in any one animal 
and in only two animals (IDs: 93 and 125). Colonisation with H. somni or M. haemolytica 
was not observed on any occasion in 13 and 4 animals respectively. All animals 
experienced carriage of P. multocida on at least one occasion and over a wide range of 
densities (2–6 log10 genome copies/ml). Carriage of P. multocida was not detected at 
Week 2 in 13 out of 25 calves that were colonised at Week 0, with re-acquisition of 
carriage in 8 of these 13 calves 2 weeks later (Week 4). In general, P. multocida carriage 
was maintained for longer uninterrupted periods than either H. somni or M. haemolytica 
carriage, with two animals (IDs: 110 and 123) sustaining P. multocida carriage for the 
whole study duration, one of which (ID: 123) at densities between 4–6 log10 genome 
copies/ml. 
 
6.3.9.2 Blue Barn 
Carriage rates of H. somni increased in the Blue Barn 2 and 4-weeks post vaccination, 
with this apparent increase due to colonisation in naïve animals (Figure 6.15, panel b). 
Two subpopulations of animals can be seen to become colonised with H. somni, the first 
with transient carriage from Week 0; the second with transient carriage 2 weeks 
following vaccination (from Week 6). Only two animals were not colonised at any visit 
(ID: 164 and 100). H. somni carriage density was similar pre- and post-vaccination. At 
Week 0 carriage with M. haemolytica occurred between 2 and 5 logs. Two and four-
weeks post vaccination, rates of M. haemolytica carriage were unchanged and density 
was similar. M. haemolytica was undetected in 5 animals for 10 weeks, until acquisition 
on Week 12. A further 8 of the 29 animals were not colonised on any occasion. No 
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animals sustained carriage for the whole study period and of those colonised density 
ranged between 2 and 6 log10 genome copies/ml. Carriage of P. multocida was 
maintained for the study period in only one animal (ID:169), over a range of densities 
(2–5 logs). One animal was not colonised on any occasion (ID: 139). Otherwise, carriage 
was transient and over a range of densities 2–6 log10 genome copies/ml.  
 
6.3.9.3 Green Barn 
At Week 0 H. somni was detected in 13 animals. All but one of these 13 animals 
experienced carriage between 1–2 log10 genome copies/ml, the exception (ID 176) 
carrying at 4–5 logs (Figure 6.15, panel c). H. somni was undetected from Week 2. 
M. haemolytica carriage was not maintained by any animal for the entire study period 
and densities ranged between 2–6 logs. Following vaccination at Week 8, carriage rates 
of M. haemolytica decreased, and only one naïve animal experienced acquisition 4 weeks 
later. M. haemolytica was undetected from 4 animals. All animals experienced 
colonisation with P. multocida on any one occasion over a range of densities. No animal 
was found to be colonised on fewer than three occasions, other than ID 160 which died 
in Week 3 having been colonised the two previous weeks. P. multocida was detected at 
every occasion in 8 animals and, in general, carriage density was higher in these animals 
than in those experiencing transient carriage.
 190 
 
Figure 6.15: Density carriage patterns of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida. Density determined by qPCR on nasal swabs collected on 
Weeks 0 to 12 from 29 calves housed in the Red Barn (panel a), Blue Barn (panel b) and Green Barn (panel c). Density of carriage is depicted as a colour series each representing 
a range of log10 genome copies/ml. Time of vaccination is indicated by an arrow. One animal (ID: 160) died, as shown by no coloured shading from Week 4 in the Green Barn. 
Animals are ordered based on their carriage patterns: animals sustaining carriage over consecutive visits appear first, animals with transient to no carriage detected appear in 
descending order.  
ac b
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6.3.10 Effect of viral infection on bacterial carriage density 
6.3.10.1 Bacterial carriage density combining 1st and 2nd crossover points 
Changes in the mean bacterial density between groups created from combining the 1st 
and 2nd crossover points are visualised in Figure 6.16. Density of H. somni was seen to 
decrease 2 and 4-weeks post vaccination, but very few animals had carriage in either 
control or vaccine groups (Table 6.13). At Week 0 mean carriage density of 
M. haemolytica was greater in vaccine group animals compared to controls but declined 
and increased to similar levels of control animals thereafter. Density of P. multocida 
carriage was lower in animals in the vaccine group compared with controls at Week 0. 
Two weeks after receiving vaccine there was an apparent increase in P. multocida 
carriage density in vaccinated animals not observed in unvaccinated controls, while at 4 
weeks density appeared somewhat higher than at baseline in both groups. 
 
 
Figure 6.16: Between cluster analysis of Pasteurellaceae carriage considering the 1st and 2nd crossover 
points as replicates. Carriage densities of Histophilus somni, Mannheimia haemolytica and Pasteurella 
multocida in control and vaccine group animals are shown at 0, 2 and 4-weeks post vaccination. Error bars 
represent standard error of the mean.  
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The mean carriage densities of the three bacterial species for animals in the control and 
vaccine group at Week 0, 2 and 4 are shown in Table 6.13. There was no evidence to 
suggest a difference in mean M. haemolytica or P. multocida density between animals in 
either group 2 or 4-weeks after vaccination. Following vaccination, density of carriage 
of H. somni and M. haemolytica tended to decrease, whereas an approximate two-fold 
increase in density of P. multocida was observed 2-weeks post vaccination (Figure 6.16). 
 
Table 6.13: Density of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida carriage in 
control and vaccine groups: at 0, 2 and 4-weeks post vaccination considering 1st and 2nd vaccine crossover 
points as replicates 
    
 
 
Arithmetic mean carriage density*  
(genome copies/ml) 
 
Species Week  Control 
group 
(N) Vaccine  
group 
(N) Mean Ratio†  CI95% P-value 
H. somni 0 37 (12) 2592  (11) NA‡ NA‡ NA‡ 
 2 3016  (9) 166  (2) NA‡ NA‡ NA‡ 
 4 52,744  (6) 50  (4) NA‡ NA‡ NA‡ 
M. haemolytica 0 20793  (29) 81,064  (19) 2.99  0.841–12.0 0.0974 
 2 13,477  (22) 7,922  (11) 0.571  1.75–2.21  0.380 
 4 59,116  (28) 49,920  (11) 0.844  0.0928–
19.2 
0.889 
P. multocida 0 49,207  (66) 16,735  (41) 0.341  0.148–
0.851 
0.0177 
 2 39,906  (58) 75,094  (26) 1.87  0.528–8.39 0.361  
 4 82,917  (62) 38,305  (38) 0.462  1.60–1.47  0.165 
* Arithmetic mean carriage density in animals positive 
† Ratio and its 95% confidence interval (CI95%) of the arithmetic mean for vaccinated animals to that of 
unvaccinated animals calculated at 0, 2 and 4-weeks post vaccination using gamma regression adjusting for 
number of replicate determinations. 
‡ NA: not applicable; too few observations for meaningful analysis  
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6.3.10.2 Density of P. multocida following vaccination: within-barn comparisons 
The geometric mean P. multocida density for paired positive swabs taken from the same 
animal on the day of vaccination and either 2 or 4-weeks post vaccination and found to 
be positive is shown for each barn in Table 6.14. At the 1st crossover point (Red Barn 
vaccinated) there was no evidence for an increase in density at 2 and 4-weeks post 
vaccination. Similarly, there was no evidence for an increase in density 2-weeks post 
vaccination at the 2nd crossover point in the Blue Barn; however, at 4 weeks density was 
slightly reduced and differences were not significant. There was evidence to suggest a 
significant decrease in carriage density 2-weeks post vaccination at the 3rd crossover 
point (Green Barn, p = 0.040). At 4 weeks, density was reduced further in the Green Barn 
(p = 0.0508). Confidence intervals for these estimates in the Green Barn were large. The 
change in geometric mean P. multocida density between paired swabs for each barn is 
given in Table 6.15. 
 




* Geometric mean P. multocida density (genome copies/ml) CI95%
† P-value‡ 
  Before vaccination 
After 
vaccination N Ratio  
 
1st  
(Red: Week 0) 2 4735 9270 12 1.96 
0.0563–
4.628 0.534  
 4 3030 4292 17 1.55 0.107–3.89 0.622  
2nd  
(Blue: Week 4) 2 3229 5689 10 1.76 0.056–5.74 0.611  
 4 1785 1196 12 0.670 0.269–8.38 0.635  
3rd  
(Green: Week 8) 2 20635 4845 25 0.235 1.07-17.0 0.040  
 4 42607 8194 16 0.192 0.993-27.2 0.0508 
* Week post vaccination; †Confidence interval for the change in mean density before and after 
vaccination (ratio of geometric means). ‡ Paired t-test to assess whether the mean natural log 








6.3.10.3 Density of P. multocida following vaccination: between-barn comparisons 
Comparisons among barns of the changes in P. multocida density post vaccination 
following each crossover point are shown in Table 6.15. For all analyses, residuals and 
variances were approximately normally distributed and homogenous respectively. There 
was weak evidence to suggest a difference between barns in density 2-weeks post 
vaccination at the 1st and 3rd crossover point - density of carriage was increased in 
vaccinated animals following the 1st crossover point but decreased following the 3rd 
crossover point. There was no evidence to suggest a significant difference in the change 
in density between barns on other occasions.  
 
 195 
Table 6.15: Between-barn comparison of the fold-change in geometric mean Pasteurella multocida nasal carriage densities before and after respiratory viral vaccination in 
healthy beef cattle. The fold-change was calculated for paired positive swabs on the day of vaccination and either 2 or 4-weeks post vaccination. 
Vaccine crossover 
point Week 
Fold-change in geometric mean  
P. multocida density F-statistic
 df(w)* df(b) * P-value 
  Red (N) Blue (N) Green (N)     
1st (Red: Week 0) 2w/0w 1.96  (12) 1.01 (10) 0.224 (19) 2.77 38 2 0.0753 
 4w/0w 1.55 (17) 1.19 (11) 0.378 (18) 1.19 43 2 0.313 
2nd (Blue: Week 4) 2w/0w 0.708 (12) 1.76 (10) 0.744 (15) 0.442 34 2 0.646 
 4w/0w 1.04 (19) 0.670 (12) 3.99 (19) 1.87 47 2 0.166 
3rd (Green: Week 8) 2w/0w 0.394 (22) 2.20 (8) 0.235 (25) 2.55 52 2 0.088 
 4w/0w 0.211 (13) 1.84 (7) 0.192 (16) 1.50 33 2 0.238 
Shaded cells represent barns in the intervention phase 
The ratio of geometric mean density was compared between barns using ANOVA 
* within (w) and between (b) degrees of freedom 
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6.4 Discussion 
A double blind randomised controlled trial using a stepped wedge design was conducted 
to investigate the effect of respiratory viral infection on upper respiratory pathobiont 
colonisation dynamics in healthy cattle, using a live attenuated intranasal viral vaccine 
as a model infection system.  
 
Studies in humans and mice have demonstrated nasal bacterial carriage rates, carriage 
duration, and density of carriage with important pathobionts to increase following 
intranasal vaccination with LAIV [253] [252]. In mice, these increases in pathobiont 
carriage duration and density were similar to those observed following wild-type 
influenza virus infection, raising the possibility that wild-type virus infection in cattle 
may cause a similar phenomenon. Consistent with these observations, respiratory viruses 
infecting cattle are considered as primary pathogens which lead to secondary bacterial 
pneumonia [19]. Therefore, in this study it was hypothesised that following deliberate 
respiratory viral infection in cattle, nasal carriage and density of carriage with important 
respiratory pathobionts may increase.  
 
For the three bacterial species studied, the odds of carriage were lower following viral 
infection (Table 6.12). There was evidence of a significant, lasting effect of viral 
infection on carriage of M. haemolytica (OR: 0.48, CI95%: 0.27–0.85). Viral infection 
may only have a transient effect on bacterial carriage; this was investigated in mixed 
effect models by including time since vaccination as a predictor specified as three 
categories: vaccinated 2, 4 or ≥6 weeks (Model 2). There was weak evidence to suggest 
a transient effect of vaccination for M. haemolytica (p = 0.0887) but no such evidence 
for H. somni or P. multocida. The odds of carriage were similar among the 4 week and 
≥6 week categories for M. haemolytica and P. multocida, so this model was simplified 
to include two categories: 2 or ≥4 weeks (Model 3). Model simplification resulted in a 
better fit for both bacteria and provided evidence to suggest a transient effect of 
vaccination on M. haemolytica carriage (p = 0.0384).  
 
Pathobiont carriage was assessed 2 and 4-weeks after each vaccination ‘crossover point’, 
in ‘vertical’ (between cluster) analyses using log-linear models. As did the mixed models, 
these analyses suggested bacterial carriage rates tended to decrease following vaccination 
 197 
(Tables 6.5 to 6.11). The advantage of this vertical analysis approach is that it makes use 
of the study design staggering the rollout of intervention, thus allowing for investigation 
into the impact of vaccinating animals at different times (i.e. preserves the randomisation 
order) and indeed, whether animals housed in separate barns respond comparably. 
Similar trends in carriage of M. haemolytica were seen regardless of the timing of 
vaccination (i.e. following the three crossover points): carriage rates either decreased 
following vaccination or remained similar to their pre-vaccination level (Table 6.6, Table 
6.8 and Table 6.10). The odds of P. multocida carriage were lower in vaccinated animals 
2 weeks following the 1st and 2nd vaccination crossover points (OR: 0.534, CI95%: 0.214–
1.31; OR: 0.219, CI95%: 0.065–0.628), and at 4 weeks, the carriage rate in vaccinated 
animals was either lower than (OR: 0.164, CI95%: 0.00862–0.947) or similar to (OR: 1.19, 
CI95%: 0.475–3.11) controls. These results suggest that despite differences in the timing 
of vaccination, the effect of vaccination on bacterial carriage rate was broadly similar 
among the barns. One exception of note was that following the 3rd crossover point, the 
odds of P. multocida carriage in the most recently vaccinated cluster (Green Barn) were 
higher (OR: 8.68, CI95%: 2.21–58.7; OR: 1.76, CI95%: 0.712–4.45) compared to the earlier 
vaccinated clusters (Blue and Red Barns).  
 
Log-linear models were also used to assess the effect of prior bacterial carriage on 
subsequent bacterial carriage. The odds of subsequent carriage given prior carriage were 
similar or increased for the three bacterial species at each crossover point, bar one 
occasion (3rd crossover) where the odds of subsequent M. haemolytica carriage were 
lower (OR: 0.467, CI95%: 0.140–1.36). On a few occasions, large confidence intervals for 
estimated odds ratios were wide (Table 6.5, Table 6.8, Table 6.9, and Table 6.11), 
indicating uncertainty around these estimates. This was probably due to low variation in 
counts of animals across covariates There might be an effect of vaccination on bacteria 
already colonising the upper airways different to that for the likelihood of colonisation 
of uncolonised upper airways. Therefore, to investigate whether the relationship between 
vaccination and bacterial carriage also depended on prior carriage, the interaction 
between prior carriage and vaccination was assessed. There was no evidence of an 
interaction between prior carriage and vaccination in any of the analyses, but the study 
was probably insufficiently powered to detect such an interaction. 
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The observation of reduced bacterial carriage rates following vaccination was also seen 
in the analysis combining the 1st and 2nd crossover points as experimental replicates. 
Although quite crude in its approach, this analysis did again identify that the odds of 
carriage for all three bacterial species studied was lower 2 and 4-weeks post vaccination 
(Table 6.4), consistent with results from log-linear and mixed effect models.  
 
One possible explanation for the reduction in bacterial carriage observed in this study 
following vaccination could be as a consequence of vaccine-induced immune responses 
triggered by administration of the vaccine. This could occur through several possible 
mechanisms arising from the ability of both BRSV and BPIV-3 to infect bovine epithelial 
cells, albeit replicating poorly [14] [5], and that intranasal delivery of both viruses 
triggers local mucosal immune responses [18]. 
Firstly, as live vaccine viruses replicate in host cells, at least some level of innate immune 
responses will be subsequently activated [305]. The consequent immune responses are 
likely to create an unfavourable mucosal environment which may inhibit not only viral 
replication but also bacterial replication and promote pathogen clearance. As an example, 
human RSV triggers toll-like receptor 4 signalling (usually associated with Gram-
negative bacteria), with the potential for downstream nuclear factor NF-κß mediated 
production of antimicrobial peptides. Similarly, inflammation leads to quantitative 
changes in mucin production for several weeks following respiratory viral infection 
[306]. In cattle, several MUC genes have been identified [307], and MUC gene 
expression is potentially altered following attenuated viral infection leading to increased 
mucin secretion and/or differences in the type of mucins produced at the respiratory 
mucosa, in turn affecting microbial adhesion [308]. 
Secondly, as part of this process of infection and subsequent immune response, virus is 
likely to cause at least some damage to the epithelium, creating the potential for 
translocation of bacteria to the lamina propria. Mucosal adaptive immune responses to 
translocated bacteria may then trigger production of local, bacteria-specific IgA in 
addition to virus-specific antibody induced by vaccine. Secretion of IgA back across the 
epithelial surface, could then lead to inhibition of bacterial proliferation through classical 
adaptive mechanisms such as agglutination and blockade of functional surface molecules 
[309]. It is unknown how much ‘damage’ an attenuated virus may cause and indeed 
whether this mechanism is likely to occur, but this would be possible to test 
experimentally. 
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Thirdly, changes in local host innate and/or adaptive immune responses may be sensed 
not only by resident pathobionts, but also by other components of the microbiota (16). 
However, since the respiratory microbiome, like other microbiomes, is an ecosystem in 
which species interact continuously with each other, alterations in the level of any of the 
other commensal organisms are likely to impact on the levels of the pathobionts tested. 
If certain organisms proliferate or die back then this changes the niche (e.g. changes in 
nutrient or binding site availability). Contrary to the study hypothesis, this study suggests 
that, in some cases, nasal pathobiont carriage rates in healthy cattle decrease following 
attenuated respiratory viral infection, although no discernible effects on density of 
carriage were observed. This observation was unexpected as rates of bacterial carriage, 
carriage density and carriage duration has been seen to increase in other studies using 
LAIV [252] [253]. There are important differences to this study and those using LAIV 
which may have contributed to the differences in biological outcomes, including the host 
species, host respiratory microbiome and the vaccines used. 
 
Aside from vaccine-induced immune responses, the observed reduction in bacterial 
carriage rates following vaccination may be a result of differences in the natural history 
of carriage among the three bacterial species. Of the three bacteria, overall carriage rates 
were lowest for H.  somni (109/604; 18.0%) and carriage was transient, with apparent 
clearance also observed. Conversely, P. multocida was detected most frequently 
(399/604; 66.1%) with carriage commonly sustained for long durations or even the whole 
study period. Carriage with M. haemolytica was transient but carried at a lower rate than 
P. multocida (154/604; 25.5%). It could be possible that vaccination non-specifically 
inhibits acquisition of bacterial carriage, an effect more profoundly observed for 
M. haemolytica as a consequence of both being commonly carried and transient.  
 
Density profiles for each bacterium (Figure 6.13) were similar to those obtained for 
animals sampled the previous year (Chapter 4, Figure 4.4): H. somni was carried at low 
densities (1–2 log10 genome copies/ml), whereas M. haemolytica and P. multocida 
carriage extended over a wide range (2–6 log10 genome copies/ml). When carriage was 
maintained over several consecutive weeks it tended to occur at higher densities (Figure 
6.15), corroborating results reported in Chapter 4. This suggests that the density profiles 
 200 
obtained for each bacterium are reflective of their natural history and not due to sampling 
error. This study did not detect any discernible effects of viral infection on bacterial 
density, but the study was not powered to do so, it was powered primarily to detect 
changes in carriage rates. Variation in the density of carriage among animals in the same 
barn on the same day was high (Figure 6.14) and often carriage rates were low. When 
the difference in P. multocida density within clusters before and after vaccination was 
considered (Table 6.15), the direction and magnitude of effects varied between barns. It 
is likely that density of Pasteurellaceae carriage is influenced more by other factors than 
by vaccine viral infection, such as recency of acquisition, environment or even host 
genetics and hence studies of carriage density undertaken in more controlled settings 
might be more informative [137]. On the other hand, an advantage of this study is that it 
was conducted at a highly instrumented research farm emulating modern suckler beef 
production. As such, results pertaining to carriage biology may be more reflective of UK 
farms than they would be from studies using fewer animals in highly controlled settings. 
 
Few studies in cattle using live attenuated vaccines have been conducted to investigate 
viral-bacterial interactions. One study investigating the effect of temperature and 
humidity on nasal and tracheal bacterial flora of 12-week-old calves, remarked on a 
significantly higher total bacterial colony count 7 days after intranasal vaccination with 
a live attenuated IBR vaccine containing thermosensitive BHV-1 [137]. No further 
details were provided on the effect of viral infection on particular bacterial species other 
than that for M. haemolytica, but so few animals were colonised with this bacterium that 
conclusions could not be drawn. Some conflicting evidence exists following deliberate 
exposure to wild-type BHV-1 in cattle – one study reported no effect on tonsil or nasal 
colonisation with M. haemolytica [138], whilst another reported induction of 
M. haemolytica nasal shedding; however, shedding was induced in only 4 of 8 calves 
studied [310]. Thus, the present study has helped bridge an important knowledge gap on 
the influence of live attenuated respiratory viral vaccination on bacterial colonisation. 
 
Stepped wedge studies are inherently confounded by calendar time. To account for this 
confounding, the basic Hussey and Hughes mixed effect model assumes a homogeneous 
secular trend across clusters and is specified as a fixed effect. However, effects of time 
may not be linear and misspecification of time trends may lead to biased treatment effects 
or biased standard errors [311]. Varying secular trends over time were accounted for in 
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mixed model analysis by including a random effect of time within cluster [303] [312]. 
This random effect is an example of a crossed random effect because every cluster is 
observed at every time point and therefore represents a kind of interaction between time 
and cluster. A limitation to the model implemented in this study was that it assumed no 
correlation structure. In reality, this assumption may not be true, and it may be more 
likely that observations further apart in time are indeed less correlated [311]. As such, 
autoregressive correlation structures at the cluster (or individual within cluster) level may 
be more appropriate. Currently there are no published examples of closed cohort stepped 
wedge studies implementing autoregressive correlation structures, but both Hooper and 
Hemming have acknowledged their potential [303] [311].  
 
Although the vertical, between-cluster analysis approach did not account for 
confounding on the response by time (i.e. different intervention rollout times) the 
horizontal mixed effect models included a random effect for time within cluster to 
account for this; consequently, the horizontal analysis can be seen to strengthen vertical 
comparisons. The rationale for performing both analyses is further strengthened by 
Davey et al. who highlighted the need to identify an efficient vertical analysis and 
compare this to the results of a mixed effects analysis, as has been done in this study 
[287]. In addition to these two analysis approaches, data from both the 1st and 2nd 
crossover points were combined into one single analysis, effectively treating the first two 
crossover points as experimental replicates. This allowed a greater number of 
observations to be modelled thereby giving greater statistical power, but ignored 
differences with respect to the timing of vaccination.  
 
Throughout the study animals remained generally healthy. No Dictyocaulus viviparous 
larvae were detected and the nutritional plane of animals was similar among the different 
farmlet treatments, both at pasture and when housed (see Appendix D). One animal (ID: 
177) presented with signs of pneumonia (increased respiration rate, elevated temperature, 
and dry adventitious lung sounds detected on auscultation). However, no nasal discharge 
was observed. Paired serum samples collected from this animal at the time of illness 
provided evidence of a rising titre to BRSV. These serological results should be treated 
with caution; at Week 0 this animal already had high levels of serum antibody to BRSV 
and it was later vaccinated at Week 4 with Rispoval RS+PI3 IntraNasal, seven weeks 
prior to signs of disease onset. Accordingly rising antibody titres may not have resulted 
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exclusively from natural exposure to circulating BRSV. It is possible that vaccination 
reduced the severity of this illness. Of note, carriage patterns for this animal were 
unremarkable compared to others housed in the same barn. 
 
A limitation to this study is that detection of respiratory viruses was not undertaken 
during its course. PCR assays capable of detecting wild-type virus and vaccine strains 
could have been employed. Such information could have been used to look for 
association between viral infection and bacterial carriage and provide insight into the 
duration of viral-infection following vaccination. Moreover, it could provide evidence 
for viral-infection due either to vaccination or a circulating natural infection. Virus 
isolation could also have been employed to provide evidence of active viral infection 
[283] [278]. Instead, this study used serology to provide evidence of exposure to naturally 
circulating respiratory viruses (Table 6.2). Bloods were collected prior to vaccination at 
the start of the study (Week 0), and after vaccination at the last sampling occasion (Week 
12). Seroconversion for any of the five agents tested (BRSV, BPIV-3, BHV-1, BVDV 
and Mycoplasma bovis) was investigated. Ideally, if resources permitted an additional 
blood sample collected at the study mid-point would have been informative.  
 
Seroconversion to both BRSV and BPIV-3 was observed (Table 6.2), a reassuring result 
given vaccination was against these agents; however, it was not likely to have been 
associated with natural infection as animals remained generally healthy during the study. 
In addition, at Week 12, the number of animals with detectable antibodies to both these 
viruses was lowest in the Green Barn. This may reflect that this cluster was last in 
sequence to be vaccinated, just two weeks previously, whereas the Red and Blue Barn 
animals were respectively vaccinated four and six weeks previously and therefore had 
longer for antibody responses to develop. As such, there was no serological evidence to 
suggest that outcomes observed in this study were influenced by wild-type viral infection.  
 
At Week 0, detectable antibody titres to BVDV (Blue Barn: 2/26; Green Barn: 1/28) and 
BHV-1 (Blue Barn: 2/26; Green Barn: 2/28; Red Barn: 1/28) occurred in younger calves 
aged 5.0–6.4 months (and thus may represent maternal antibody [313]. Two of the five 
calves positive for BHV-1 at Week 0 also had detectable antibodies to BVDV. 
Seroconversion for both BVDV (one calf in the Red Barn and one calf in the Green Barn) 
and BHV-1 (one calf in the Green Barn) was observed and implies that a natural infection 
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may have been circulating on the NWFP before the start of the study given  - this could 
have occurred through bought-in breeding stock. The relatively high proportion of 
animals seroconverting (11/24) to M. bovis in the Red Barn is interesting and raises the 
question whether this was a stochastic event or the due to a barn effect. The Red Barn is 
situated centrally and could be more sheltered and hence be less well ventilated (despite 
identical building design) compared with the Blue and Green barns on either side. 
Consistent with this hypothesis was that the Blue and Green barns were highly correlated 
with each other in terms of both temperature (r = 0.97) and humidity (r = 0.92), more so 
than either were with the Red Barn (correlations Red with Blue and Green: rtemperature = 
0.10, rhumidity ≈ 0.2; Figure 6.6).  
 
As discussed previously, RCTs are robust research designs [285]. This study uses a 
variant of an RCT - the stepped wedge design. This allowed every animal to act as its 
own control and permitted phased implementation of vaccination to clusters (barns). 
Concerns about possible transmission of live-vaccine virus shed in nasal secretions of 
vaccinated animals to co-housed controls militated against possible alternative study 
designs with rollout of vaccination to clusters within each barn; for example, three 
clusters of ten animals in each barn, with rollout of vaccine following a stepped wedge 
design to one cluster in each barn simultaneously. Instead, a pragmatic approach was 
taken to administer treatment at the barn level to avoid such risk of cross-contamination. 
To some extent the statistical power of the study was limited by the small number of 
clusters (three barns), and that only one cluster was randomised to receive the treatment 
at each crossover point, but the minimum number of clusters required for reasonable 
estimation of the intervention effect in stepped wedge studies is under-explored [312]. 
 
The study was strengthened through its randomisation strategy: animals were 
individually randomised to clusters following covariate-based constrained 
randomisation. This procedure ensured that covariates (breed, sex, sire, age, weaning 
weight, average daily growth rate) were balanced across clusters (Table 6.1). The 
advantage of such a rigorous randomisation procedure is that variation in covariates 
among groups is minimised as much as possible, thus decreasing the likelihood of 
confounding by these nuisance variables. Interestingly, Haines and Hemming recently 
recommended restricted randomisation procedures (e.g. covariate based randomisation, 
stratification, matching) for balancing cluster level covariates across intervention and 
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condition phase arms of stepped wedge studies [314]. It can be argued that for infectious 
disease studies where the outcome of interest is an infectious agent readily detectable by 
rapid molecular techniques, then the outcome of interest could itself be incorporated as 
a covariate in restricted randomisation, provided that samples can be collected and 
assayed quickly, or as Moulton proposed, baseline prevalence data which is already 
available at the outset could be taken and used as a constraining variable in the 
randomisation procedure. This approach then avoids the need to adjust for any initial 
differences at the time of analysis [170]. A further study strength was the implementation 
of administering placebo to clusters at the same time as those randomised to receive the 
intervention. This allowed for any changes in the measured outcomes to occur as a result 
of the intervention and not from the intranasal procedure. It also allowed the study to be 
blinded, minimising bias. The blinding was achieved through masking the contents of 
the syringe (Figure 6.3), which was highly effective. 
 
In conclusion, this study demonstrates that following intranasal vaccination with 
attenuated BRSV and BPIV-3, rates of nasal carriage of H. somni, M. haemolytica and 
P. multocida were reduced in healthy cattle, but there was little evidence to suggest an 
effect on nasal carriage density. To my knowledge this is the first example of 
implementing a trial of stepped wedge design in veterinary research. Although the 
stepped wedge study is not necessarily difficult to implement, it is complicated and 
challenging to analyse whilst methods of analysis and reporting are still a rapidly 
developing field. Targeted approaches such as qPCR can be used to assess for species-
specific changes following respiratory viral infection. Collectively, this work provides a 
platform for further investigation of viral-bacterial interactions in the upper respiratory 
tract of cattle using live attenuated vaccination and molecular detection techniques as 
tools for future work. These approaches may be useful for studying viral-bacterial 
interactions in other host species and/or with different target microorganisms.  
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Chapter 7 General Discussion 
The work presented in this thesis attempts to provide insights into carriage of respiratory 
pathobionts in the bovine upper airways and how this might be affected by transient 
respiratory viral infection. Key findings of these studies described are highlighted and 
discussed, and recommendations provided for further work in this area. 
 
The methodological approaches for detecting Pasteurellaceae from bovine nasal swabs 
presented in Chapter 3 have provided a valuable platform for further carriage studies. 
The three qPCR assays developed and optimised offer advantages over culture - they are 
rapid, reliable and are capable of quantifying bacterial DNA over a large range. While 
combining the three qPCR assays into a multiplex assay would be ideal, this is 
unachievable with the current annealing temperature of the M. haemolytica assay (69°C), 
which is higher than that of the H. somni and P. multocida assays (60°C).  
As discussed previously in Chapter 3, obtaining full genome sequences of 
Mannheimia spp. could aid in future design of primers allowing for an optimised assay 
with a lower annealing temperature. An alternative approach to qPCR for nucleic acid 
detection and quantification is the emerging technique of digital PCR (dPCR) [315]. In 
analogue qPCR, the amplification single is logarithmic and the quantification is based on 
external calibration [316]. In contrast, dPCR offers linear and digital quantification, 
based on the number of positive and negative reactions [316]. The digital format of the 
reaction may be divided into i) hundreds or thousands of chambers on a single plate or 
array (microfluidic-based approach), or ii) into thousands or millions of droplets (droplet-
based approach) [316]. Prior to PCR amplification, the sample is partitioned – each 
reaction chamber receives at random either 0 or ≥1 copies of the target DNA. Poisson 
statistics can be used to measure DNA quantities, providing there are negative partitions. 
Compared to qPCR, dPCR is reportedly more tolerant to some PCR inhibitors, sequence 
variations, and different types of DNA template and master mixes. In addition, dPCR 
performs better when measuring low DNA concentrations (enhanced repeatability 
compared to qPCR), but has a restricted reaction volume, which may yield lower 
analytical sensitivity [315] [317]. 
 
Before the work presented in this thesis was conducted, there were few recent studies 
investigating upper respiratory tract (URT) carriage with H. somni, M. haemolytica or 
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P. multocida in cattle within the UK. Only one study has reported nasal carriage rates 
using culture-amplified PCR, which was conducted in Scotland in 2010 and reported 
rates of P. multocida carriage in beef and dairy calves [149]. The lack of carriage studies 
is surprising given that BRD continues to present a significant economic and welfare 
burden to the UK cattle industry. The work presented in Chapters 4, 5 and 6 has helped 
to bridge this knowledge gap. In these studies using qPCR, the three pathobiont species, 
H. somni, M. haemolytica and P. multocida, exhibited remarkably different carriage rates 
and density profiles, both in early life and when cattle were older. Rates of carriage were 
highest at the start of winter housing for all pathobiont species over the two years of study 
(Chapters 4 and 6), but rates did differ between years and the two cohorts. Although 
carriage rates differed between years, general trends in carriage rates of the three 
pathobionts were similar: P. multocida was carried at the highest rates, followed by 
H. somni and M. haemolytica. Furthermore, the density profiles were similar between 
years for the three bacterial species: M. haemolytica and P. multocida were carried over 
a wide range of densities (2–6 log10 genome copies/ml), with H. somni carried over a 
narrower range (1–2 log10 genome copies/ml). This was also true in early life for 
H. somni when colonisation was detected as early as 1 week of age, with similar density 
profiles seen at 1 week and 2, 3 and 7 months of age (Chapter 5, Figure 5.4). Obtaining 
distinct, consistent density profiles for each bacterium across different study years, with 
different animals, and at different ages suggests that these profiles are not due to sampling 
error and reflect real distributions of carriage density. Neither M. haemolytica nor 
P. multocida were detected in calves until 7 months of age, with the exception of two 
calves which were colonised with P. multocida at 3 months of age. Changes in 
colonisation patterns as calves age may have implications for later respiratory health and 
also for developing vaccination strategies [160]. 
 
A well-known limitation of the technique used is that PCR will detect DNA from non-
viable organisms that persist in the respiratory tract even when viable organisms are no 
longer present or cannot be detected by culture. It can be argued that specific detection 
of DNA from these unculturable organisms provides evidence of either current or recent 
colonisation and is thus of biological interest. In studies in humans it has often been found 
that samples are positive by culture and negative by PCR [171] perhaps reflecting that, 
on occasion, culture has the potential to be more sensitive than PCR when there are very 
small numbers of organisms present. Interestingly, this phenomenon was not encountered 
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in the study presented in Chapter 4, perhaps reflecting the poor sensitivity of culture for 
these bacterial species. Of particular interest is that H. somni was only isolated from one 
of 60 nasal swabs cultured, but it was commonly detected by PCR. Sequencing of PCR 
products from PCR-amplified nasal swab samples determined positive for H. somni 
confirmed their identity, strengthening confidence in this assay’s ability to detect 
H. somni reliably.  
 
Moraxella bovoculi was isolated from one nasal swab (10-month-old heifer, Chapter 3) 
with a further 5 out of 60 swabs identified as either Moraxella or Pasteurella based on 
biochemical testing of isolates (10-month-old cattle, Chapter 3). Other authors have 
reported isolation of Moraxella-like organisms from calves suffering from respiratory 
disease. These findings prompted further investigation using PCR and confirmed the 
presence of M. ovis in bronchoalveolar lavages and nasopharyngeal swabs collected from 
calves suffering with respiratory disease on separate farms [318]. More recently, using 
16S rRNA sequencing, the presence of Moraxella in bovine URT samples has been 
highlighted by other investigators. Lima et al. reported a significantly increased mean 
relative abundance of Moraxella in the nasal passages of dairy calves diagnosed with 
pneumonia, otitis or a combination of both compared to healthy calves at 14 days of age 
[264]. Sequencing of maternal vaginal and calf URT microbiota has also revealed a high 
abundance of Moraxella in both of these sites – the second most abundant genus 
identified after Mannheimia [268]. Moraxella catarrhalis is frequently carried in the 
nasal passages of healthy children [171] and is recognised as a significant human 
bacterial pathogen involved with respiratory disease and otitis media [220] [221]; 
similarly, Moraxella may be carried in the nasal passages of healthy cattle and contribute 
towards respiratory disease. Further work is needed to test this hypothesis, and to this 
end PCR or sequencing could be performed on collected nasal swabs from healthy and 
diseased cattle, and/or pneumonic lung tissue collected from cattle at post mortem. 
 
Short nasal swabs were employed in Chapters 4–6 to sample nasal flora. Short swabs 
were advantageous compared to deep-guarded swabs in that the procedure was quick and 
less invasive. It is not known with certainty whether and to what extent the bacteria are 
evenly distributed within the upper respiratory tract of colonised animals, but one study 
did detect M. haemolytica from 15 different anatomical locations within the nasal cavity. 
Notably, the authors reported no differences between nasal passages [9], a finding 
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supported by others [310]. While some authors have suggested M. haemolytica 
preferentially colonises the palatine tonsil [139] [158], in this work deep-guarded swabs 
performed no better than short swabs for detection of M. haemolytica (Chapter 4). In fact, 
M. haemolytica was not detected from any short or deep swab collected from the same 
animal. Future studies investigating different sites of colonisation should consider larger 
sample sizes, as this study comparing 30 paired swabs was inconclusive. In common with 
all studies of mucosal colonisation, the studies presented in this thesis are subject to 
sampling error – colonisation will have remained undetected on occasion by obtaining 
the swabs from the wrong place, at the wrong time or insufficiently frequently and, 
indeed, the choice of the nasal cavity may not have been optimal for detection for one or 
more of these organisms. Accordingly, the results are likely to be underestimates and 
there is a need to develop sufficiently non-invasive techniques which will permit more 
frequent or even continuous sampling with due consideration to animal welfare. More 
broadly, these are studies in healthy cattle, and it cannot be certain whether and to what 
extent the strains of bacteria carried in the nasal passages have the potential to cause or 
contribute to outbreaks of disease or how specific virulence factors may vary among the 
same bacterial species. 
 
Longitudinal studies characterising bacterial carriage in humans are common but 
veterinary medicine has lagged behind; emphasis has been placed on studies identifying 
the aetiological agents involved with disease outbreaks or risk factors contributing 
towards those outbreaks [10] [24] [147]. As such, there is little knowledge on the natural 
history of respiratory pathobionts of cattle. In Chapter 4 the association between density 
and duration of carriage was investigated using interval-censored survival analysis. In 
this study it was observed that density of P. multocida carriage was significantly 
associated with carriage duration, and that the highest density category investigated 
(≥4.77 log10 genome copies/ml) was associated with the longest carriage duration (hazard 
ratio: 0.414 per day; CI95%: 0.197 – 0.868). This observation could have implications for 
the transmission of pathobionts within a susceptible population – animals with higher 
density carriage above a critical threshold could potentially be more infectious due to 
increased bacterial load and remaining infectious for longer periods of time; therefore, 
increasing opportunities for transmission events [251]. 
 
 209 
Exploring the complexity of infectious disease systems can be achieved through 
mathematical models. Mathematical models could be used to enhance basic 
understanding of infectious diseases, for example, to determine transmission routes, to 
predict disease outbreaks, or to test the effects of prevention strategies. Epidemiological 
surveys are important sources of data for parametrizing models [319]. Similarly, the 
studies in this thesis reporting rates of carriage and clearance rates could be used to 
provide initial parameter estimates for transmission models of BRD, for example, either 
SIS (susceptible-infectious-susceptible) or SIR (susceptible-infectious-recovered) 
compartmental models. Transmission models could then be used to inform prevention 
and control strategies, for example, investigating timing of vaccination (considering age 
and environmental influences) and/or optimising stocking densities.  
 
To investigate the effect of respiratory viral vaccination on bacterial carriage patterns, a 
rigorous randomised controlled trial was conducted (Chapter 6). The results suggested 
that following vaccination, carriage of clinically important bacterial species in the bovine 
URT decreased. This observation supports the hypothesis that respiratory viral infection 
can alter the respiratory microbiota and suggests that strategic vaccination schedules 
could be used to favourably manipulate microbiota, as well as to generate immunity to 
respiratory viruses. Future work focusing on elucidation of the immunological 
mechanisms associated with the non-specific effects of vaccination described in Chapter 
6 and comparison of these mechanisms with wild-type infection could be highly 
rewarding. In addition to non-specific effects of vaccination on bacterial species, effects 
may be serotype specific. The qPCR assays employed did not discriminate between the 
different serotypes of bacteria targeted. Of the capsular serotypes of M. haemolytica, A2 
is frequently isolated from healthy cattle, whilst A1 and A6 are associated with BRD 
[113]. Consequently, there is a knowledge gap relating to long-term carriage dynamics 
of specific serotypes. Longitudinal carriage studies could be employed to characterise 
serotype-specific carriage and the influence of respiratory viral infection and/or 
respiratory viral vaccination on bacterial serotypes. Moreover, this work indicates that 
vaccines have the potential to have broader impacts than that relating to either a reduction 
of the disease caused by or prevalence/transmission of the target organism of the 
vaccines. This may have implications for future studies evaluating the effects of vaccines 
– should vaccine studies be broadening investigations to consider effects on the 
microbiome, and how will this impact on defining the outcomes of studies?  
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The three bacterial species investigated in Chapter 6 exhibited remarkably different 
carriages rates and dynamics of carriage. The strongest evidence for an effect of 
respiratory viral infection on bacterial carriage rate was observed for M. haemolytica. 
For this bacterium, carriage was often transient and overall rates observed (25.5%) 
were in-between that for H. somni (18.0%) and P. multocida (66.1%). If, indeed, 
vaccination does interfere with colonisation, differences in colonisation patterns among 
bacterial species could determine whether an effect of attenuated respiratory viral 
infection was observed within the study design implemented. Moreover, the ability of 
the study to detect an effect depends on the size of the effect, the size of the study and 
the heterogeneity of the population with regard to bacterial carriage rates and density of 
carriage. Thus, results from this study can be used to inform design of future studies to 
elucidate the unexpected inhibitory effects of attenuated respiratory viral vaccination on 
bacterial carriage dynamics. It would be rewarding to explore whether this phenomenon 
is related to an effect on the likelihood of acquisition, abundance of carriage and/or 
duration of carriage. For example, future work could employ interval-censored survival 
analysis, as demonstrated in Chapter 4 to investigate this. There was no evidence of an 
interaction between prior carriage and vaccination in any of the log-linear analyses 
conducted in Chapter 6; however, it is likely these analyses were underpowered. Further 
experiments powered to detect an interaction between prior carriage and vaccination may 
help elucidate whether effects of vaccination are on acquisition of bacterial colonisation 
or on bacteria already colonised or both.  
 
The randomised controlled trial with stepped wedge design presented in Chapter 6 is 
unique in several ways. Firstly, to my knowledge, it is the first application of a stepped 
wedge design in veterinary research. Accordingly this study lays a foundation for further 
trials where phased implementation of an invention at the group level in veterinary 
settings may be beneficial, for example, at the farm level within a national setting. 
Secondly, it is unusual in that the investigator had control over designating participants 
to clusters, to which the intervention was then delivered. More commonly, in cluster 
randomised controlled trials the clusters are predetermined, for example, general 
practices, schools, hospitals, or villages or other communities [170]. Thirdly, the 
intervention in Chapter 6 (vaccination) was not maintained after its introduction. This 
differs to the stepped wedge trials most commonly employed in healthcare settings, 
where once introduced, the intervention is typically maintained, for example, staff 
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training/education on hand-hygiene or a school breakfast programme [320] [321] [322]. 
Possible transient effects of vaccination were explored through mixed effects models. 
There was evidence to suggest that, for M. haemolytica, the effect of vaccination on 
bacterial carriage rates was strongest 2 weeks post administration and waned thereafter.  
The animals studied in this thesis were bred and housed at the North Wyke Farm 
Platform, Rothamsted Research. This provided a unique opportunity to work with a 
largely closed herd, on an operational farm, within a research setting. This was 
advantageous as the farm is highly instrumented and extensively monitored for running 
long-term experiments involving grazing livestock. If the studies had been conducted on 
a commercial farm then changes to the study environment or animals may have been 
more frequent, potentially introducing confounders. Future studies conducted at 
Rothamsted offer great potential as the herd studied at the Farm Platform will soon be 
comprised mainly of the Stabiliser suckler beef breed – a genetically stable composite 
breed expected to have less animal to animal variability, as is currently seen with the 
cross-bred beef breeds on the farm [323]. In addition, all cattle will be genotyped. The 
calf cohort involved in the stepped wedge study presented in Chapter 6 were the first 
cohort to have 50,000 single nucleotide polymorphisms genotyped, and these results are 
currently being compiled into a database of respective phenotypes and genotypes. It 
would of interest to return to these genotypes to look for possible associations with the 
bacterial carriage patterns described for these animals.  
 
Recent advances using genetics to help control BRD include genome-editing resistance 
to M. haemolytica leukotoxin (Lkt) [324]. Binding of Lkt to the signal peptide of 
ruminant specific CD18, the b subunit of b2 integrins, expressed on the surface of 
ruminant leukocytes results in cell lysis. It has been demonstrated that Lkt binds to the 
amino acids 5–17 of signal peptide of CD18 [109]. Cleavage of the CD18 signal peptide 
in ruminants is inhibited by the signal peptide sequence encoding glutamine. Using gene 
editing glutamine was substituted for glycine, which in non-ruminants induces cleavage 
of the signal peptide. This substitution produced leukocytes that expressed the signal 
peptide-less CD18 on their surface, in turn resisting leukotoxin-induced cytolysis. 
Genome-editing technologies could play an important role in breeding livestock resistant 
to disease.  
 
 212 
Manipulating the respiratory microbiome might prove to be useful to support respiratory 
health and management of BRD, but the success of this approach would hinge partly on 
better defining the role of respiratory microbiota and its interplay with the immune 
system [325]. Historically, emphasis has been placed on investigating bovine respiratory 
pathobionts as pathogens; for example, much work has been conducted on elucidating 
virulence factors, such as the leukotoxin of M. haemolytica [85] [326] [327]. However, 
it is equally important to consider whether and how pathobionts may contribute towards 
respiratory health [328]. Development of technologies such as high-throughput 
sequencing, metabolomics and transcriptomics has allowed investigation of complex 
microbial communities and their interaction with the host [209]. This has led to a 
paradigm shift in how we view determinants of disease, and instead of attributing one 
pathogen to a disease, we can now consider disease as a consequence of several specific 
interactions within the microbial environment [329]. As discussed in Chapter 1, 
management events such as transport, weaning and social reorganisation may predispose 
cattle to BRD. These events have been investigated in relation to URT microbiota using 
sequencing, for example, at weaning and arrival at the feedlot [178], and before versus 
after transport to the feedlot [330]. In addition, emphasis has been placed on 
characterising the URT microbiota from healthy versus diseased animals within feedlots 
[177]. Of note, all of these studies have been conducted in US feedlot settings and none 
to date have focused on extensive or intensive beef production systems in the UK. Future 
work employing such technologies could investigate changes in the respiratory microbial 
ecosystem before and after respiratory viral infection, or indeed following other stressors, 
such as transportation or weaning [160] [264]. Moreover, using such technologies, 
livestock offer a unique opportunity to study the transmission of microbiomes within 
closed herd settings, a topic of recent interest in human medicine [331].  
 
In summary, this thesis has provided novel perspectives and insights into bovine 
respiratory disease within a UK setting. Three real-time PCR assays were evaluated, 
optimised and validated on collected bovine nasal swabs, providing a platform for 
studying carriage dynamics with H. somni, M. haemolytica and P. multocida. The 
longitudinal carriage studies conducted have provided unique and detailed information 
on the natural history of these three bacterial species in healthy cattle: at early life, during 
winter housing and following respiratory viral infection. Moreover, this work has drawn 
parallels between human and veterinary fields to address challenges in livestock farming; 
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pioneering the use of live attenuated vaccines as model infection systems in cattle to 
enhance understanding of empirical associations between host-pathogen interactions. 
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Management of farmlet swards  
Inorganic fertiliser is applied annually to the Green farmlet permanent pasture system, 
no field has been reseeded for at least 20 years [167]. Blue farmlet pastures are 
supplemented with low levels of inorganic fertiliser, fertiliser is replaced predominately 
by nitrogen fixation capacity of clover, emulating the driving principles of organic 
farming. Farmlet fields were progressively reseeded in 2013 – 2015, achieving sufficient 
productivity levels for future self-sufficiency. Initial sowings were 25kg AberMagic 
(high sugar perennial ryegrass, Lolium perenne) per ha plus 3.5kg AberHerald (white 
clover, Trifolium repens) per ha. The Red farmlet undergoes regular planned periodic 
reseeding with innovative varieties of grasses. From June onwards, grass is cut and 
harvested for silage. A lactobacillus additive is included to improve fermentation in the 
silage clamps. 
 
Bull details  
Table A.1: History and details of bulls at the North Wyke Farm Platform 2015–2017  
Official Tag Date of Birth  Breed Additional Information  
UK 142911 303178 09/04/15 ST Serving cows/heifers for 2017 spring calving 
UK 380678 601707 24/03/15 ST Serving cows/heifers for 2017 spring calving 
UK 303596 501955 28/04/12 ST Serving cows/heifers for 2017 spring calving 
UK 701354 700138 21/08/08 CH Serving cows/heifers for 2017 spring calving 
UK 141011 400520 29/11/07 CH 
Serving cows/heifers for Spring 2015 & 2016 
calving.  
UK 362915 500228 04/04/10 HE Serving cows/heifers for Spring 2015 calving. 
UK 365879 100867  Unknown LIM 
Sired cows/heifers that have been bought in 
(naturally or AI). Calves born 2016. 
UK 104665 600203  Unknown CH 
Sired cows/heifers that have been bought in 
(naturally or AI). Calves born 2016. 
UK 123916 112296  Unknown ST 
Sired cows/heifers that have been bought in 
(naturally or AI). Calves born 2016. 
 
Media recipes: 1% agarose gel 
For 150 ml of agarose, 1.5 g of agarose powder is dissolved (Sigma Aldrich) in 150 ml 
of Tris-acetate-EDTA (TAE buffer used at 1x (Fluka Analytical Science). Microwave on 
full power for 3 minutes. Cool under running water. Add 7.5 µl ethidium bromide 




Bacteriological characteristics of Pasteurellaceae 
Table B.1: Characteristics of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida 
Characteristic P. multocida M. haemolytica H. somni 
Colony morphology 
Regular, smooth, 0.5–
2mm, grey,  
no ß-haemolysis 
Regular, smooth, 1–
2mm, greyish,  
ß-haemolysis 




bacilli, short chains, 







Haemolysis - + v 
Catalase + + - 
Oxidase + + + 
Urease v - - 
Indole + - + 
X factor - - - 
V factor v - - 
D- Galactose + + - 
D- Glucose + + + 
Acid from D-Mannose  + -  
Acid from lactose  - + - 
Acid from mannitol  +  + 
Acid from sucrose    - 
Acid from trehalose  v -  
V: variable  
Data compiled from several sources [72] [332] [206] [333] [207] 
 
In silico alignment of candidate primers to target bacterial species 
Candidate primers for H. somni, M. haemolytica and P. multocida were aligned against 
available sequences in the Genbank library. For H. somni and M. haemolytica amplicon 
homology to available reference genome sequences was 100%. For P. multocida 
amplicon homology ranged to available genome sequences was between 97–100%. Data 
are available at the University of Bristol data repository, data.bris, at 
https://doi.org/10.5523/bris.nyqkgnysra9q2ic5dok0swnbg. 
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Sequencing bacterial strains  
Table B.2: 16S rRNA gene sequence data from short bovine nasal swabs collected from healthy cattle on the North Wyke Farm Platform in January 2016 and cultured for the 
presence of Pasteurellaceae: identity given from BLAST identification of sequences, bacteriological biochemistry (API test strips) and final identification.
Isolate no. BLAST identification output 
Identity  
(% homology) API 20NE API NH Final ID 
V1-71-1 (11) 
Mannheimia haemolytica strain NIVEDI/MHS-4 16S 






Mannheimia haemolytica NIVEDI/MHS-4 16S ribosomal RNA 




Mannheimia haemolytica NIVEDI/MHS-4 16S ribosomal RNA 




Mannheimia haemolytica strain NIVEDI/MHS-4 16S 
ribosomal RNA gene, partial sequence 99 Mannheimia haemolytica  
Mannheimia 
haemolytica 
V1-26-1 Moraxella bovoculi strain 57922, complete genome 99 
Moraxella spp. (82.3%), 
Pasteurella (4%)  Moraxella bovoculi 
V1-65-1 
M. haemolytica strain NIVEDI/MHS-4 16S ribosomal RNA 




Arcobacter skirrowii strain VPH/V129/2014 16S ribosomal 
RNA gene, partial sequence 99 
Unidentified by culture, API 
not performed  Arcobacter spp. 
V1-38-5 
Pasteurella multocida subsp. multocida PMTB2.1, complete 




Pasteurella multocida subsp. multocida PMTB2.1, complete 




Pasteurella multocida subsp. multocida PMTB2.1, complete 
genome 99 Pasteurella multocida  
Pasteurella 
multocida 
      










Table B.2 continued 
Isolate no. BLAST identification output 
Identity  
(% homology) API 20NE API NH Final ID 
V1-66-2 
Rhodococcus equi strain FY1 16S ribosomal RNA gene, partial 




Jeotgalicoccus huakuii strain Nc5RA-2 16S ribosomal RNA 
gene, partial sequence 98 
Morexella spp. (82.3%), 
Pasteurella spp. (4%)  Jeotgalicoccus sp. 
V1-72-1 (11) 
 
Mannheimia ruminalis strain HPA98; CCUG38466 16S 
ribosomal RNA gene, partial sequence 99  
Haemophilus 
paragallinarum Mannheimia sp. 
 
Mannheimia ruminalis strain HPA98; CCUG38466 16S 
ribosomal RNA gene, partial sequence 99    
V1-72-1 (23) 
 
Mannheimia sp. MCCM 00145 16S ribosomal RNA gene, 




Mannheimia ruminalis strain HPA98; CCUG38466 16S 





Mannheimia sp. MCCM 00145 16S ribosomal RNA gene, 
partial sequence 98  
Haemophilus 
paragallinarum Inconclusive 
 Haemophilus parasuis strain SC1401, complete genom 99    
V1-67-1 
 
Achromobacter xylosoxidans strain S3A 16S ribosomal RNA 
gene, partial sequence 100 
Achrobacter dentrificens 
(78.3%), Bordetella 
bronchohioseptica (18.3%)  Achromobacter sp. 
 
Achromobacter denitrificans strain 1104 16S ribosomal RNA 
gene, partial sequence 100    
V1-27-2 
 
Mannheimia sp. MCCM 00145 16S ribosomal RNA gene, 
partial sequence 
 100 
Pasteurella spp. (47.9%), 
Morexella spp. (25.6%), 
M. haem/B. trehalosi (12.1%)  Mannheimia sp. 
 
Mannheimia ruminalis strain HPA98; CCUG38466 16S 
ribosomal RNA gene, partial sequence 99    
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Table B.3: Variable region 16S rRNA gene sequence data from strains supplied by APHA for use in specificity panel testing. Sequences amplified using primer pair 337F & 
907R
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Table B.3 continued     






























equuli  99 








TGCCCTTGAGGCGTGGCTTCCGGAGCTAACGCGTTAAGTCGACCGCCTGGGGAGTACGGCCGCAAGGTTAAAACTC 528 Escherichia coli  100 
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Table B.3 continued     
































* Sequences shown are cleaned of primers and anomalies identified according to visualisation of chromatograms 
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Table B.4: Variable region 16S rRNA gene sequence data from strains supplied by APHA for use in specificity panel testing. Sequences amplified using primer pair 785F & 
1100R
APHA Strain ID Sequence* Length (bp) BLAST identity Identity (%)  

















haemolytica  100 

















haemolytica  100 
















suis  100 
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Table B.4 continued     
APHA Strain ID Sequence* Length (bp) BLAST identity Identity (%)  

























281 Streptococcus suis 
100 
Streptococcus pluranimalium 
APHA C06551 NA† NA† NA† NA† 




Sequencing the Mhae-SGR primer binding region of the Mannheimia spp. sodA 
gene 
Table B.5: DNA sequences relating to the reverse primer binding region of Mhae-SGR within the 
Mannheimia sodA gene 
Strain Sequence* 
M. haemolytica 33396 CAGGCGTTTCAGGCTATCCGATTTTAGTCTT 
M. haemolytica V1-53-2 CAGGCGTTTCAGGCTATCCGATTTTAGTCTT 
M. haemolytica V1-71-1 CAGGCGTTTCAGGCTATCCGATTTTAGTCTT 
M. haemolytica V1-37-1 CAGGCGTTTCAGGCTATCCGATTTTAGTCTT 
M. varigena APHA CAGGCTACCCAATTTTAGGTTTAGACGTGTG 
M. granulomatis CCUG 45422 T CAGGCTACCCAATTTTAGGTTTAGATGTTTG 
M. ruminalis CCUG 38470 T CAGGCTATCCGATTTTAGGCTTAGACGTTTG 
M. glucosida CCUG 38457 T CAGGCTACCCAATTTTAGGCTTAGACGTTTG 
M. glucosida CCUG 38459 CAGGCTACCCAATTTTAGGCTTAGATTGGGA 
M. glucosida CCUG  38460 CAGGCTACCCGATTTTAGGCTTAGACGTTTG 
M. glucosida CCUG 38467 CAGGCTATCCGATTTTAGGCTTAGACGTTTG 
*Sequences highlighted in yellow relate to the reverse compliment of the Mhae-SGR primer described 
by Guenther et al. [151] located within the Mannheimia sodA gene. Nucleotides highlighted in green 





Growth curves and best fit logistic curves for bacterial species in liquid culture 
 
 
Figure B.1: Growth curves in liquid culture for (A) H. somni, (B) M. haemolytica and (C) P. multocida. 
Observed points are shown as black circles. The best fit logistic curve for each species is shown in red. 
Estimated growth rates (µ) ∓ standard error, generation times ("), goodness of fit (σ) and degrees of 
freedom (df) are given for each species. Two points were removed during model fitting for M. haemolytica 
at 14 and 24 hours in late stationary phase, points not shown.   
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Inter- and intra-assay reproducibility: qPCR development 
For the three qPCR assays detecting H. somni, M. haemolytica and P. multocida the inter 
and intra-assay variability was calculated. Data are available at the University of Bristol 
data repository, data.bris, at https://doi.org/10.5523/bris.nyqkgnysra9q2ic5dok0swnbg. 
 
 
Table B.6: Within- and between-assay variance: PCR standard curves. 
Species Dilution %CV (w)* %CV (b)† 
P. multocida  1 3.78 0.00 
 2 2.53 0.00 
 3 2.23 1.63 
 4 1.23 1.40 
 5 1.34 0.00 
  6 1.67 1.26 
M. haemolytica 1 1.39 0.95 
 2 0.82 1.62 
 3 0.51 1.61 
 4 0.82 1.24 
 5 0.00 0.00 
  6 1.57 2.58 
H. somni 1 1.81 1.86 
 2 2.46 1.01 
 3 0.48 2.33 
 4 1.49 0.59 
 5 1.00 0.88 
 6 1.07 0.00 
  7 1.75 0.23 
* Within-assay variance: coefficient of variation between Cq values of 5 technical replicates at each 
dilution on the same day of testing. † Between-assay variance: coefficient of variation between Cq 
values of biological replicates performed on different days (duplicate for H. somni, triplicate for 
P. multocida and M. haemolytica) 
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Sequencing PCR products from H. somni, M. haemolytica and P. multocida PCR assays 




length  BLAST identity Identity (%)  
P. multocida ATCC® 43137 10-1 
dilution† 
TGGCTTGGCTGAGTTCGCTCGTAGAACAGCATGTGAACTATGTAAAACAGCTGAAGAG
CGCCA 63 P. multocida 100 
P. multocida ATCC® 43137 10-2 
dilution† TGAGTTCGCTCGTAGAACAGCATGTGAACTATGTAAAACAGCTGAAGAGCGCCA 54 P. multocida 100 




AGTGAGGTGTGAATATCTATAGTGACG 143 H. somni 96 





GAAAAATAAGGGCTTTCCCGCACTCTTTTAGTTTAAACGAGAAA 222 H. somni 98 




ACTTAAGTGAGGTGTGAATGAAA 140 H. somni 100 




TAATCGCCTTCCTTGATTCCAACCAT 145 H. somni 100 





GTTCACGCCAAAAC 191 M. haemolytica 98 
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length  BLAST identity Identity (%)  
H. somni, UoB, V1-48§ 
ACGTGACTAACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCGAGCGTTAATCGG
AATGACTGGGCGTAAAGGGCACGCAGGTGGTGACTTAAGTGAGGTGTGAATAAA 112 H. somni  100 
H. somni, UoB, V1-42§ 
ACGGAGGGTGCGAGCGTTAATCGGAATGACTGGGCGTAAAGGGCACGCAGGTGGTGA
CTTAAGTGAGGTGTGAAGACTTATTG 83 H. somni  100 
H. somni, UoB, V1-45§ 
CTTGCTACTCCGTGCCAGCAGCCGCGGTAATACGGAGGGTGCGAGCGTTAATCGGAAT
GACTGGGCGTAAAGGGCACGCAGGTGGTGACTTAAGTGAGGTGTGAACACCTTGTC 114 H. somni  98 
H. somni, UoB, V1-50§ 
CGCTCGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGTTAGCCGGTGCTTCTTCTG
TGATTATCGTCAATCAATTAATCTCTTAAACTAATCGCCTTCCTGATCG 108 H. somni  99 
H. somni, UoB, V1-9§ GTTTCTTCTGTGATTATCGTCAATCAATTAATCTCTTAAACTAATCGCCTTCCTCGTA 58 H. somni  100 
H. somni ATCC® 43625 10-2 
dilution‡ 
GCTACGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGTTAGCCGGTGCTTCTTCTG
TGATTATCGTCAATCAATTAATCTCTTAAACTAATCGCCTTCCTGATT 107 H. somni  98 
H. somni ATCC® 43625 10-3 
dilution‡ 
AGCTCGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGTTAGCCGGTGCTTCTTCTG
TGATTATCGTCAATCAATTAATCTCTTAAACTAATCGCCTTCCTCGAC 107 H. somni  100 
H. somni ATCC® 43625 10-4 
dilution‡ 
ATTGCGCTCGCACCCTCCGTATTACCGCGGCTGCTGGCACGGAGTTAGCCGGTGCTTCT
TCTGTGATTATCGTCAATCAATTAATCTCTTAAACTAATCGCCTTCCTCGAT 111 H. somni  100 
* Sequences shown are cleaned of anomalies identified according to visualisation of chromatograms 
† Reference strain dilution of qPCR standard curve 
‡ Reference strain dilution of overnight culture used to generate qPCR positive controls 
§ Bovine nasal swabs collected from healthy calves on the North Wyke Farm Platform and determined H. somni positive by the qPCR assays described in this chapter 
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Appendix C  
Effect of pen and barn on bacterial carriage rates 
Differences in the carriage of Histophilus somni and Pasteurella multocida between 
animals in pens within two barns was investigated prior to combination of animals into 
one cohort (n = 60) for survival analyses. For both bacterial species, datasets were 
constructed by counting the number of calves positive and negative for carriage 
(response) for each pen within each barn. General linear models with a Poisson error 
distribution and log-link function were fitted using the base ‘glm’ function of R version 
3.5.0.  
 
A sequence of nested multi-level models were built from the baseline model (M0); 
response of carriage plus main effect of barn and nested effect of pen within barn. Two 
additional models were considered: M1 = baseline (M0) plus the effect of barn on 
carriage; and M2 = model M1, plus the effect of pen nested within barn on carriage. The 
impact of additional terms included in a more complex model was assessed by comparing 
the change in residual deviance from a nested, simpler model with the upper-tailed 
critical value (p < 0.05) of the appropriate chi-squared distribution (as identified by the 
change in the residual degrees of freedom between the models).  
 
There was no evidence for differences in carriage rates between barns for P. multocida 
on any sampling occasion (Day 0, p = 0.549; Day 33, p = 0.487; Day 47, p = 0.824; Day 
62, p = 0.0617; Day 75, p = 0.174). No evidence for barn differences were found for  
H. somni on Day 0 (p = 0.0693) or day 47 (p = 0.0979), but evidence was found on Day 
33 (p = 0.001), Day 62 (p < 0.001) and Day 75 (p < 0.001). Differences in carriage rates 
between pens were found on two occasions only: H. somni on Day 47 (p = 0.0178) and 
P. multocida on Day 62 (p = 0.0199). 
  
 258 
Interval-censored survival analysis 
Rules to define carriage episodes  
Interval-censored survival analysis was used to estimate the rate (‘hazard’) of clearance 
of bacterial carriage and the median duration of carriage. Models were fitted in R (version 
3.5.0) using the package icenReg [240]. 
The following definitions, rules and assumptions were applied: 
I) Carriage episode: a period where a calf is positive for H. somni or P. multocida. 
A period may span multiple visits/observations if carriage is detected 
consecutively without interruption. If carriage is interrupted, i.e. lost and then re-
acquired, the period following re-acquisition of carriage constitutes a new 
carriage episode.  
II) The covariates, sex and density when first positive, were assumed to be time-
invariant.  
III) The maximum possible duration of carriage was from the first carriage-positive 
visit to the day before the first following carriage-free visit. 
IV) The minimum possible duration of carriage was set from the first to the last 
positive visit in the series, assuming carriage was uninterrupted between visits. 
V) If the episode was interrupted by one or more missed visit’s then the minimum 
duration was up to the last positive visit before the first missed one. 
VI) If the last positive visit was the calves last visit in the study, then the duration was 
right-censored at 365 days (otherwise it would have been infinite). 
Follow-up was interrupted by one missed visit for one calf (ID 23, Day 47).  This missed 
visit interrupted a carriage-free episode and therefore it was not necessary to define a 
carry-free interval. Recurrent-episodes of carriage and non-carriage were distinguished 
for each calf when observed, for example episode 1, 2 and 3. No more than 3 episodes 





Datasets were constructed prior to analysis in R. Briefly, minimum and maximum 
carriage intervals were defined for each possible carriage permutation using the rules 
outlined above and inputted into a VLOOKUP table in Microsoft® Excel. There were 32 
different carriage scenarios possible.  
Carriage or no carriage for each animal at each visit was coded as either 1 or 0 
respectively. This resulted in each animal having a five-digit binary number representing 
their carriage on each visit of the study. Similarly, all possible carriage permutations (n 
= 32) were coded as a five-digit binary number, with each binary number corresponding 
to its decimal number (from 0 to 31); creating a code. This decimal code was inputted 
into the same VLOOKUP table and corresponded to a defined carriage interval, allowing 
future lookup of any given carriage permutation from an animal. 
 
Support for underlying exponential distribution 
 
 
Figure C.1: Clearance of Histophilus somni carriage in the nasal passages of 29 calves completing 5 visits, 
carriage determined by qPCR on collected short nasal swabs (Cq ≤ 35). Nasal swabs collected at days 0, 
33, 47, 62 and 75 (Day 0 = visit 1). The natural logarithm of the proportion of calves remaining positive at 




Figure C.2: Clearance of Pasteurella multocida carriage in the nasal passages of 29 calves completing 5 
visits, carriage determined by qPCR on collected short nasal swabs (Cq ≤ 35). Nasal swabs collected at 
days 0, 33, 47, 62 and 75 (Day 0 = visit 1). The natural logarithm of the proportion of calves remaining 
positive at each visit was plotted and checked for linearity (Adjusted R2 = 0.912).  
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Assessment of pasture and silage quality: 2015 born cohort 
To investigate the similarity of feed type between the three barns (farmlets) forage quality 
assessments for each farmlet were compared. Although the study in this chapter reports 
bacterial carriage for animals housed in the Green and Red barn, the Blue is presented 
for completeness. The metabolisable energy (ME) and crude protein (CP) of pasture and 
silage samples collected in 2015–2016 for each farmlet is shown in Table . ME and CP 
were similar between farmlets for both forage types with small numerical differences 
observed. ME was higher in pasture (12.1–12.2) compared to silage (10.1–10.3). 
Similarly, CP was higher in pasture (17.4–20.7) compared to silage (8.7–12.8) and was 
observed over a greater range compared to ME.  
 
Table C.1: Mean metabolisable energy and crude protein of pasture and silage samples collected between 
April 2015 to March 2016 on the North Wyke Farm Platform 
Sample type   Variable  Farmlet N Mean  Standard deviation  
Pasture ME Blue 33 12.2 0.69 
  
Green 42 12.2 0.49 
  
Red 33 12.1 0.57 
 
CP  Blue 33 20.1 3.13 
  
Green  42 20.7 1.25 
  
Red 33 17.4 1.73 
Silage ME Blue 29 10.1 0.20 
  
Green 29 10.3 0.27 
  
Red 29 10.1 0.31 
 
CP  Blue 29 8.7 0.58 
  
Green  29 12.8 0.70 









ME was similar between farmlets for pasture samples (p = 0.444; Figure C.3 panel a and 
b), but it did differ significantly for silage (p = 0.008): ME of silage was significantly 
higher in the Green farmlet compared to the Blue (p = 0.018) and Red (p = 0.042) (Figure 
C.4, panel a). CP was significantly lower (p < 0.001) in the Red compared to Blue (p = 
0.003) and Green (p < 0.001) farmlet pasture samples (Figure C.3, panel c); temporal 
trends were similar up August 2015, thereafter greater differences between farmlets were 
observed (Figure C.3, panel d). Conversely, for silage, CP was consistently lower in the 
Blue farmlet (Figure C.4, panel c and d) and differed significantly from both Green and 
Red farmlets (p < 0.001).  
 
 
Figure C.3: Analysis of pasture samples collected between April 2015 to October 2015 for Blue, Green 
and Red farmlets. Metabolisable energy shown in panels a and b; crude protein is shown in panels c and 




Figure C.4: Analysis of silage samplescollected between October 2015 to March 2016 for Blue, Green and 
Red farmlets. Metabolisable energy is shown in panels a and b; crude protein is shown in panels c and d. 
Outlier samples are shown by grey dots (panel a and c). Error bars represent standard error of the mean. 
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Carriage rates of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida 
Table C.2: Histophilus somni, Mannheimia haemolytica and Pasteurella multocida nasal carriage rates determined by qPCR  
 Histophilus somni carriage Mannheimia haemolytica carriage Pasteurella multocida carriage 
Day n/N CI95%* n/N CI95%* n/N CI95%* 
0 29/60 0.354 – 0.615 8/60  0.063 – 0.251 57/60  0.852 – 0.987 
33 22/60 0.249 – 0.502 6/60  0.041 – 0.212 50/60  0.710 – 0.913 
47 13/59 0.127 – 0.351 2/59  0.006 – 0.127 44/59  0.613 – 0.846 
62 8/60 0.063 – 0.251 0/60  0.000 – 0.075 37/60  0.482 – 0.736 
75 8/60 0.063 – 0.251 1/60  0.001 – 0.101 39/60  0.515 – 0.766 
* Confidence intervals for single proportions calculated using the Wilson score 
 
Co-carriage rates of Pasteurellaceae 
Table C.3: Co-carriage of Pasteurellaceae in the nasal passages of healthy calves determined by qPCR 
 
H. somni and  
P. multocida carriage 
M. haemolytica and P. multocida 
carriage 
M. haemolytica and H. somni 
carriage 
H. somni, M. haemolytica and 
P. multocida carriage 
Day n/N CI95%* n/N CI95%* n/N CI95%* n/N CI95%* 
0 28/60 0.339–0.599 8/60 0.0634–0.251 3/60 0.0130–0.148 3/60 0.0130–0.148 
33 20/60 0.220–0.468 6/60 0.0413–0.212 1/60 0.000871–0.101 1/60 0.000871–0.101 
47 9/59 0.0763–0.275 2/59 0.00589–0.127 0/59 0–0.0762 0/59 0–0.0762 
62 7/60 0.0521–0.232 0/60 0–0.0750 0/60 0–0.0750 0/60 0–0.0750 
75 5/60 0.0311–0.191 1/60 0.000871–0.101 0/60 0–0.0750 0/60 0–0.0750 
* Confidence intervals for single proportions calculated using the Wilson score 
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Appendix D 
Covariate based constrained randomisation  
Allocation of calves to three clusters (barns) involved balancing three categorical 
variables (breed, sex and sire) and three continuous covariates (age, weaning weight, 
average daily growth rate) across the three clusters. Given the 2016 calf crop 
characteristics, 7 groups of breed/sex/sire combinations were possible: -  
1. 6 ST Steers - 2 to each farmlet 
2. 7 LIMX Steers - 3 to one farmet, 2 to the other two 
3. 5 LIMX Heifers - 1 to one farmlet (linked to 3 above), 2 to the other two 
4. 28 CHX (Other) Heifers - (10, 9, 9) allocation to farmlets 
5. 16 CHX (Other) Steers - (5, 6, 5) allocation to farmlets 
6. 10 CHX (400250) Heifers - (3, 3, 4) allocation to farmlets 
7. 15 CHX (400250) Steers - 5 to each farmlet 
 
 
Log-linear models for vertical analysis of bacterial carriage 
 
Construction and sequence of log-linear models  
A sequence of nested models was built by adding explanatory variables to the baseline 
model until the saturated model, which included all explanatory variables and the 
interactions between them was reached. The baseline model consisted of the response 
(count of calves with bacterial carriage) plus the combinations of explanatory variables. 
To this baseline model, the explanatory variables of prior carriage at day of vaccination, 
treatment (vaccine/control), and farmlet nested within treatment were added. 
Dependence and independence between explanatory variables was assessed by inclusion 
of an interaction term, or lack of, respectively. The sequence of nested models and the 
comparisons between competing models is shown in Table D. D.1. 
 
Log-linear model selection for evaluation of the association between carriage and 
explanatory variables  
The effect of vaccination and prior carriage was estimated from either Model 1, 2 or 3 
based on comparisons between nested models. The impact of additional terms between 
competing models was assessed by comparing the change in residual deviance with the 
 266 
upper-tailed critical value (p < 0.05) of the appropriate chi-squared distribution (as 
identified by the change in the residual degrees of freedom between the models). If the 
impact of additional of terms was significant, then the coefficients relating to explanatory 
terms from the complex model were evaluated. If additional terms were not significant, 
the simpler, parsimonious model was evaluated i.e. Model 1 for prior carriage and Model 
2 for treatment. To assess for differences in the level of carriage between clusters in the 
same intervention phase, Model 5 was compared to Model 2 (Table D.1) Model fit was 
assessed by comparing the fitted counts to observed counts and observing the residual 
deviance in relation to the residual degrees of freedom.  
 
Table D.1: Sequence of log-linear models used for vertical analysis of bacterial carriage at each crossover 
point of the stepped wedge trial 
Model  Model structure Description  
Model 
Comparison 
M0 Count ~ R + P * (T1/T2) Baseline: Defines overall structure of the data  
M1 M0 + R * P Does carriage depend on prior carriage? M1 vs M0 
M2 M0 + R * T1 Does carriage depend on treatment? M2 vs M0 
M3 M0 + R * P + T1 Does carriage depend on prior carriage and vaccination, but independently? 
M3 vs M1; 
M3 vs M2 
M4 M0 + R * P * T1 Does carriage depend on prior carriage and vaccination, but dependently? M4 vs M3 
M5 M0 + R * (T1/T2) 
Does carriage depend on variation 
between the two clusters in the same 
treatment phase? 
M5 vs M2 
M6 M0 + R * P + (T1/T2) 
Does carriage depend on prior carriage 
and the additional, independent effect of 
variation between the two clusters in the 
same treatment phase? 
M6 vs M5 
M7 M0 + R * (P+T1/T2) + (P * T1) Combines models 4 and 6 to provide the saturated model 
M7 vs M4; 
M7 vs M6 
M8 M0 + R * P * (T1/T2) Saturated: describes perfectly any set of expected frequencies M8 vs M7 
Notation: - 
R: response of carriage either 2- or 4-weeks post vaccination; P: prior carriage at day of vaccination; 
T1: treatment (vaccine/control); T2: cluster (blue/green/red) 
+ denotes an additive effect 
* denotes an interaction effect 
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Assessment of pasture and silage quality: 2016 born cohort 
The metabolisable energy (ME) and crude protein (CP) of pasture and silage samples 
collected in 2016–2017 for each farmlet is shown in Table D.2. For both pasture and 
silage samples ME and crude protein CP values were similar between farmlets (Table 
D.2). Silage fed to animals housed during the stepped wedge study was divided based on 
its storage, either in a bale or clamp. ME was similar between bales and clamp storage; 
however, CP was higher in bales. ME was marginally higher in pasture compared to 
silage. Similarly, CP was higher in pasture compared to silage.  
 
There was little evidence to suggest a difference between ME of farmlet pasture samples 
(Figure D.1a; p = 0.060). However, there was strong evidence to suggest that the CP of 
pasture was significantly different (Figure D.1c; p = 0.00387) between farmlets, with 
both Blue (p = 0.0206) and Green (p = 0.0075) significantly higher than Red; however, 
numerically differences were small (Table D.2). Greater temporal variation was seen for 
pasture ME compared to CP (Figure D1b and D.1d). Over the summer months CP 
increased and peaked in August (Figure D.1d). There was moderate evidence to suggest 
a difference in ME of bale silage samples (Figure D.2a, top panel; p = 0.0430) between 
farmlets, with Blue significantly higher than Green (p = 0.0193). There was strong 
evidence to suggest a difference in the ME of clamp silage samples (Figure D.2a, bottom 
panel, p < 0.001), with the mean ME of each farmlet significantly different from each 
other (p < 0.001). There was evidence to suggest a difference in CP of bale silage samples 
(p = 0.0337), with Blue higher than Green (p = 0.0674) and Red (p = 0.218). For clamp 
silage samples, there was strong evidence for a difference in CP between farmlets 
(p < 0.001), with the mean CP of each farmlet significantly different from each other 
(p < 0.001). Mean CP for the Blue and Red farmlets was higher in silage from bales 
compared to the clamp (Table D.2).  
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Table D.2: Mean metabolisable energy and crude protein of pasture and silage samples collected between 
May 2016 to April 2017 on the North Wyke Farm Platform 
Farmlet Sample Variable * Mean Standard deviation  N 
Blue Pasture ME 12 0.407 20 
Green Pasture ME 11.8 0.243 20 
Red Pasture ME 11.7 0.356 20 
Blue Pasture CP 22.8 3.45 10 
Green Pasture CP 23.1 3.17 10 
Red Pasture CP 20.5 3.98 10 
Blue Silage (Bale) ME 10.8 0.320 9 
Green Silage (Bale) ME 10.6 0.320 14 
Red Silage (Bale) ME 10.7 0.00952 7 
Blue Silage (Bale) CP 17.6 3.8 9 
Green Silage (Bale) CP 15.2 1.14 14 
Red Silage (Bale) CP 14.4 0.567 7 
Blue Silage (Clamp) ME 10.8 0.187 23 
Green Silage (Clamp) ME 11.2 0.072 18 
Red Silage (Clamp) ME 10.6 0.206 25 
Blue Silage (Clamp) CP 11.1 1.27 23 
Green Silage (Clamp) CP 15.82 0.383 18 
Red Silage (Clamp) CP 12.9 0.548 25 




Figure D.1: Analysis of pasture samples collected between May to October 2016 for Blue, Green and Red 
farmlets. Metabolisable energy is shown in panels a and b; crude protein is shown in panels c and d. Error 




Figure D.2: Analysis of silage samples collected between September 2016 to April 2017 for Blue, Green 
and Red farmlets. Metabolisable energy is shown in panels a and b; crude protein is shown in panels c d. 
Outlier samples are shown by grey dots (panel a and c). Error bars represent standard error of the mean 
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